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ABSTRACT.
1-Deoxynojirimycin (DNJ) is a 1-deoxy-glucose analogue and 
glucosidase inhibitor which has also been found to inhibit 
replication of Human Immunodeficiency Virus.
It is known to be produced by several strains of Streptomyces 
lavendulae and in the present study, Streptomyces subrutilus 
445 has also been identified as a producer of DNJ and the 1- 
deoxy-mannose analogue, 1-deoxymannojirimycin (DMJ). DNJ can 
be assayed in fermentation samples by virtue of its 
inhibition of pig kidney trehalase, after the removal of the 
interfering inhibitor no j irimycin by a heat and acid 
treatment. DNJ and nojirimycin inhibit this trehalase with Ki 
values of 3.43 x 10-6 and 2.6 x IO"5 M respectively.
The production of DNJ in defined media is subject to 
supression by glucose and phosphate. Addition of ammonium 
sulphate to the cultures also inhibits DNJ production 
although it is unclear whether this is purely a supressive 
effect. Glucose and starch are the best carbon sources and 
proline the best nitrogen source in defined media containing 
only one major carbon and one major nitrogen source.
Glucose is the biosynthetic precursor to both DNJ and DMJ and 
a pathway is proposed which involves a glucose to fructose 
isomerisation, an inversion of the sugar backbone, and an 
epimerisation of nojirimycin B to nojirimycin.
ABBREVIATIONS.
GlC Glucose.
Man Mannose.
NAG N-Acetyl glucosamine.
AZT 3'-Azido-3 * deoxythymidine.
M Molar.
mol Moles.
Ki Inhibition constant.
Km Michaelis constant.
HPLC High Performance Liquid Chromatography.
GC Gas Chromatography.
U Units.
1 Litres.
m Metres.
min. Minutes.
rpm. Revolutions per minute.
h Hours.
9 Grams.
t.l.c. Thin Layer Chromatography.
rf. Relative flow-rate.
ft. Feet.
nmr Nuclear Magnetic Resonance.
ATCC American Type Culture Collection.
°C Degrees Celsius.
ppm Parts per million.
PPGpp Guanosine 3 'diphosphate 5 'diphosphate.
PPPGpp Guanosine 3'-diphosphate 5'triphosphate.
cfu Colony forming units.
ATP
t
Tris 
EDTA 
RAS S
Adenosine 5 ' -triphosphate.
Time.
Tris (hydroxymethyl ) aminomethane. 
Ethylenediaminetetraacetic acid.
Reduced arginine, starch and salts medium. 
Ethyl methane sulphonate.EMS
'Under the most rigorously controlled 
conditions of temperature, pH, aeration, 
and nutrient concentration, the organism 
will do as it damn well pleases."
S.J. Hochauser, 1983.
CHAPTER 1. INTRODUCTION.
1.1. 8TRBPTOMYCBS.
Streptomyces, a genus of the Actinomycetes, are Gram positive 
filamentous bacteria which are found ubiquitously in soil 
(Kutzner, 1981) and have also been isolated from fresh water 
(Burman, 1973) and marine (Okazaki and Okami, 1976) 
environments. Streptomyces are highly adapted to their 
natural environment, being able to utilise a wide range of 
carbon sources and withstand long periods of adverse 
conditions such as frost, drought and flooding. Their life 
cycle, shown in Figure 1.1., involves much differentiation, 
resulting in the development of a mycelium of hyphae and the 
subsequent production of spores which are desiccation but not 
heat resistant. This enables them to cope with the range of 
conditions that they are likely to meet in their natural 
environment.
A few Streptomyces species, such as S .scabies which cause 
common scab disease of potatoes are pathogenic (Kutzner, 
1981), but the industrial importance of this group of 
organisms lies in their ability to produce a large number of 
structurally diverse secondary metabolites.
1
Figure 1.1. Life cycle of St rep t o/nyces. (Taken from Gratae, 
1989) .
1.3. SECONDARY METABOLITES AND THEIR ROLE IN THE 
PRODUCING ORGANISM.
The metabolic pathways of organisms such as the 
Streptomycetes can be divided up into so-called primary and 
secondary metabolism. Whereas primary metabolism consists of 
reactions which are essential for the cell, such as those 
involved in respiration, protein synthesis and DNA
2
replication, the reactions and products of secondary 
metabolism are not vital for the survival and replication 
of the cell. In nature secondary metabolism is confined to 
only a few taxonomic groups, most notably the higher 
plants, the fungi and the Actinomycètes. Of the 
Actinomycètes, the Streptomyces genus is especially 
productive. A recent estimate states that out of 6152 known 
secondary metabolites from Actinomycètes, 4876 are produced 
by members of the Streptomyces genus (Goodfeliow and 
O'Donnell, 1989). Many secondary metabolites have been 
found to be active as antibacterial or antifungal agents 
and the exploitation of these and other non-antibiotic 
secondary metabolites by man will be discussed later.
The products of secondary metabolism are structurally 
diverse and aspects of the genetics and biochemistry of 
their production have been studied. Their function and 
evolution in the producing organism is generally poorly 
understood although the large amount of genetic material 
and energy required to make them bears testament to their 
value to their producers.
Zahner has proposed (Zahner et al., 1982b, Zahner et al., 
1983), that secondary metabolism acts as a stage for the 
random generation of new metabolites in an organism. If the 
new metabolite is advantitious to the organism, the ability 
to make it will be maintained in the organism and if it is 
harmful, then it will be lost. If the product is neither of 
these, then the ability to make the metabolite may be
3
maintained long enough for another step to be added onto the 
pathway thereby making another product which might find a use 
in the producing organism.
The genetic instability seen in Streptomyces genes (Cullum et 
al., 1989; Mathumathi et al., 1990; Demuyter et al., 1991) 
involves the deletion and amplification of pieces of the 
genome and might provide a mechanism for the evolution of 
such pathways. Indeed, homology between the genes for two 
distinct amidino transferases involved in the biosynthesis of 
streptomycin, and isopenicillin N synthetase and the 
expandase catalysing consecutive steps in the biosynthesis of 
(5-lactams in Cephalosporium acremonium and Streptomyces 
clavuligerus (Hunter and Baumberg, 1989) might be seen as 
evidence for the involvement of amplification followed by 
divergent evolution of these genes to produce the pathways as 
they exist today. Evolution of the same genes in different 
organisms to produce enzymes with slightly different 
substrate specificities or activities might explain the 
occurrence of different, yet structurally related, 
metabolites in different species. During the evolution of 
pathways to secondary metabolites it would be important to 
produce a gene with a resistance capability, although this 
might originally have been only a secondary function prior to 
the inclusion of a step producing an antibiotic product. The 
existence of resistance genes which also play a biosynthetic 
function and ones acting by the modification of the 
antibiotic (Cundliffe, 1989) tallies well with this
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evolutionary path but another route must be hypothesised for 
those using other mechanisms, such as the modification of a 
target site.
It has been suggested that antibiotic production pathways are 
very old and that they have originated from ones in primary 
metabolism (Piepersberg, 1991). Evidence for this origin is 
clear in the case of the biosynthesis of polyketides. The 
process is catalysed by an enzyme system which has a lot of 
similarities, both in the reactions catalysed and in the 
enzyme components catalysing them to the Type II fatty acid 
synthetases seen in the prokaryotes (Hunter and Baumberg,
1989) .
The horizontal transfer of genes involved in secondary 
metabolism, was also hypothesised by Zahner (Zahner et al., 
1982). There is evidence for the transfer of genetic material 
between organisms which live in close contact in the soil, 
such as actinomycetes, fungi and higher plants. For example, 
P-lactam antibiotics are found in both Streptomyces and fungi 
such as Cephalosporium and the biosynthetic pathway is the 
same in both groups. The genes for lactam biosynthesis in 
both Streptomyces and fungi are clustered (Smith et al.,
1990) and very close homology between isopenicillin N 
synthetase genes from the different groups of producers also 
suggests a common ancestry (Weigel et al., 1988). In the case 
of higher plants, deoxynojirimycin and deoxymannojirimycin, 
which are both made by Streptomyces lavendulae (Ezure et al., 
1985; Ezure et al., 1988), are found in the roots of the
5
mulberry (Yagi et al., 1976) and in the tropical bean 
Lonchocarpus sp. (Fellows et al., 1979) respectively. It 
appears more likely that the wide distribution of the same 
metabolite between species or genera has occurred through the 
evolution of the ability to produce that metabolite in one 
organism and then its transfer to and propagation in other 
organisms rather than the de novo generation of that 
capability in all those different organisms.
The maintainence of the highly organised and often intricate 
pathways of secondary metabolism implies that the metabolites 
and\or the pathways themselves have some function in the 
producing organism. Many people have tried to determine what 
this may be. Initially, ideas were based around a single 
function encompassing all secondary metabolites, eg. as 
storage products. In 1961, Bu'lock (Bu'lock, 1961) suggested 
that secondary metabolic pathways, rather than their 
products, were of importance to the cell, providing a 
mechanism by which the primary metabolism can be kept 
"ticking over" whilst the normal growth of the cell is 
arrested, perhaps due to nutrient limitation. By functioning 
so as to provide a slow supply of energy and intermediates to 
the secondary metabolism, the primary metabolic pathways will 
be maintained in better order to resume normal function when 
conditions for vegetative growth are restored (Woodruff, 
1966).
However, it seems plausible now that a whole series of 
functions are carried out, with different functions being
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fulfilled by different metabolites. These functions may 
include acting as storage products, detoxification products, 
shunt metabolites, and providing defense against predators 
and advantage over competitors at times when they are 
especially vulnerable such as sporulation. Some may also act 
to control differentiation events, sequester minerals from 
the soil and as pathogenic and symbiotic agents (Demain, 
1989b; Vining, 1990).
1.3. SECONDARY METABOLITES AND MAN.
Although the role(s) of secondary metabolites in the 
producing organism remain unclear, their bioactivity is being 
successfully expoited by man. Plant extracts have been used 
in healing for many centuries and some metabolites from 
plants, such as codeine and quinine, are still used in 
medicine today. This section will concentrate on those 
secondary metabolites produced by microorganisms for which 
man has found a use.
Programs screening fermentations, usually of fungi or 
actinomycetes, against an identified target such as a 
particular pathogen or an enzyme involved in a key step in 
the development of a disease may highlight an active 
compound. These active compounds may themselves not be 
clinically useful agents, but their isolation and the
7
elucidation of their structure can provide a useful starting 
point for the chemical synthesis of a series of new 
compounds, structurally based on the natural one. The 
synthetic or semisynthetic analogues may possess greater 
activity and less toxicity than the original and therefore be 
more useful. Concern over the environmental effects of 
chemical pesticides and herbicides used in agriculture has 
led to an increase in the importance of finding microbial 
products, which are less environmentally damaging and can 
replace them.
Secondary metabolites produced by microorganisms can be 
divided into groups according to their structures. Table 1.1 
shows the main groups along with examples of commercially and 
medically important members of each group.
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METABOLITE APPLICATION
Streptomycin
(Streptomyces griseus)
Treatment of tuberculosis and urinary tract 
Infections.
Spectlnomycki
(S.spectabilis)
Treatment of gonorrhea.
Kanamycln
(S.kanamyceticus)
Infections by gram-negative bacteria.
Qentamyclns
(Micromonospora spp.)
Serious Infections by gram negative pathogens.
Hygromycln B
(S.hygroscopicus)
Antihelminth for swine.
NUCLEOSIDES
Nlkkomydna
(S.tendae)
Antifungal Insecticides.
Herblcldine Marble Idea.
Potyoxina
(S.cacaol)
Protection of fruit and vegetable crops against 
fungal diseases.
AAACBQUOES
Erythromycin
(Saccharopolyspora 
erythraea)
Used against grkm positive Infections 
especially W.egfonaMa endCNamidia.
Tyloaln
(Streptomyces frediae)
Growth promoter for pigs and poultry. 
Treatment of respiratory Infections tot animals.
Avermectlna
(S.evermitiHs)
Antlhehnlntha and Insecticides.
PEPTID ES
Phosphlnothrlcln
(S.viridochromogenes)
Herbicida, Inhibitor of glutamine synthetase.
Actlnomycln
(S.antibloticus)
Antitumor agent
Staphylomydn
(S.virginlae)
Peed additive for swine and pouRry.
Cyclosporin A
( Tolypoladium inf latum)
Immunoeuppressor used to prevent rejection 
of transplanted organa.
Bleomycin
(S.vertlclllua)
Cancer chemotherapy.
Table 1.1. Some applications of secondary metabolites.
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TETRACYCLINES
Chlortetracycline
(S.aureofadons)
Growth stimulant in animals and trsstment 
of Infections by gram positive cocci
Oxytetracycline 
(Streptomycas spp.)
Treatment of acne.
POLYENE«
Nystatin
(S.nourtei)
Candida Infsctiona of mucoua membranes
Candlckfln
(S.grlseus)
Candidal vaginitis.
Amphotericin •
(S.nodosus)
Savers aspergilliosis, hystoplasmosls 
and coccldloMomycotle
ANSAMYC1NS
Herblmyclna Fungicidal herbicides.
Rifampicin
(Derivative of rtfamycin 
from Nocardia)
Treatment of tuberculosis and leprosy.
ANTHRACYCUNE«
Adrtamydn 
(S.peocedus)
Chemotherapy for breast cancer and 
acuta leukemia.
Daunomydn
(S.peucetius)
Cancer chemotherapy.
POLYETHER«
Monenaln
(S. dnnamonensia)
Coccldoetat, Insecticide and growth 
promoter In ruminants.
Sallnomycln
(S lb u .)
insecticide and growth 
promoter In ruminants.
6-LACTAMS
Clavulanlc acid
(Sclavuligorus)
B-Lactamase Inhibitor used to enhance the 
effect of amoxycillin In the drug 'Augmentin'.
OTHER«
Cyctoeertne
(S to p to rrycf tpp.)
Treatment of tuberculosis.
Chloramphenicol
(S.vanezualaa)
Used againetSa/mone/ta, typhoid, bacterial 
meningitis and for opthalmologlcal Infections
Table 1.1. (continued)
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1.3.1. ANTIBIOTICS.
The first clinical use of an antibiotic, penicillin, was 
reported in 1941 (Abraham et al., 1941) and until fairly 
recently, the main thrust of the search for new microbial 
products was still centered around the discovery of 
antimicrobial or antifungal agents. The large number of 
antibiotics found and amount of knowledge accumulated about 
them bears testament to the importance placed on them. 
Antibiotic compounds produced by microorganisms show enormous 
structural diversity, ranging from small, low-molecular 
weight molecules such as methylenomycin A (Haneishi et al., 
1974) to large macrolides and peptide antibiotics such as 
bleomycin (Crandall and Hamill, 1986). These metabolites are 
shown in Figure 1.2.
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HjC COOH
Methylenomycm A
Bleomycin
Figure 1.2.
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The usefulness of certain antibiotics in the treatment of 
infection lies in the fact that their target sites in the 
bacteria are not found in the host's cells. (3-Lactam 
antibiotics (eg. penicillins and cephalosporins), for example 
interfere with the bacterial cell wall biosynthesis and 
aminoglycosides such as streptomycin and kanamycin act by 
binding to the 30S subunit of bacterial ribosomes to cause 
interference to protein biosynthesis. As the eukaryotic cells 
of the host contain a different type of ribosome and do not 
need to have peptidoglycan in their cell walls, they are 
unaffected by the antibiotic whilst the bacterium is killed. 
Despite the number of clinically useful antibiotics already 
available, the search for new ones is still important due to 
the development of resistance to commonly used antibiotics 
amongst previously treatable pathogens.
1.3.2. N O N - A N T I B I O T I C  MIC R O B I A L  SECONDARY 
MBTABOLITBS.
Although the discovery of new antibiotics is still important, 
the realisation that microorganisms may be the source of 
pharmacologically useful but non-antibiotic metabolites has 
led to a targeted search for such compounds. The search 
starts with the identification of a target for the screen. 
This may be a particular receptor or enzyme playing a key 
role in some stage of disease development, or a viral life
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cycle. A screening system is then built around the target 
which needs to be selective, sensitive, high-throughput and 
preferably simple, cheap and amenable to automation. Some of 
the compounds shown up in such screens are already known 
antibiotics and some are new compounds which may or may not 
also show antibiotic activity. As mentioned before, these may 
be useful in their natural form, but may also serve as a 
starting point for the chemical synthesis of analogues for 
trial.
1.4. NITROGEN-CONTAINING GLYCOSIDASE INHIBITORS FROM 
PLANTS AND MICROORGANISMS.
1-Deoxynoj irimycin (DNJ) is one of a group of nitrogen- 
containing compounds which have been isolated from plants and 
microorganisms over the last 30 years. They have been found 
to be potent inhibitors of glycosidases and have attracted 
much interest due to these and their other properties, 
including antiviral and antineoplastic activities.
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1.3.1. HISTORY AND 8NZYMB INHIBITORY PROPERTIES.
1.3.1.1. NOJIRIMYCIN.
Nojirimycin, shown in Figure 1.3, (5-amino-5-deoxy-D-
glucopyranose) was first described in 1966 (Inouye et al., 
1966) and has been isolated from fermentations of 
Streptomyces lavendulae SF425, S . roseochiomogenes R468, 
S.nojiriensis SF426 (Ishida et al., 1967a), S.lavendulae ATCC 
31434 (Ezure et al., 1985) and S.ficellus Dietz sp. NRRL8067 
(Argoudelis and Reusser, 1976) as well as Bacillus 
amyloliquefaciens DSM7, B.polymyxa DSM365, B.subtilis DSM704 
and B.subtilis var. niger DSM675 (Schmidt et al., 1979). It 
was originally discovered on the basis of its antibiotic 
activity against a streptomycin and chloramphenicol resistant 
strain of Shigella flexneri (Nishikawa et al., 1965). 
Nojirimycin was also shown to be able to prevent rice plant 
disease caused by Xanthcunonas oryzae (Ishida et al., 1967b).
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Figure 1.3.
Nojirimycin is a structural analogue of glucose, see Figure
1.3. > and even shares some of its properties, for example, 
it will react with the enzymes glucose oxidase and glucose 
dehydrogenase (Muller, 1986) and will reduce Fehlings regent 
(Ishida et al., 1967a). Nojirimycin is reported to be 
unstable in aqueous solutions at neutral or acidic pH which 
lead to problems with early attempts at isolation (Ishida et 
al., 1967). However conversion to its more stable bisulphite 
adduct, shown in Figure 1.4, eases isolation and storage 
Nojirimycin has since been isolated more easily as its
6
bisulphite adduct (Argoudelis and Reusser, 1976; Inouye et 
al.. 1968).
CH2OH V " '
—  OH
soa- H O ----
•OH
HO NH3+
OH CH2OH
Cyclic form Open form
Figure 1.4.
The first report of the enzyme inhibitory properties of 
nojirimycin came in 1970. Prompted by an observation by 
Cleayssens and DeBruyne that D-xylose derivatives with ring 
sulphur or nitrogen atoms were capable of inhibiting some 
glycosidases (Cleayssens and DeBruyne, 1965), Niwa et al. 
looked for similar traits in nojirimycin. They found that (J- 
glucosidases from Trichoderma viride and apricot emulsin as 
well as Takadiastase and glucoamylase from Rhizopus niveus 
were inhibited by the nojirimycin (Niwa et al., 1970). Reese 
et al. expanded on these findings by studying the inhibition 
of various glycosidases by nojirimycin and its bisulphite
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adduct and found that exo-glucanases such as trehalase were 
less strongly inhibited than glucosidases were and that endo- 
glucanases including the a- and (1-amylases were not 
inhibited at all (Reese et al., 1971). The basis of the 
inhibition of these enzymes by nojirimycin lies in its 
resemblance to the glucose units in their substrates. The 
bisulphite adduct of nojirimycin is also able to inhibit 
glycosidases and has been shown to exist in a cyclic form 
(Kodama et al., 1985) like nojirimycin so that it too 
resembles glucose. However, although both nojirimycin and its 
bisulphite adduct are potent inhibitors of (3-glucosidases, 
nojirimycin has also been shown to inhibit a-glucosidase 
whereas the bisulphite adduct does so only very weakly 
(Kodama et al., 1985). This may be because whereas 
nojirimycin exists as a 60:40 mixture of a-:(l- epimers (Niwa 
et al., 1970) , the bisulphite adduct only exists, in aqueous 
solution as the (J-configuration (Kodama et al., 1985), and 
so cannot bind to and inhibit the a-glucosidase. Studies on 
the affect of pH on the potency of the inhibition by 
nojirimycin indicate that the inhibitor binds in its 
unprotonated form (Dale et al., 1985).
Other biological properties of nojirimycin include its 
ability to alter glycoprotein biosynthesis (Peyrieras et al., 
1983). In the presence of nojirimycin, a much shortened 
oligosaccharide chain is transferred to the glycosylation 
site of the protein (the biosynthesis of glycoproteins will 
be discussed in more detail later). Although the exact
18
mechanism is not known, nojirimycin itself may be transferred 
to the glycan and cap it so that only a truncated glycan is 
made (Peyieras et al., 1983)
1 . 4 . 1 . 2 .  N O J X R X M Y C X N  B .
Nojirimycin B (5-amino-5-deoxy-mannopyranose), shown in 
figure 1.5, is an analogue of mannose in the same way that 
nojirimycin is an analogue of glucose. It has been co­
isolated as its bisulphite adduct with nojirimycin from 
Streptomyces lavendulae SF425 and found to show weak 
antibiotic activity against Xanthomonas oryzae (Niwa et al., 
1984) .
H(
CHjOH
•OH
HC
CHjOH
•OH
Nojirimycin B Mannose
HC
HO ’N'
H
OH
>CH2OH HO' CHjOH
OH
Figure 1.5.
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Nojirimycin B inhibits emulsin (J-glucosidase with a 
comparable potency to nojirimycin. Nojirimycin B bisulphite 
adduct has been shown to be a stronger inhibitor of this 
enzyme than either of the native nojirimycins (Niwa et al.. 
1984) .
1.4.1.3 . CASTANOSPERMINE.
Castanospermine, (1R.6S,7R, 8 R , 8aR-tetrahydroxy- 
octahydroinolizine), was first isolated in 1981 from the seed 
of the legume Castanospermum australe, found in the rain 
forest of eastern Australia (Hohenschutz et al., 1981) and 
has since been isolated from the dried pod of another legume, 
Alexa leiopetala Sandwith, which comes from Guyana and 
several other members of this genus (Nash et al.. 1988).
The six-membered ring of castanospermine has three hydroxyl 
groups which have the same stereochemistry as the 
corresponding ones in glucose and nojirimycin. The hydroxyl 
group at C-l in glucose and nojirimycin is missing in 
castanospermine and the five membered ring acts like a bridge 
between the ring nitrogen and the C-6 of nojirimycin (see 
Figure 1.6).
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Castano spermine
Figure 1.6.
The enzyme inhibitory properties of castanospermine also 
resemble nojirimycin. It has been found to inhibit lysosomal 
a-glucosidase and P-glucosidases from almond emulsin a (Saul 
et al., 1983) and the bruchid beetle (Fellows, 1987). 
Castanospermine also inhibits Aspergillus P-xylosidase, P- 
glucocerebrodase (Saul et al., 1983), and a range of other 
a- and P-glucosidases including cockroach trehalase 
(Jahagirdar et al., 1990), amyloglucosidase (Saul et al..
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1984) and glucosidase I involved in glycoprotein processing 
(Pan et al., 1983, Hori et al., 1984, Szumilo et al., 1986a). 
Glucosidase II of glycoprotein processing is also inhibited 
by castanospermine, but to a lesser extent than glucosidase I 
(Pan et al., 1983, Kaushal et al., 1988).
Castanospermine has been identified as an antifeedant for 
aphids (Dreyer et al., 1985). This may be due to its 
inhibition of thioglucosidase from mustard and aphids 
(Schofield et al., 1990) which hydrolyses natural 
antifeedants produced by plants.
1.4.1.4 6 - EPICASTANOSPBRMINE.
6-Epicastanospermine (IS,6R,7R,8R,8aR-tetrahydroxy- 
octahydroindolizine) , shown in Figure 1.7, has also been 
isolated from Castanospermum australe. Like castanospermine, 
this compound was found to strongly inhibit amyloglucosidase 
but unlike castanospermine it also showed some activity 
against f3-galactosidase and only poor activity against 0- 
glucosidase and the glucosidases I and II of glycoprotein 
processing. Common with castanospermine, no inhibitory 
activity was observed against either o- or (J-mannosidases 
(Molyneux et al., 1986).
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6-Epicastano spermine
Figure 1.7.
1.4.1.5.SWAINSONXNB.
Swainsonine, (IS,2R,8R,8aR-trihydroxyloctahydroindolizine), 
shown in Figure 1.8, was first isolated in 1973 from the 
fungus Rhizoctonia leguminicola (Guengerich et al., 1973), a 
known producer of a similar alkaloid, slaframine, which is 
known to cause excess salivation in cattle (Aust et al., 
1966) . It has since been isolated from the Darling pea, 
Swainsona canescens, from Australia (Colegate et al., 1979) 
and two types of locoweed found in the U.S.A., Astragalus 
lentiginosus (Molyneux and James, 1982) and Astragalus 
emoryanus (Davis et al., 1984), all of which can cause 
poisoning of cattle. The symptoms of the poisoning are very 
similar to those of a condition found in man and other
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mammals called mannosidosis, caused by a genetic deficiency 
in the mannosidase enzyme (Davis et al., 1984). Swainsonine 
has also, more recently, been found in another fungus, 
Metarhizum anisopliae F3622 (Hino et al., 1985a).
Swainsonine
Figure 1.8.
Swainsonine has been shown to be the agent in Swainsona which 
is responsible for the cattle poisoning (Dorling et al. , 
1980). The similarity between this poisoning and mannosidosis 
is due to the inhibition of mannosidases by swainsonine, a 
potent and selective inhibitor of a-mannosidases from jack 
bean and lysosomal preparations (Dorling et al., 1980, 
Schneider et al., 1983, Colegate et al., 1979, Kang and 
Elbein, 1983a), and of the glycoprotein processing 
mannosidase II involved in the maturation of complex type 
glycans (Tulsiani et al., 1982). Swainsonine is not an 
inhibitor of 0 -mannosidase, or o -  and 0-glucosidases (Kang
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and Elbein, 1983a). The inhibition of mannosidase by 
swainsonine is competitive (Kang and Elbein, 1983a) involving 
the tight binding of the inhibitor, whose cationic form bears 
a strong resemblance to the mannosyl ion (Dorling et al., 
1980- see Figure 1.9) to the active site of the enzyme. 
Kinetic studies indicate that the inhibitor is removed, only 
slowly, from its binding site at high concentrations of 
substrate (Kang and Elbein, 1983a) .
Figure 1.9.
1.4.1.6. DBOXYNOJIRIMYCIN (DNJ).
1-Deoxynojirimycin (1,5-dideoxy-l,5-imino-D-glucitol) was 
first isolated from a natural source in 1976 when it was 
found in the roots of the mulberry. M oms sp. (Yagi et al., 
1976) . Prior to that date it had been synthesised through the 
catalytic hydrogenation of nojirimycin (Inouye et al., 1968)
OH
OH OH
Swainsonine cation Mannosyl cation
25
and since then it has been isolated from Bacillus subtilis 
(Schmidt et al., 1979), Streptomyces lavendulae (Murao and 
Miyata, 1980, Ezure et al., 1985) and another mulberry, Morus 
bombylis (Daigo et al.. 1986).
Figure 1.10.
DNJ is a structural analogue of 1-deoxy-glucose (see Figure
1.10) and it shows a similar range of enzyme inhibitory 
properties to nojirimycin. DNJ has been found to be a potent 
inhibitor of both a-and (3-glucosidases, trehalase, p -
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glucosidase (Murao and Miyata, 1980), aphid thioglucosidase 
(Schofield et al., 1990), invertase and exo-(J-l, 3-glucanase. 
This inhibitor can also effect the production of 
glycoproteins by inhibiting the glucosidases I and II of 
glycoprotein processing (Szumilo et al., 1986a, Saunier et 
al., 1982).
The inhibition by DNJ of a-glucosidase, an enzyme which is 
responsible for the final steps of carbohydrate digestion, 
has led to hopes that it might be useful in the treatment of 
diabetes mellitus. An analogue of DNJ, BAY m 1099 (Figure
1.11), has been observed to inhibit the post-prandial rise 
in glucose levels in non-insulin dependent diabetics without 
any adverse side effects (Joubert et al., 1986; Schnack et 
al.. 1986).
Figure 1.11.
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1.4.1.7. DEOXYMANNOJIRIMYCIN (DMJ).
dmj (1,5-dideoxy-l,5-imino-D-mannitol) has been isolated from 
the tropical legume Lonchocarpus sericeus in 1979 (Fellows et 
al., 1979) and also from cultures of Streptomyces lavendulae, 
which also produces DNJ (Ezure et al., 1988).
1 -Deoxymannojirimycin 
OH
H
1- Deoxy-mannose 
OH
Figure 1.12.
DMJ is an analogue of 1-deoxy-mannose (see Figure 1.12) which 
is reflected in its inhibition of a-mannosidases including 
the a-mannosidases IA and IB of glycoprotein processing
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(Fuhrmann et al., 1985, Evans et al., 1985), and also a-L-
fucosidase (Winchester et al., 1990). An early report that 
DMJ was an inhibitor of insect trehalase (Evans et al., 1983) 
was later shown to be due to contamination with another 
inhibitor, DMDP (Evans et al., 1985).
1.4.1.8 . 2R,5R-DIHYDROXYMETHYL- 3R,4R-DIHYDROXY-
PYRROLIDINE (DMDP).
DMDP, shown in Figure 1.13, was initially isolated from 
Derris elliptica in 1976 (Welter et al., 1976) and later from 
another tropical legume, Lonchocarpus sericeus, which also 
produces DMJ (Evans et al., 1985).
Hr
HOHgC'**’ CH2OH HOH2C'*‘' CH20H
N*
H
O'
DMDP Fructose
Figure 1.13.
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Structurally, DMDP is analogous to fructose and, in common 
with other compounds already described, is an inhibitor of a 
range of glycosidases. DMDP will inhibit a- and 
glucosidases (Fleet and Fellows, 1988; Evans et al. , 1985)
and others including trehalase, P-xylosidase, invertase 
(Evans et al., 1985), maltase (Fellows, 1987), 
thioglucosidase (Schofield et al., 1990) and o-mannosidases 
(Cenci di Bello et al., 1985). DMDP also interferes with 
glycoprotein processing by inhibiting the action of trimming 
glucosidase I (Elbein et al., 1984b) and has been found to 
act as an antifeedant against locusts. Locusts migratoria L. 
(Fleet and Fellows, 1988) and the bruchid beetle (Fellows, 
1987).
1.4.1.9. OTHERS.
The compounds described above have received considerable 
interest due to their potentially useful biological 
activities, which will be discussed later, but they are not 
the only glycosidase inhibitors produced by plants or 
microorganisms which are structural analogues of 
monosaccharides. Others in this class include the 
Streptomyces lydicus product galactostatin (5-amino-5-deoxy- 
D-galactopyranose) which inhibits {J-galactosidases from a
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range of sources (Miyake and Ebata, 1987), fagomine (1,2,5- 
trideoxy-1,5-imino-D-arabinohexitol) from buckwheat, 
Fagopyrum esculentum, which inhibits isomaltase, BRl (2S- 
carboxy-3R,4R,5S-trihydroxypiperidine) which is a |J- 
glucuronidase inhibitor from the legume Baphia racemosa, ABl 
(1,4-dideoxy-l, 4-imino-D-arabinitol) , the o-glucosidase 
inhibitor from another legume Anglocalyx boutiqueanus (Fleet 
and Fellows, 1988), and a third hydroxylated pyrrolizidine 
from Castanospermum auscra1e , called australine 
((lR,2R,3R,7S,7aR)-3-(hydroxymethyl)-1.2.7- 
trihydroxypyrrolizine), which is an inhibitor of 
amyloglucosidase and of glycoprotein processing glucosidase I 
(Tropea et al.. 1989). All of these compounds are shown in 
Figure 1.14.
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Figure 1.14.
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1.4.2. POTENTIAL MEDICAL AND SCIENTIFIC APPLICATIONS 
OF THE INHIBITORS.
Members of this family of glycosidase inhibitors are showing 
promise as tools in research in areas of biology and 
medicine. The specificity and potency of the inhibitors has 
led to their employment in studying the biological roles of 
the enzymes they inhibit and they have been especially useful 
in the study of the role of the glycan moieties of 
glycoproteins. The potential application of DNJ derivatives 
as antidiabetic agents has already been discussed and this 
and others of these inhibitors also showing promise as 
antiviral and antimetastatic agents.
1.4.2.1. BIOSYNTHESIS OF GLYCOPROTEIN GLYCANS.
The glycan moieties of glycoproteins are added co- 
translationally to asparagine residues in the polypeptide 
chain occurring in a specific sequence of four amino acids. 
The initial stage in the synthesis is the production of a 
lipid-linked oligosaccharide from which the GlC3Man9NAG2 
structure is transferred en bloc to the protein which is 
being threaded through the membrane of the rough endoplasmic 
reticulum into its lumen during its synthesis. The 
oligosaccharide then undergoes a series of trimming reactions
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to produce a finished glycan of either the complex or high- 
mannose type according to the glycoprotein being produced. 
These trimming reactions are shown in Figure 1.15.
The first enzymes to act on the structure are located in the 
rough endoplasmic reticulum membrane and are the trimming 
glucosidases I and II. Glucosidase I removes the terminal a- 
1,2-linked glucose residue from the structure and glucosidase 
II sequentially removes the next two a-l,3-linked ones. 
There is some evidence that a third glucosidase may also be 
capable of removing the third glucose (Fuhrmann et al., 
1985) . At this stage the glycan may stay as a high mannose 
type or undergo further processing which begins with the 
removal of four a-1,2- linked mannose residues. The first 
can be removed by an o-mannosidase in the endoplasmic 
reticulum but the rest of the processing takes place in the 
golgi where mannosidases 1A and IB are situated and are both 
capable of removing all four of the residues. Following the 
addition to the structure of an N-acetylglucosamine (NAG) 
unit, a further two mannoses are removed by the action of 
mannosidase II. A series of glycosyl transferases then 
elaborate the structure with galactose, sialic acid, NAG and 
fucose residues to produce the final complex glycan. Once the 
trimming reactions are complete, the glycoprotein leaves the 
golgi and is transported to its site of action eg. on the 
surface of the cell or excreted from it.
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The use of inhibitors of glycoprotein processing including 
DNJ, DMJ, swainsonine and castanospermine allow the specific 
modification of glycans so that the role of the glycan or 
individual parts of it can be studied have shown that the 
glycans of glycoproteins have a variety of roles. They can 
act to protect the protein from proteolysis, direct the 
cleavage of a larger precursor glycoprotein, modify the 
physical or biological properties of the protein, direct the 
protein to its correct location in the cell, and have also 
been shown to play a part in embryonic development, cell-cell 
interactions and differentiation (Olden et al., 1985). 
Glycans on different proteins may have different roles and 
the glycan moiety of a single glycoprotein may perform 
several functions.
The effect that these inhibitors have on the processing of 
glycoproteins is responsible for the antiviral activity shown 
by some of them.
1.4.2.2. ANTIVIRAL PROPERTIES.
In 1987, the first reports of DNJ and castanospermine acting 
as antiviral agents appeared. Three groups (Walker et al., 
1987; Tyms et al., 1987; Gruters et al., 1987) reported
activity against Human Immunodeficiency Virus (HIV), the 
causative agent in AIDS and a fourth reported their activity 
against another retrovirus, and HIV model, Moloney leukemia
virus (Sunkara et ai., 1987). DMDP was also initially 
reported to show activity against HIV replication (Tyms et 
al., 1987) but the inhibition of replication was later shown 
to be inseparable from the cytotoxicity of the compound 
(Karpas et al., 1988). In the first reports, DNJ and 
castanospermine were shown to inhibit the production of 
multinucleated cells, or syncitia, produced by the fusion of 
cells carrying the CD4 antigen in the presence of HIV or HIV 
infected cells in a process similar to that of the entry of 
the virus to the cell. They were also shown to reduce viral 
infectivity at non-cytotoxic concentrations. It is believed 
that their antiviral activity comes from their ability to 
alter the glycosylation of the HIV envelope glycoprotein 
gpl20. Gpl20 has 24 potential sites for N-glycosylation 
(glycosylation through an asparagine residue, as described 
earlier) and the glycans make up 50% of its molecular weight 
(Karpas et al., 1988). Most of the glycans on gpl20 exist as 
the high-mannose type (Shimizu et al., 1990).
The initial step in the infective cycle of HIV is the 
interaction between gpl20 and the CD4 antigen on the surface 
of some cells of the immune system. This leads to the 
internalisation of the virus by either endocytosis or fusion 
of the viral envelope and the cell membrane (Grewe et al., 
1990). The inhibition of syncitium formation by DNJ and 
castanospermine show that this interaction and fusion process 
is interfered with by these compounds. Gpl20 made in the 
presence of DNJ or castanospermine will have the three
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glucose residues normally removed by trimming glucosidases I 
and II still present. The terminal glucose residue appears to 
be the crucial one as bromoconduritol, an inhibitor which 
only inhibits glucosidase II, is inactive against HIV 
(Sunkara et al., 1987). The abnormal gpl20 produced in the 
presence of DNJ or castanospermine has been found to have a 
comparable affinity for CD4 to gpl20 to its normal glycan 
(Walker et al., 1987) so latter stages of the interaction 
such as the fusion of the membranes are affected by the 
change in the glycan, and not the initial binding to the 
receptor. It has recently been proposed that an alteration in 
the conformation of the V3 loop of gpl20 is induced by the 
alteration in its glycosylation. Cleavage of the V3 loop 
necessary for infection of the cell after gpl20-CD4 binding 
may be inhibited by this conformational change (Jones and 
Jacob, 1991). Reduced cleavage of the gpl20 and gp41 
precursor, gpl60 (Walker et al., 1987; Pal et al., 1989) and 
reduced surface expression of gpl20 (Walker et al., 1987) as 
is also seen with other surface glycoproteins in the presence 
of these inhibitors (Edwards et al. , 1989) may also 
contribute to the reduction of infectivity of the virus.
Since the discovery that castanospermine and DNJ are capable 
of reducing the infectivity of HIV, the synthesis of 
analogues with increased activity and reduced toxicity has 
been a major target. In 1988, a series of N-alkylated DNJ 
molecules were produced by Fleet et al. and tested against 
the virus (Fleet et al., 1988; Karpas et al., 1988). Of
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these, N-methyl DNJ, N-ethyl DNJ and N-butyl DNJ, all shown 
in Figure 1.16, were found to be particularly potent, 
reducing syncitium formation by 100% at non-cytotoxic 
concentrations (Fleet et al.,1988). Furthermore, prolonged 
incubation of HIV infected cells with N-butyl DNJ was found 
to result in the levels of the virus being reduced to 
undetectable levels and perhaps being eliminated from the 
cell culture (Karpas et al., 1988). N-butyl DNJ is undergoing 
clinical trials in the U.S.A. for possible use as an anti HIV 
drug.
Figure 1.16.
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In 1990, Shimizu et al. (Shimizu et al., 1990) reported the 
synthesis of some more ONJ derivatives, of which some were 
even more potent reducers of syncitium formation than N-butyl 
DNJ. These compounds showed no cytotoxicity at concentrations 
used and are shown in Figure 1.17.
Figure 1.17.
Although various inhibitors have been found to alter the 
pattern of glycosylation of surface glycoproteins of the 
influenza virus (Elbein et al.. 1984a; Pan et al., 1983), the 
vesicular stomatitis virus (Kang and Elbein, 1983b), Semliki 
forest virus, (Naim and Koblet, 1988), and fowl plague virus
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(Romero et al., 1983), the infectivity of each of these 
viruses remained unaffected by the changes. Castanospermine 
has, however, also been reported to reduce the infectivity of 
cytomegalovirus, as have DNJ and DMDP (Taylor et al., 1988), 
and prolong the survival of mice infected with Rauscher 
Murine Leukemia virus, though it was less effective and more 
toxic than AZT (Ruprecht et al., 1989). Glucosidase 
inhibitors also reduce the infectivity of Feline 
Immunodeficiency Virus (Stephens et al., 1991).
1 . 4 . 2 . 3 .  A N T I N B O P L A S T I C  A N D  I M M U N O M O D U L A T O R Y  
P R O P E R T I E S .
The oligosaccharide components of cell surface glycoproteins 
have been found to be altered from their normal forms when a 
cell becomes cancerous. In general, this alteration involves 
a change to a more highly branched and sialylated structure 
(Ogata et al., 1976; Pierce and Arango, 1986) and evidence 
suggests (Kerbel et al., 1987) that it may be involved in 
promoting the fast rate of growth in associated with cancer 
cells and later metastasis. Metastasis of cancers, the 
removal of cells from a primary tumor and their movement and 
colonisation of a secondary site, is the major cause of death 
in cancer patients and is much increased by surgery (Olden et 
al., 1988).
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These observations led to the testing of the effect of 
glycoprotein processing inhibitors on tumor growth and 
metastasis. In 1985, inhibition of pulmonary metastasis of 
B16 melanoma and growth of sarcoma 180 ascites tumor in mice 
by swainsonine was reported (Hino et al., 1985b) and a year 
later, both swainsonine (Humphries et al., 1986a) and 
castanospermine (Humphries et al., 1986b) were shown to 
inhibit the experimental metastasis of B16-F10 murine 
melanoma cells. They have also been shown to inhibit the 
proliferation of tumor cells (Hadwiger et al., 1986; Dennis 
et al., 1990). The anticancer effects of these compounds have 
been attributed to changes in the structure of glycoprotein 
glycans, in particular the loss of (1-1-6 branched complex 
type glycans (Yagel et al., 1989; Dennis et al., 1990). 
Alterations in the immunogenic properties of the altered 
glycoproteins may at least partly explain these properties of 
swainsonine and castanospermine. The antiproliferative effect 
of interferon was demonstrated to be enhanced by swainsonine 
treatment (Dennis, 1986) and later, glycosylation changes 
induced by swainsonine were found to make cancer cells more 
susceptible to interferon boosted natural killer cells 
(Ahrens and Ankel, 1987). The production of immunoglobulins 
(Karasuno et al., 1990) and activities of interleukin-1, a 
stimulator of many immune responses, and tumor necrosis 
factor (Muchmore et al., 1990) are also enhanced by changes 
in the oligosaccharides brought about by swainsonine. Also, 
an immunosuppression, caused by a protein factor, is often
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associated with cancer and was £ound to be reversed by 
swainsonine both in vitro and in vivo (Hino et al., 1985a; 
Hino et al., 1985b).
Inhibition of metastasis of B16-BL6 melanoma and M5076 
reticulum sarcoma tumor cells is not limited to 
experimentally simulated metastasis (Newton et al., 1989) but 
different types of metastatic cell lines are affected 
differently with respect to their ability to metastasise by 
different inhibitors of glycoprotein processing (Bruyneel et 
al., 1990). This indicates that although at this point only 
swainsonine and castanospermine are well characterised as 
inhibitors of cancer growth and metastasis in the relatively 
small sample of cancer cell lines studied so far, others in 
the group may yet be found to show similar effects in other 
types of cancers.
OBJECTIVES .
The aims of this project were to achieve a greater 
understanding of the biosynthesis of 1-deoxynojirimycin (DNJ) 
in Streptomyces.
One aim was to develop a more selective enzymatic assay 
system for DNJ than the ones used to date (eg. Stein et al., 
1984; Ezure et al., 1985), and to use this to screen for new 
producers and study the biosynthesis of DNJ in these
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organisms and in the known producer, Streptomyces lavendulae 
ATCC 31434.
The effects of different culture conditions and nutrients 
were also investigated in order to assess factors which play 
an important role in the regulation of DNJ biosynthesis.
The biosynthetic pathway of DNJ was also studied with the use 
of isotopically labeled precursor molecules.
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CHAPTER 2 ASSAY AND SCREENING.
2.1. INTRODUCTION.
METHODS FOR SCREENING AND ASSAYING MICROBIAL 
M E T A B O L I T E S .
The importance of a good assay in the study of the production 
of a secondary metabolite cannot be over emphasised. An assay 
should be sensitive, selective (ideally for a single 
metabolite), accurate, and, especially when many samples are 
to be assayed, preferably quick and inexpensive. The initial 
interest in a particular metabolite may arise from a positive 
hit in a screen and as the requirements for a good screening 
procedure are essentially the same as those for a 
quantitative assay, the former may be adapted to allow 
quantification of the metabolite. Although screening for a 
product can be carried out without any knowledge of the 
structure of the metabolite concerned, its quantification 
requires the purification of a sample for use as a standard 
in an assay.
Screening and assay methods can be grouped into a number of 
different classes, the most traditional of these being the 
antimicrobial bioassay. The antibiotic activity of many 
secondary metabolites makes them amenable to study by this
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kind of system which involves the use of a microorganism 
which is sensitive, or hypersensitive, to the compound 
concerned without being affected by other compounds made by 
the organism under investigation. Quantification may be 
carried out using the agar diffusion method, for example. 
This involves unknown samples as well as standard solutions 
of known concentrations being used to impregnate discs of 
paper. These are then laid on the top of an agar plate seeded 
with the sensitive organism or are put directly into wells 
cut in the agar. The zone size of non-growth around the well 
or disc can be used to establish the antibiotic titre by 
comparison to standards of known concentration. This method 
is used in the assay of many antibiotics.
Many secondary metabolites are capable of acting as enzyme 
inhibitors and can be assayed on the basis of this activity. 
The choice of enzyme is important where a compound is capable 
of inhibiting more than one. It must be inhibited strongly 
enough to provide a sensitive assay and should be selective 
for only the inhibitor of interest. The production of 
families of metabolites with similar chemical structures can 
lead to problems with selectivity as the biological activity 
of the compounds might also be similar. Finding an enzyme 
inhibited by only one of these can be difficult.
The problem of selectivity can be overcome by the use of 
combined separation and assay methods such as High 
Performance Liquid Chromatography (HPLC) or Gas 
Chromatography (GC), which are also used when the target
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compound has no utilisable biological activity. These assay 
techniques require the development of a suitable separation 
protocol and in the case of metabolites which are not easily 
detected may require a derivatisation procedure to attach 
fluorescent or U.V. active chromophores prior to assay.
ASSAY A MD SCREENING METHODS FOR DBOXYNOJIRIMYCIN
( D N J ) .
Assay methods for DNJ in microbial fermentations need to be 
selective as both nojirimycin (NJ) (Ezure et al., 1985; Stein 
et al., 1984) and deoxymannojirimycin (DMJ) (Ezure et al., 
1988) may be produced simultaneously by organisms. 
Glycosidase inhibitory properties provide a convenient method 
for the assay of these compounds, but although the enzyme 
inhibitory spectrum of DMJ is significantly different from 
that of DNJ, that of NJ is very similar (Table 2.1.), which 
poses problems when attempting to quantify DNJ without 
interference from NJ. Quantitative assays for DNJ have 
accounted for this by assaying the two compounds using 
enzymes which are strongly inhibited by one inhibitor and 
less so by the other. The use of Rabbit intestinal sucrase 
and emulsin (i-glucosidase to assay DNJ and NJ respectively in 
microbial fermentations has been reported (Ezure et al., 
1985; Stein et al., 1984). Both of these enzymes are 
inhibited by both DNJ and NJ. The P-glucosidase is inhibited
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E N Z Y M E SO U R C E R E F E R E N C E
Su cra se Aureobasidlum  pullulans R e e se  et al., 1971
Saccharom vces sp. R e e se  et al., 1971
Rabbit sm afl intestinal H anozet et al.. 1961
G lucoam ylasa not g iven 8chntfdt M  al., 1970
A ip .fQ llK i» n lq f  * R e e see ta l., 1971
E n d o n ijc g s ip . • R e e se  «tat.. 1971
H te o p m n lv tu i N lw a et al.. 1970
B -G lu co sid ass Em ulsln * E v a n s et «L. 1963
Alm ond em ulsin  * R e e se  et el.. 1971
A w n n O n  lu ch u o n H  • R M M M X . .  1971
A ip f f l^ j »  nja>f * R e e se  et el., 1971
Auraobasld lum  puHulana • R m h  M  X .. 1971
Punld  Ilium  m ellnli • R e e se  et sl., 1971
Apricot em ulsin M w a X X .,1 9 7 0
Trichodarm a vfrida N lw a et sl.. 1970
a -G lu co sid a ss Y e a st* E va n s X lL ,  1963
A sp e rgillu s nloer * R e e se  et sl.. 1971
Trichoderm a viride • R e e se  et sl.,1971
PenM lllu fn^arvum R e esee ta l.. 1971
Piecflom vcee  variotfi* R e e se  et aL. 1971
Trehalase T ric ftod fm « r— M i A labran  e taL. 1963
^uidgfrM ldhJTn p jjy lan a R e e se  et al.. 1971
Pan lcM um  p w w m R e esee ta l., 1971
M yro sina se Yeflow m ustard R e e see ta l., 1971
R e e se  et aL, 1971
Exo-6-1,3-glucanase B M M o n ly c M » * R e e se  et aL, 1971
C lyvM ap o riu ro  P fu inow m  * R e sse  et aL, 1971
Mnttans not given Schm idt etaL, 1979
C ellu lase B a sid io m yce * sp. R e e se  et a l. 1971
C M vw w K m u m B n iln M u in R e e se  e tsl.. 1971
T rtchodxm a vfclda R e e se  et al., 1971
a-A m ylase not given M w a  et al.. 1970
8-Am ylase not given N lw a et al.. 1970
a -M a nn o sida se Rat epid idym us Kodam aet al.. 1685
B-M  an n o s Id as« PtnidlM um  app. R e e see ta l., 1971
S n a i R e ese  et al.. 1971
Isom alt a se not given 8chm idt et al.. 1979
Penid lllum  m elinil R e ese  et al., 1971
Takadiastase PW iQ PW  n l* e » N lw a e tsl.. 1970
• -  Inhibitor uMd u  bisulphite idduot
Table 2.1. Glycosidases inhibited by NJ.
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GLYCOSIDASES INHIBITED BY DEOXYMANNOJIRIMYCIN
ENZYME SOURCE REFERENCE
a-Mannosidase Jack bean Evans et al.. 1965
Human liver Winchester et al.,1990
a-Fucosidase Bovine epididymus Evans et al., 1065
Human liver Winchester et al.. 1990
Mannosidase 1 Mung beans Szumilo et al., 1966b
Rat liver Bischoff and Kornfeld, 1964
Qlucosidase 1 Calf liver Schweden et al., 1966
GLYCOSIDASES INHIBITED BY DEOXYNOJIRIMYCIN
ENZYME SOURCE REFERENCE
a-Glucosidase Yeast Evans el al.. 1965 
Murao and Miyata, I960
Rabbit Murao and Miyata, 1960
B-Glucosidase Emulsin Evans et al., 1965
Almond Murao and Miyata, 1960 
Pale et al.. 1965
Aspergillus aculeatus Murao and Miyata, 1980
Trehaiase Chaetomium aureum Murao and Miyata, 1960
Rabbit Murao and Miyata. 1960
Cockroach Nishimura et al., 1990
Qlucosidase 1 Calf liver Schweden et al.. 1966 
Fuhrmann et al., 1965
Mung bean Szumiio et al. ,1966a
Saccharomyces cerevisiae Fuhrmann et al.. 1965
Qlucosidase N S. cerevisia« Fuhrmannstal., 1965
Calf Fuhrmann et al., 1965
0*1,6-Qlucosidass Rat liver Bollen and Stalmans, 1969
Qlucoamylase Rhizqpusniyeus Murao and Miyata, 1960
Thioglucosidase Brevicoryne brassicas SchofiekJ étal., 1990
B-Xylosidase Aspergillus niger Evans et rt.. 1965
Sucrase Rabbit Murao and Miyata, I960
Rabbit sm all intestine Hanozet étal., 1961
Table 2.1.(Continued) Glycosidases inhibited by DNJ and DMJ
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by NJ with an IC50 of 2.85 x 10'6M and DNJ with one of 8.1 x 
10_5M (Schmidt et ai., 1979) and the sucrase with Ki values 
of 2.2 x 10_8M and 1.2 x 10-7M by DNJ and NJ respectively at 
the pH used by Ezure (Hanozet et al., 1981). Although the two 
inhibitors show different strengths of inhibition of the two 
enzymes, both assays will become inaccurate in the presence 
of significant quantities of the other inhibitor.
In addition to the enzymatic assay for DNJ, Ezure also used 
an HPLC method involving separation on a reverse phase HPLC 
column and detection with a refractive index detector. A 
method for DNJ assay using GC has also been described by 
Fleet and Fellows (1988).
On the screening side, DNJ has been screened for using a 
plate screen based on the inhibition of glucoamylase 
catalysed degradation of starch in the presence of DNJ (Ezure 
et al., 1985). DNJ has also been found in a Streptomyces 
strain during a screen for inhibitors of the trehalase of 
Chaetomium aureum MS-27 (Murao and Miyata, 1980) but no 
mention of its use in the quantification of DNJ has been 
reported.
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2.2. MATERIALS AND METHODS.
2.2.1. STANDARD ASSAY CONDITIONS.
The trehalase assay used was based on that of Dahlqvist 
(Dahlqvist, 1984). The amount of glucose liberated from 
trehalose by trehalase was compared with and without the 
presence of inhibitor. The inhibitor was in the form of an 
aqueous solution of a standard inhibitor or a supernatant 
sample from a centrifuged microbial culture. Three 
incubations for each sample to be assayed were set up as 
follows.
Blank -Inhibitor +lnhibitor
Trehalase solution
in 0.1M maleate
buffer pH 6.0 20)11 20)11
(0.0358 U\ml)
Inhibitor solution 20)il 20)11
Distilled water 20)11 20)11
5
These were incubated at 37°C for 15 minutes and then 56mM 
trehalose in 0.1M maleate buffer pH 6.0 (20jll) was added to 
each one to initiate the reaction. After a further incubation 
of 60 minutes at 37°C, the following additions were made.
Glucose assay kit
solution (GOD-PAP 1000*11 1000*11 1000*ll
from Boehringer)
Inhibitor solution - 20*ll
Distilled water 20*il - 20*il
A final incubation of 30 minutes at 37°C was followed by the 
reading of the absorbances of each solution at 510nm on a 
Pye-Unicam SP1800 UV spectrophotometer.
The values for the absorbances at 510nm with and without the 
inhibitor were corrected for the blank value and the 
percentage inhibition of trehalase by samples was calculated 
according to the equation below;
% Inhibition = 1 AtSIQnmJ t inhibitor
A(510nm) - Inhibitor
x 10 0
2.2.2. SCREENING.
XAINTAINANCE OF MICROORGANISMS.
Strains of Streptomyces and Streptovertici11ium were 
maintained on Oatmeal agar (see Appendix) plates at 4°C and 
in 20% glycerol at -20°C. Strains used regularly were sub­
cultured at least monthly.
CULTIVATION OF MICROORGANISMS
Soyabean medium (Ezure et al.. 1985), consisting of 2%
soluble starch, 1% soyabean meal, 0.05% KCl, 0.05% MgS0 4, 
7H20, 0.2% NaN03, 0.5% NaCl, and 0.35% CaC03 (pH 7.4) in 30ml 
aliquots in 250ml conical flasks were inoculated from freshly 
grown, and sporulating, Streptomyces or Streptoverticillium 
strains on oatmeal agar plates (see Appendix). They were 
then incubated at 28°C, 190 rpm, for 7 days after which the 
cultures were decanted into sterile Universal bottles and 
centrifuged in a Beckman JA20 rotor (3000 rpm, 10 min) . The 
supernatant was decanted for assay.
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TREHALASE SCREEN.
Supernatant samples were used under standard assay conditions 
without pre-treatment.
LARGER SCALE FERMENTATION, PURIFICATION AND ANALYSIS 
OF DNJ.
Strains giving inhibition in the trehalase screen were then 
grown on a 11 scale (25 x 40ml fermentations in soyabean 
medium). These were inoculated and incubated as for the 
original screening, pooled and centrifuged (3000rpm for 10 
min.) in a Beckman JA20 rotor. The strong cation exchange 
resin, Dowex 50-X8 (H+ form) (150g) was then added to the 
supernatant and this was stirred at room temperature for lh. 
The resin was then removed by filtration and washed with 
water before being resuspended in 1M NH4OH (500ml) and 
stirred for a further lh at room temperature. The resin was 
again removed by filtration, washed with fresh 1M NH4OH 
(200ml). The washings were pooled, evaporated to dryness 
under reduced pressure and then the residue resuspended in 
70% aqueous ethanol (10ml). This solution was applied to an 
alumina column (lOOg) equilibrated in 70% ethanol and eluted 
with the same solvent. Samples of the 10ml fractions 
collected were subjected to T.L.C. analysis on silica plates 
using a butan-l-ol:ethyl acetate:acetic acid:water (1 :1 :1 :1 ) 
solvent system and visualised with ninhydrin. Fractions
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containing a component running with the same rf (0.42) as the 
DNJ standard were pooled and evaporated to dryness under 
reduced pressure. The residue was taken up in distilled water 
(5ml) and a sample (0.5ml) taken for mass spectrometric and 
gas chromatographic analysis.
The remainder from strain 445 and the patented producer ATCC 
31434 were further purified for NMR analysis by preparative 
TLC using the same solvent system as above. The sample 
removed from the TLC plate was freeze dried and redissolved 
in deuterium oxide (2ml) for NMR analysis on a Bruker 
Spectrospin WH400 N.M.R..
OAS CHROMATOGRAPHIC ANALYSIS.
The sample (300jil) was freeze dried and then silylated with 
the addition of Sigma Sil-A (40|il) and incubation at 70°C for 
2 0 minutes before injection into the chromatograph.
Sample 445 was run in a Pye-Unicam series 204 chromatograph 
fitted with a 5 ft glass OV-17 column. The gas flow (N2 ) was 
30ml\min, with a detector and injector temperature of 250°C 
and an oven temperature program of 125°C(2min) 6 \min 200°C 
( 1 0  min).
Sample 194 was run in a Carlo Erba Fractovap 2450 
chromatograph fitted with a 30m DB5 capillary column.
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DetectorNinjector temperature was 250°C, the column was 
isothermal at 200°C and the N2 flow was kept at 4ml\min.
2.2.3. USB OF TREHALASB INHIBITION TO QUANTIFY DNJ.
INHIBITION OF TRBHALASE BY DEOXYNOJIRIMYCIN AND OTHER 
INHIBITORS.
The standard assay conditions described above were used to 
assess the degree of inhibition of trehalase by aqueous 
solutions of 1-deoxynojirimycin (DNJ), 1-deoxymannojirimycin 
(DMJ) and nojirimycin (NJ) . The DMJ and DNJ used were 
obtained from Sigma and the NJ was obtained as its bisulphite 
adduct (gift of Prof. S. Ogawa, Keio University, Japan). 
Conversion to the free base was by the method of Inouye 
(Inouye et al., 1968).
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KINETICS OP THE INHIBITION OF TRBHALASB BY DNJ AND
NJ.
0.0385 U\ml trehalase in 0.1M maleate buffer pH 6.0 (20*il) 
were added to inhibitor solution (2 0*ll), in triplicate, for 
each concentration of inhibitor and substrate used. These 
were incubated at 37°C for 15 minutes and then trehalose in 
0.1M maleate buffer pH 6.0 (20*il) added. The three reactions 
were terminated by the addition of glucose assay kit solution 
(GOD-PAP from Boehringer) (1000*11) at 5, 10, and 15 minutes 
after the addition of the trehalose. Trehalose solutions used 
were 0, 14, 28, 42 and 56mM and at least two different 
inhibitor solution concentrations were used.
EFFECTS OF pH ON THE TREHALASE ASSAY.
Standard assay conditions were used with the inhibitor 
solution being 0.1mg\ml DNJ and the pH of the maleate buffer 
being varied between 5.5 and 7.0.
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EFFECTS OF GLUCOSE CONCENTRATION ON THE TRBHALASE
ASSAY.
Standard assay conditions were used but with the inhibitor 
solution being replaced by aqueous solutions of D-glucose of 
concentrations up to 2mg\ml.
ELIMINATION OF INHIBITION OF TREHALASE DUB TO NJ.
Solutions of DNJ and NJ (100)11) were incubated with equal 
volumes of hydrochloric acid solutions for various lengths of 
time at different temperatures. They were then freeze dried 
and the residue resuspended in distilled water (100)il). The 
inhibition of trehalase due to these solutions was then 
assayed under standard assay conditions.
2.2.4. COMPARISON OF ASSAY OF DNJ BY TRBHALASB METHOD 
TO THAT BY GAS CHROMATOGRAPHY.
Three samples were assayed by the two methods to compare the 
results. The first was an aqueous 0.05mg\ml solution of DNJ 
and the second was made by freeze drying 0.05mg\ml DNJ 
(0.5ml) and resuspending the residue in supernatant (0.5ml)
58
from a centrifuged culture of the non-DNJ producing 
S.lividans TK24 grown in soyabean medium. The third sample 
was a supernatant sample from a culture of the producer 
S.subrutilus 445.
HBAT\ACID TREATMENT OF SAMPLES.
The sample to be treated (200(Xl) was added to an equal volume 
of 6M HCl and heated in a boiling water bath for 6 hours. It 
was then freeze-dried and the residue resuspended in 
distilled water (20 0^ 1 ).
TREHALASE ASSAY.
The assay was carried out under standard conditions, in 
triplicate. DNJ concentrations were calculated by reference 
to the standard DNJ\trehalase inhibition curve.
59
OAS CHROMATOGRAPHIC ASSAY.
0.05mg\ml Methyl-fJ-D-glucoside (50|ll) was added to the test 
solution (50|ll) and then freeze-dried in a glass vial. The 
silylating agent Sigma Sil-A (SOjll) was then added through a 
self sealing lid and the vial heated to 70°C for 20 minutes. 
The samples were then injected into a Carlo Erba Fractovap 
series 2450 preparative gas chromatograph fitted with a 30m J 
and w DB5 capillary column. The nitrogen flow rate was 
3ml\min, the oven temperature an isothermal 190°C and the 
injector\detector temperature 250°C. The peaks were 
integrated using a Pye-Unicam DP88 computing integrator and 
the concentration of DNJ was calculated using the methyl-(i-D 
glucoside peak as a standard. Each sample was assayed in 
triplicate.
2.3. RBSULTS AND DISCUSSION.
2.3.1 SCREENING.
TRBHALASB SCREEN.
Attempts to use a plate method for the screening of 
fermentations for DNJ based around its inhibition of 
glucoamylase (Ezure et al., 1985) were unsuccessful, as an
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STRAIN NUMBER INHIBITION 7 (% INHIBITION)
069
194
316
216
094
190 
550
445 
085 
091 
0255
0446 
0500 
0517 
0524 
0716 
0936 
164
191 
233 
260 
422 
454 
512 
620 
630 
742 
639 
675 
642 
7601 
730 
6.720 
3602 
146 RB  
TK24 
31434
0767
0547
051
Table 2.2. Screening results.
♦  (15%. 16%)
+ (47%, 66%)
♦  (79%. 67%)
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unacceptable level of false positives were observed. For this 
reason an assay similar to one already described (Murao and 
Miyata, 1980) was adopted. The screening results are shown in 
Table 2.2.
PURIFICATION AND IDENTIFICATION OF DNJ FROM SCREENING 
POSITIVES.
The purification method used is based on the one used by 
Murao and Miyata (Murao and Miyata, 1980). The active 
charcoal step was omitted as was the anion exchange section. 
It was found that the coloration of the medium was removed 
efficiently by the alumina column and so the charcoal step 
was not needed and that the ommission of the anion exchange 
column did not affect the purity of the final product. Thin 
layer chromatography showed that the after the alumina column 
almost only DNJ and DMJ were left. Some, but not complete, 
separation of these two compounds was also seen in the 
fractions taken from this column.
The mass spectrum for 31434 (Fig. 2.1) shows a large peak at 
m\z*164, corresponding to M+l for DNJ or DMJ. Other large 
peaks appear at m\z= 146, 132, and 110 are the results of 
successive dehydrations of the parent ion. The spectra of 194 
(Fig. 2.2) and 445 (Fig. 2.3) both show the m\z = 164 peak 
described above although the peaks for the fragment ions are 
lost in the other peaks caused probably by impurities in the
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sample. These spectra also contain peaks at m\z=180 which 
might be due to NJ. However rapid dehydration of the NJ would 
make the appearance of this peak unlikely. Again the spectrum 
of 194 shows up more impurities than that of 445.
DS9® SJT6®0®1 . *5  *T=  ®5:54 +CI LRP 26-Jur.-89 16:18 AMMONIA 
T IC -  6522112 1WX® 264688 TRCU MZ 163,179 
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Figure 2.1. Mass spectrum of S . lavendulae 31434 product.
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Figure 2.2. Mass spectrum of S . racemochromogenes 194 product.
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2.3. Mass spectrum of S.subrutilus 445 product.
64

Gas chromatographic analysis of the partly purified fractions 
show the presence of DNJ in both 194 (Fig. 2.4) and 445 (Fig. 
2.5) fermentations. The 445 sample shows only one main peak 
whereas the 194 sample has many. The GC method used for the 
194 sample was more sensitive than for 445 implying that 
there was less DNJ in the 194 sample relative to the 
impurities. This coupled with the lower level of inhibition 
of trehalase shown by 194 indicate a smaller titre of DNJ in 
the 194 fermentation. For this reason it was decided to 
concentrate on strain 445 for further studies.
The final step of purification by preparative TLC allowed a 
little separation of the DNJ and DMJ although the degree of 
separation was variable. TLC of the final 31434 and 445 
samples showed the presence of both DNJ and DMJ in each, 
although much less DMJ was present relative to DNJ in the 
31434 sample. S.lavendulae has been shown to produce both 
compounds and these results show that 445 (S. subrutilus) 
does too. The different proportions of the two epimers in the 
samples from the two strains need not reflect differences in 
the production of these compounds by the two organisms as the 
degree of separation of DNJ and DMJ may vary in different 
separations. The isolation of DMJ from Lonchocarpus sp. 
(Fellows et al., 1979) follows a similar route to that used 
here for DNJ. Recrystallisations of DNJ and DMJ from methanol 
(Ezure et al.. 1985; Ezure et al., 1988) and methanol:acetone 
(Fellows et al., 1979) have been used in purification
66

Proton Splitting pattern Shift (PPM) Coupling constants (Hz)
H-1a dd 2.4 12.34 (H-1e) 
10.8 (H-2)
H-1a dd 3.03 12.36 (H-la) 
5.16 (H-2)
H-2 ddd 3.4 5.16 (H-le) 
9.07 (H-3) 
10.8 (H-la)
H-3 t 3.24 9.07 (H-2) 
9.06 (H-4)
H-4 t 3.15 9.7 (H-5) 
9.18 (H-3)
H-5 ddd 2.48 2.97 (H-6a) 
6.25 (H-6e) 
9.56 (H-4)
H-6a dd 3.77 2.96 (H-5) 
11.67 (H-6e)
H-6a dd 3.55 6.2S (H-5) 
11.7 (H-6a)
Table 2.3. 1H NMR assignments for S.lavendulae 31434 product.
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protocols but were found to be impractical with the small 
amounts of material being handled in these experiments.
On the basis of the TLC of the final product it was possible 
to determine that the major component of the 31434 sample was 
DNJ. The assignments of the peaks in the 1H-nmr spectrum 
(Fig. 2.6 and Table 2.3) were made with the aid of the COSY 
spectrum. The presence of DMJ is shown by the presence of the 
characteristic multiplet at 3.9ppm corresponding to the H-2 
proton of DMJ. The H-2 proton of DNJ shows up as a ddd 
pattern at 3.4ppm. The large difference in the shift of these 
two protons is due to the change of stereochemistry at this 
position.
Both of these characteristic H-2 patterns are seen in the 1H- 
nmr spectrum of the 445 sample (Fig. 2.7). The presence of 
DNJ is highlighted by the growth of its peaks in the spectrum 
upon addition of authentic sigma DNJ (Spectrum 445 + DNJ - 
Fig. 2.8). The positions of H-4 and H-3 of DNJ are reversed 
in this spectrum compared to the 31434 sample. The reason for 
this is unknown but may be due to the presence of a higher 
level of DMJ. In other spectra of the mixed isomers these 
peaks are overlapping and indistinguishable (D.Hardick 
personal communication). Both spectra were run under 
identical conditions and in the same solvent.
Figure 2.7. *H NMR spectrum of 445 product.
Figure 2.8. XH NMR spectrum of 445 product spiked with 
authentic DNJ.
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It is interesting to note that both of the strains found to 
produce DNJ in this screen, S . racemochromogenes 194 and 
S.subrutilus 445, are taxonomically very closely related to 
the patented producer S . 1 avendulae ATCC 31434. Ezure 
conducted a screen where of 8500 Streptomyces Strains 
isolated freshly isolated from soil, all 96 strains found to 
produce DNJ were identified as S.lavendulae (Ezure et al. , 
1985).
2.3.2. USB OF TRBHALASE IN QUANTITATIVE ASSAY OF DNJ.
INHIBITION OF TRBHALASB BY DNJ AND NJ.
The enzyme employed in the assay was Pig kidney a,o- 
trehalase (EC 3.2.1.28) obtained from Sigma. The protein has 
a molecular weight of 80 000 and an optimal pH of 5.9 
(Yoneyama, 1987). Trehalases are highly specific for 
trehalose (glucopyranose-a,a-glucopyranoside) as substrate 
(Alabran et al., 1983; Yoneyama, 1987) and catalyse the 
reaction shown in equation 1 .
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a D-Glucose
Equation 1. The trehalase reaction.
The high degree of specificity shown by trehalase is an 
advantage in such an assay as the concentration of substrate 
for the reaction is unlikely to be altered by the presence of 
trehalase in the fermentation samples in the same way that 
the potential substrate concentration for a less specific 
glucosidase might be. Other glucosides in the fermentation 
sample might act as substrates for the enzyme, thereby 
increasing the effective substrate concentration and the 
reaction rate in the sample run with the inhibitor. This 
would lead to the assay becoming inaccurate but is unlikely 
to occur with the trehalase assay despite trehalose being 
used as a storage material in the spores of some 
microorganisms (McBride and Ensign, 1987). However as both 
the trehalase and its substrate will remain intracellular 
they should not interfere with this assay which is concerned 
only with extracellular materials.
72
%  INHIBITION OF TREHALASE
Figure 2.9. Inhibition of trehalase by DNJ. 
%  INHIBITION OF TREHALASE
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The results (Figs 2.9, 2.10) show that both DNJ and NJ are 
inhibitors of pig kidney trehalase (EC 3.2.1.28). DMJ was 
found to be inactive against the enzyme. This shows that the 
stereochemistry at the C-2 position of the inhibitor is an 
important factor in the recognition of the inhibitor by the 
enzyme. The inhibition kinetics (Figs. 2.11, 2.12) show the 
competitive nature of this inhibition at pH 6.0. This is not 
surprising since both resemble the glucose subunits of the 
trehalose substrate. DNJ is a stronger inhibitor of the pig 
kidney trehalase than NJ as is shown by the Ki and IC50 
values (Fig. 2.13) which are both around 10-fold smaller for 
DNJ than NJ. DNJ is reported to inhibit a trehalase in mouse 
small intestinal mucosal homogenate with an IC50 value of 6.7 
x 10"5M (Schofield et al., 1986) and a rabbit intestinal 
trehalase with an IC50 of 3.4 x 10_5M (Nishimura et al.. 
1990) . Both of these values are comparable to the one 
obtained for DNJ on the pig kidney trehalase obtained in this 
study.
The Km value calculated from the inhibition kinetics is 1.7mM 
which is comparable to the literature value of 2. ImM 
(Yoneyama, 1987). The Vmax» also calculated from the kinetic 
data, was 4 x 10"^ nmolXmin.
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Figure 2.11. Lineweaver-Burk plot of inhibition of trehalase 
by DNJ.
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INHIBITOR IC5o <M> K, (M)
DNJ 4X10'5 3.45 X10-«
NJ 2.9 XKT4 2.6 X 1(T5
Km= 1.7mM
Vmax= 4 x 10-3 nmol min-1.
Table 2.4. Kinetic constants for the inhibition of trehalase 
by DNJ and NJ.
Little is known about the basis of the inhibition of 
trehalase by DNJ and NJ but some idea of how they might act 
can be gained from looking at the mechanism of action and 
their inhibition of other similar glucosidases. The mechanism 
of action of intestinal sucrase has been proposed (Cogoli and 
Semenza, 1975) and is shown below (Fig. 2.13). The 
competitive inhibition of sucrase by DNJ and NJ (Figs. 2.11,
2.12) probably arises from the resemblance of the protonated 
form of the inhibitor to the substrate in the enzyme-
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Figure 2.13. Mechanism of intestinal sucrase (Cogoli and 
Semenza. 1975)
substrate complex. The mechanism involves the formation of a 
charged species from the substrate which could be mimicked by 
the protonated inhibitor. The formation of an ion pair 
between the inhibitor and the carboxyl group at the active 
site would serve to strengthen its binding. Such 
electrostatic interactions have been implicated in the 
inhibition of calf glucosidase I by DNJ (Schweden et al., 
1986) and in the inhibition of o-fucosidase by DMJ 
(Winchester et ai., 1990). The protonation of the inhibitor
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has been shown to be very important in the inhibition of 
glucosidase (Legler, 1978) . Where analogues which were not 
able to become protonated were used, they showed little 
inhibition compared to active inhibitors. It was also 
demonstrated that when a species was already protonated it 
could not act as an inhibitor thereby indicating the presence 
of another positively charged group in the active site of the 
enzyme which would repel an already protonated inhibitor. A 
slow onset of inhibition of sucrase by DNJ and NJ has been 
noticed (Hanozet et al., 1981) and proposed to be due to a 
two stage process of inhibition by these compounds. The first 
stage is proposed to be the initial binding of the inhibitor 
at the active site of the enzyme, and the second is the 
protonation of the inhibitor at the active site leading to a 
strengthening of the forces holding the inhibitor at its 
binding site. To account for this, a 15 minute pre-incubation 
of the trehalase with the inhibitor was included in the assay 
protocol.
The implication of carboxyl groups and an imidazole group in 
catalysis by Cockchafer trehalase (Defaye et al., 1981) has 
led to the proposal of a mechanism for the action of the 
enzyme (Defaye et al., 1983). The mechanism is shown in 
Figure 2.14.
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Figure 2.14. Trehalase mechanism proposed by Defaye et al. 
(1983) .
Results from the study on the effect of pH on the inhibition 
of pig kidney trehalase (see later in this chapter) indicate 
that the protonated form of the inhibitor is the more active. 
This observation correlates well with the above mechanism. 
Defaye envisages the substrate binding to an active site 
containing a charged carboxyl group and an uncharged 
imidazole group. Protonation of the inhibitor would therefore 
mean that ion-pair formation between the enzyme and inhibitor
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would occur and stabilise the complex. The uncharged 
imidazole group would not repel the incoming and already 
charged inhibitor in the way that is hypothesised for the 
active site of (i-glucosidase (Legler et al., 1978).
EFFECT OF ACID AND HEAT TREATMENT ON INHIBITION OF 
TRBHALASB BY DNJ AND NJ.
The observation that NJ as well as DNJ was able to inhibit 
trehalase in the assay, albeit with an IC50 value ten fold 
larger than that for DNJ (Table 2.4) meant that assaying DNJ 
using the existing assay would give a false result when NJ 
was present in the fermentation. Two solutions were 
available, firstly to assay using a selective method such as 
the gas chromatographic (GC) method already described which 
does not detect NJ or secondly, to find a way to remove the 
effects of NJ from the sample. For reasons which will be 
discussed later the second approach was adopted.
In 1968 (Inouye et al., 1968) it was reported that when 
heated with HCl, NJ underwent the reaction shown in Figure 
2.15.
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would occur and stabilise the complex. The uncharged 
imidazole group would not repel the incoming and already 
charged inhibitor in the way that is hypothesised for the 
active site of (J-glucosidase (Legler et al., 1978).
b f f b c t  o f a c i d  a n d h e a t t r e a t m e n t o n i n h i b i t i o n  o f
TRBHALASB BY DNJ AND NJ.
The observation that NJ as well as DNJ was able to inhibit 
trehalase in the assay, albeit with an IC50 value ten fold 
larger than that for DNJ (Table 2.4) meant that assaying DNJ 
using the existing assay would give a false result when NJ 
was present in the fermentation. Two solutions were 
available, firstly to assay using a selective method such as 
the gas chromatographic (GC) method already described which 
does not detect NJ or secondly, to find a way to remove the 
effects of NJ from the sample. For reasons which will be 
discussed later the second approach was adopted.
In 1968 (Inouye et al., 1968) it was reported that when 
heated with HCl, NJ underwent the reaction shown in Figure
HEAT/ACID
CH2OH
Figure 2.15. Effect of acid on nojirimycin molecule.
Results of the experiments (Figs. 2.16, 2.17) show that the 
ability of NJ to inhibit trehalase declines sharply upon 
heating with HCl at 70 or 90°C. The ability of DNJ to inhibit 
the enzyme is, however, virtually unaffected by the same 
treatment. Weaker concentrations of NJ were more quickly 
destroyed by the treatment and 6M HCl at 90°C was generally 
found to be more efficient than 3M at 70°C. On the basis of 
these results a pre-treatment was adopted to remove the 
problem of interference by NJ when assaying DNJ by the 
trehalase method. The procedure involved the heating of the 
sample with an equal volume of 6M HCL at 90°C for 6h . The 
sample was then freeze-dried to remove the HCl and 
resuspended in distilled water. The heat treatment could not 
be guaranteed to remove totally the effects of NJ 
concentrations over lmg\ml but such concentrations were not
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anticipated at this stage. Apart from removing interference 
by NJ the heat and acid treatment had the added advantage of
0 1 2  3
Length of incubation with acid (h)
0.05mo\ml DNJ0.8mg\ml NJ
— © —  - A -
Figure 2.16. Inhibition of trehalase by DNJ and NJ: Effect of 
incubation with an equal volume of 3M HC1 at 70°C
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120
1.0mg\mlNJ 0.1mg\ml NJ0.06mg\ml DNJ
— 0 _  •••A—
0.5mg\ml DNJ 2.0mg\ml NJ
Figure 2.17. Inhibition of trehalase by DNJ and NJ: Effect of 
incubation with an equal volume of 6M HCl at 90°C.
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denaturing any enzymes such as proteases or maybe even 
trehalase which would also interfere with the assay. The 
inclusion of the heat\acid treatment should allow the use of 
the trehalase reaction to quantify DNJ in fermentations.
BFFBCTS OF pH ON THE TREHALASE ASSAY.
Due to the effect of the protonation of inhibitors such as 
DNJ on their inhibitory properties, the pH of the incubation 
medium also has a marked effect. This has been shown for the 
inhibition of (J-glucosidase (Dale et al., 1985) and 
intestinal sucrase (Hanozet et al., 1981) by DNJ and also for 
the inhibition of various enzymes by castanospermine (Saul et 
al., 1984). In all these cases, pH values below the pKa for 
the inhibitor showed a lower degree of binding and inhibition 
than those above indicating that it is the unprotonated form 
of the inhibitor which is active.
This is not the case for all enzymes though. The effect of pH 
on the inhibition of calf liver glucosidase I indicates that 
it is the protonated form of DNJ which is the potent form 
against this enzyme (Schweden et al., 1986). The protonated 
form of DMJ is also believed to be the active form in the 
inhibition of a-fucosidase by this inhibitor (Winchester et 
al., 1990).
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The variability of the effect of pH on inhibition by DNJ of 
different enzymes makes it important to assess which pH gives 
the highest degree of inhibition of trehalase in order to 
achieve maximum sensitivity of the assay. The results of this 
study (Fig. 2.18) show that pH 6.0 gave the highest 
inhibition and so should be used for the assay.
Figure 2.18. Effect of pH on inhibition of trehalase by DNJ.
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The highest amounts of inhibition were seen at pH 5.5 (20.9%) 
and 6.0 (21.1%), at pH 6.5, this fell to 16.6% and at pH 7.0 
is was lower still at only 12.8%. As the pKa for DNJ is 6.4 
(Schweden et al.,1986), these results would seem to indicate 
that it is the protonated form of DNJ which is inhibiting the 
pig kidney trehalase, although determination of Ki values 
should be calculated for each pH value before definite 
conclusions are drawn.
EFFECTS OF BACKGROUND GLUCOSE CONCENTRATION ON THE 
TREHALASE ASSAY.
As glucose is a product of the trehalase reaction then high 
levels of this compound in the fermentation sample being 
assayed might be expected to cause a disturbance such as 
feedback inhibition to the enzyme. No such effect was seen in 
these studies (Fig. 2.19). With the concentration of glucose 
in the added solutions of up to 0.6 mg\ml, the only effect 
was a slight activation of up to 2% of the activity of the 
enzyme. At concentrations of between 0.6 and 1.0mg\ml the 
activation rose to between 5.96 and 9.6% and at 2.0 mg\ml it 
was 34.2%. The apparent activation of the trehalase in the 
presence of the higher concentrations of glucose would mask 
some of the inhibition caused by any DNJ present. For this 
reason, samples containing glucose at a concentration likely
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to cause such an interference were diluted to a level where
the problem would be avoided prior to assay.
Figure 2.19. Effect of glucose concentration in sample on 
trehalase assay.
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2.3.3. COMPARISON OF THE TREHALASE ASSAY OF DNJ WITH 
THAT BY OAS CHROMATOGRAPHY.
The trehalase and the GC methods of DNJ assay were compared 
by assaying three different solutions using the two methods 
and then comparing the results (Fig. 2.20).
SAM PLE ASSAYED DNJ BY GC 
(MQ\ml)
DNJ BY TREHALASE 
(M g\m l)
After heat\add treatment 53.4 ±8.41 56.3 ±13.87
TK24 fermentation spiked with 0.05ma\ml DNJ
Before heat\add treatment 48.1 ±2.51 45.6 ±6.7
After heat\add treatment 62.0 ±2.38 44.3± 8.5
Strain 445 fermentation
Before heatVadd treatment 63.5 ±4.85 80 ±11.13
After heat\add treatment 68.0 ± 8.13 61.6 ±8.29
Figure 2.20. Comparison of assay results fom trehalase and GC 
assays.
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The figures for the concentration of DNJ in a 0.05mg\ml 
solution of DNJ in distilled water are comparable to each 
other and close to the correct concentration. This shows that 
the both assays give similar and accurate values for DNJ. The 
two assays also give comparable figures when assaying a 
0.05mg\ml DNJ solution made up in TK24 fermentation 
supernatant. The figures reached were a little lower than the 
expected value but may just reflect inaccuracies in the 
measurements when making up the solution. The concentration 
by trehalase assay was unchanged after heat treatment showing 
that heat treatment in the fermentation medium, as in 
distilled water, had no effect on the inhibition of trehalase 
by DNJ. The reason for the rise in the amount of DNJ assayed 
by the GC method after heat treatment is unknown. The GC 
assay of the 445 fermentation, as expected gave very similar 
figures both before and after heat treatment, as NJ present 
does not interfere with this assay. The figure given by the 
trehalase assay before heat treatment was a lot higher than 
this, the overestimate being due to the NJ present. After 
heat treatment, however, the figure was almost the same as 
that for the GC assay, as the interfering NJ had been 
removed.
Although both assays were found to be equally as accurate for 
the measurement of DNJ concentrations they were not equally 
as applicable to all samples to be assayed. The GC method has 
the advantage of not requiring the pre-treatment of samples 
but when the samples to be assayed are from fermentations in
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defined medium without purification, the time taken to elute 
all the residue from one sample before the next is injected 
severely limits the throughput of the system. An additional 
problem associated with the assay of complex medium samples 
is the tendency, when many samples are being injected, for 
the splitter on the injector to become blocked with 
involatile residue, causing overloading of the column. The 
use of a purification step prior to GC assay may help this 
situation but runs the risk of introducing inaccuracy through 
loss of DNJ. For these reasons, the trehalase assay, with a 
larger throughput and none of the problems associated with 
complex media and the GC method was used for assays involving 
such media.
When the samples were from fermentations in defined media, 
however, the GC assay method was not as disadvantageous. The 
throughput was increased to 10 minutes between sample 
injections compared to over 20 minutes with complex media and 
the lack of the need for the acid\heat treatment avoided the 
problem of high acidity sometimes seen with the defined media 
samples after such treatment and which caused problems with 
the trehalase assay.
So, in general, the trehalase was used for assays of samples 
in complex media, especially when there were many to be 
assayed and the GC assay was used for samples in defined 
media.
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CHAPTER 3. INFLUENCE OF NUTRIENTS AND CULTURE 
CONDITIONS ON THE PRODUCTION OF DNJ.
3.1. INTRODUCTION.
The nature and quantity of secondary metabolites produced by 
an organism during a fermentation is influenced by a great 
number of factors (Zahner and Kurth, 1982; Vining, 1986; 
James and Edwards, 1988; Vilches et al., 1990; Hobbs et al., 
1990; Liefke et al., 1990). In rich media allowing maximal 
growth of the organism, the production of secondary 
metabolites is usually limited to late stages in the 
fermentation, when the period of fast growth is over. The 
depletion of one or more of the essential nutrients in the 
medium may therefore be required for the initiation of 
secondary metabolism. The terms "trophophase" and "idiophase“ 
have been coined to describe the periods of fast growth and 
secondary metabolite production respectively (Bu'Lock, et 
al., 1961) . In media where only slow growth is supported, for 
example due to the supply of an essential nutrient in a 
limited or only slowly utilisable form, then secondary 
metabolite formation during the growth of the organism can be 
observed (Haavik, 1974a; Aharonowitz and Demain, 1979; 
Shapiro and Vining, 1984).
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When studying a particular metabolite, the generation of 
sufficient quantities of the compound is very important. The 
improvement of the product titre can be approached in several 
ways. The genetics of the organism can be altered, usually by 
random mutation followed by selection of overproducing 
mutants, or the conditions for the fermentation can be 
optimised. The second approach is probably best to start off 
with since it involves less of a chance element and is 
likely to yield an improvement in titre in a shorter space of 
time. The genetic would probably yield greater improvements 
in production in the long run but be more time consuming, 
especially if little or nothing of the biosynthetic origins 
or regulation of production of the metabolite is known. This 
approach is probably better left for situations where the 
metabolite has already been studied and its potential value 
assessed. An improvement in fermentation conditions via the 
identification of key nutrients are able to either stimulate 
or suppress the production of the metabolite could be carried 
out fairly early on in the investigation of a compound and 
the knowledge obtained may still be useful if the strain 
improvement process is carried out later.
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CARBON CATABOLZTE SUPPRESSION OF SECONDARY METABOLITE 
PRODUCTION.
The nature of the major carbon source in a medium can have a 
dramatic effect on the amount of secondary metabolite 
production in that medium (Demain, 1982; Demain, 1989a). 
Generally carbon sources which are readily assimilated and 
can support rapid growth of an organism suppress both the 
utilisation of other carbon sources and the production of 
secondary metabolites, although the mechanisms for these two 
effects are probably different (Vining, 1986). Glucose is a 
very good carbon source for the growth of many organisms, for 
example, but suppresses the production of a large number of 
secondary metabolites including erythromycin (Escalante et 
al., 1982), oleandomycin (Vilches et al., 1990) and 
actinomycin (Gallo and Katz, 1972). In a medium where two 
carbon sources are provided, one of which is glucose, the 
glucose is generally used first accompanied by a period of 
rapid growth. When the glucose is depleted, the utilisation 
of the second carbon source begins and secondary metabolite 
production may commence. If a carbon source other than 
glucose is favoured for growth then that may suppress the 
secondary metabolite production. This is the case in 
S . clavuligerus, where glycerol is able to suppress the 
production of candicidin (Hu et al., 1984). The suppressive 
action of a particular carbon source may be overcome by the 
use of a more slowly utilised source such as starch in the
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case of the glucose suppression of cephamycin production 
(Aharonowitz and Demain, 1978) or by a slow feeding regime of 
the suppressive source so that it does not reach suppressive 
levels. The second approach has been applied to the 
production of penicillin (Soltero et al., 1954).
The usual mode of action of carbon catabolite suppression is 
repression of the biosynthetic genes for the metabolite 
(Demain, 1989a), which can take place at the level of 
transcription, translational, or in the case of eukaryotic 
fungi, at the level of message splicing or post-translational 
modification of the protein. Repression can be shown to be 
the mechanism when the suppressive action is only exerted at 
stages in the fermentation prior to the expression of the 
biosynthetic genes. In some cases, the repression of 
individual enzymes has been demonstrated, this is so with 
phenoxazinone synthetase in actinomycin production by 
S .antibioticus (Jones, 1985), the expandase of cephamycin 
production (Lebrihi et al., 1988a) and the O-demethyl 
puromycin O-methyl transferase of puromycin biosynthesis 
(Sankaran and Pogell, 1975), for example. Enzyme inhibition 
by the carbon source may also contribute to the suppression 
of the secondary metabolite production. Carbon regulation of 
cephalosporin and cephamycin production has been reported to 
be due to both repression and inhibition of the enzyme 
deacetoxycephalosporin C synthetase involved in their 
biosynthesis (Martin et al., 1986).
NITROOBN SOURCE REGULATION OF SECONDARY METABOLITE
FORMATION.
As with the carbon source, the form in which nitrogen is 
supplied to a culture also influences the production of 
secondary metabolites (Aharonowitz, 1980; Shapiro, 1989). 
Ammonium and other inorganic nitrogen sources which are 
easily assimilated and support fast growth tend to suppress 
production of antibiotics and other secondary metabolites 
(eg. Flores and Sanchez, 1985; Demain and Piret, 1991; Held 
and Kutzner, 1990; Hobbs et al., 1990; Doull and Vining, 
1990; Truck et al.,1990a). Nitrogen sources which are
assimilated slowly allow a much slower growth rate and the
production of secondary metabolites. For example. the
production of novobiocin by S.niveus is suppressed by
ammonium so that novobiocin is not produced until the 
ammonium in the medium is depleted. Substitution of the 
ammonium with proline results in a considerable increase in 
novobiocin titre (Kominek, 1972). The addition of ammonium to 
a medium in a poorly accessible form is also a way to avoid 
its suppressive effects If ammonium is supplied to a 
fermentation the tylosin producer, S .fradiae as the sparingly 
soluble ammonium magnesium phosphate instead of the readily 
soluble ammonium lactate, then an increase in the production 
of tylosin is seen (Omura et al., 1980). Another way to
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overcome ammonium suppression is to add an ammonium 
complexing agent such as zeolite to the medium which then 
allows only its slow release and assimilation (Omura and 
Tanaka, 1986). The effect of ammonium on the production of 
secondary metabolites is always by repression, unlike carbon 
regulation, enzyme inhibition is not involved (Flores, 1991).
PHOSPHATE REGULATION OF SECONDARY METABOLITE 
PRODUCTION.
Suppression of secondary metabolite biosynthesis by excess 
phosphate is another common phenomenom in the pathways which 
have been studied so far (eg. Liras et al., 1977; Mertz and 
Doolin, 1973; Shapiro and Vining, 1983; Zhang et al., 1989, 
Hobbs et al., 1990; Kirpekar et al., 1991). Again, the 
depletion of inorganic phosphate is required before the onset 
of secondary metabolism. Production of certain groups of 
secondary metabolites is more sensitive to phosphate 
repression than others, amongst the more sensitive pathways 
are those resulting in the formation of the aminoglycosides, 
the macrolides and the tetracyclines (Martin, 1989).
During the fermentation of S.griseus, phosphate is almost 
depleted from the medium before any candicidin is made, and 
further additions of phosphate after the onset will stop 
production (Liras et al., 1977; Martin and Demain, 1976). |J-
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Lactam biosynthesis by S.clavuligerus is another example of a 
system which is affected by the phosphate concentration. The 
four main biosynthetic enzymes are all repressed by high 
concentrations of phosphate, which also acts as an inhibitor 
of the expandase and cyclase enzymes (Zhang et al., 1989). 
The amount of phosphate can also affect the relative amounts 
of secondary metabolites made, for example as its suppressive 
effect on clavulanic acid production is greater than on 
cephamycin (Romero et al., 1984) and in S.coelicolor A3 (2), 
24mM phosphate will completely prevent the biosynthesis of 
actinorhodin, without affecting that of undecylprodigiosin 
(Hobbs et al., 1990). The effect of phosphate on the 
synthesis of gramicidins also involves the inhibition of 
enzymes involved in their biosynthesis since the addition of 
phosphate to a fermentation after the synthesis of gramicidin 
S has already started results in no further synthesis and a 
drop in the activity of the enzymes until the level of 
phosphate has dropped again (Behai, 1986).
In the streptomycin producer, S .griseus, excess phosphate 
encourages the accumulation of a phosphorylated precursor to 
streptomycin (Miller and Walker, 1970) due to the inhibition 
of the final enzyme in its biosynthesis which cleaves the 
phosphate group from the precursor to yield streptomycin 
(Walker and Walker, 1971). The biosynthesis of other 
aminoglycoside antibiotics, such as neomycin and viomycin, 
also involves the use of phosphorylated intermediates. These 
antibiotics are also subject to phosphate regulation (Martin,
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1989) and a similar effect to that with streptomycin is seen 
with the inhibition of an alkaline phosphatase, which is 
involved in the biosynthesis of neomycin B in S. fradiae, by 
phosphate (Demain, 1982).
Apart from repression and inhibition of enzymes involved in 
the biosynthesis of aminoglycosides, where phosphate is 
involved as a substrate or product of the reaction, enzymes 
for other pathways where phosphate acts in neither of these 
capacities are also phosphate repressed. Amongst these are p- 
aminobenzoic acid synthetase acting in the biosynthesis of 
candicidin in S.griseus (Gil et al., 1985) and several 
enzymes involved in the biosynthesis of both the macrolide 
and the aminosugar parts of the antibiotic tylosin in 
S. fradiae (Madry and Pape, 1982).
Severe suppressive effects of phosphate concentration on 
secondary metabolite production can be removed by the 
utilisation of only a limited concentration of phosphate in 
the medium or the addition of a phosphate complexing reagent 
such as Kanuma earth (Omura and Tanaka, 1986) which would 
allow only the slow release of phosphate into the medium 
thereby avoiding high concentrations of inorganic phosphate.
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THE RELATIONSHIP BETWEEN GROWTH RATE AND THE
PRODUCTION OF SECONDARY METABOLITES.
The observation that the production of secondary metabolites 
is usually limited to fermentation conditions which permit 
only suboptimal growth rates begs the question of whether 
this factor alone can act to regulate secondary metabolism. 
Although the growth rate of an organism may well depend on 
the concentration of a repressive nutritional element, such 
as phosphate, in the medium, and therefore is linked to it, 
there is evidence that the growth rate per se might have a 
regulatory role in some systems (Vining, 1986). The 
commencement of secondary metabolism in response to a non­
specific nutrient limitation, as is often seen with the 
peptide group of antibiotics, might be seen as an indication 
that growth rate is playing a regulatory role. The importance 
of growth rate as a regulatory factor is dependant on the 
metabolite concerned. S.cattleya, for example, produces both 
cephamycin C and thienamycin but whereas the production of 
both these metabolites requires a low growth rate, this must 
also be accompanied by phosphate limitation for thienamycin 
production. The low growth rate needed for cephamycin C 
production can be due to depletion of carbon or nitrogen 
source or inorganic phosphate from the medium (Lilley et al., 
1981) . Thus for thienomycin production the low growth rate is 
probably a result of the depletion of phosphate which is the 
stimulus for the onset of the thienomycin production. Low
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growth rate alone appears to be the stimulus for cephamycin C 
production. This is corroborated by the observation that 
there is an inverse relationship between growth rate and 
cephamycin C production irrespective of the carbon source 
employed (Lebrihi et al., 1988b).
EFFECT OF TRACE ELEMENTS ON SECONDARY METABOLITE 
BIOSYNTHESIS.
The trace element content of a medium can have important 
effects on the production of secondary metabolites, although 
some trace elements, such as zinc, manganese and iron are 
more important than others (Weinberg, 1982; Weinberg, 1989). 
The trace element composition can have a stimulatory or an 
inhibitory effect on the biosynthesis of a particular 
secondary metabolite depending on the the concentration. The 
effect may be due to a single element or a combination of two 
or more.
As with the other nutrient conditions discussed, the effect 
on the production of secondary metabolites by various trace 
metals is very much dependant on the metabolite and the 
organism producing it. This is exemplified by the production 
of peptide antibiotics by three species of Streptomyces, 
S.albus, S.albulus, and S .griseoincarnatus (Miyashiro and 
Udaka, 1983). Addition of zinc to cultures of these organisms 
increased the production of antibiotic by S.albus and
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S.albulus, but decreased it in the other strain whereas 
magnesium additions were found to have the opposite effect. 
The addition of manganese stimulated production in S.albulus 
and S. griseoincarnatus but not S. albus and high levels of 
calcium increased production by all three. The addition of 
cobalt to a fermentation of Micromonospora sagamiensis alters 
the ratio of three gentamycins made by this organism without 
altering their overall yield (Kase et al., 1982).
The effect of the different trace elements may be due to 
their role as co-factors or allosteric effectors for enzymes 
of either primary or secondary metabolism. In 
S.michiganensis, copper ions are needed for the activity of 
tyrosinase, the enzyme responsible for the production of the 
secondary metabolic pigment melanin. In addition to this, 
they are also found to induce the expression of this enzyme 
(Held and Kutzner, 1990). In S . coel icolor, growth and 
actinorhodin production is affected by the trace element 
status of the medium (Abbas and Edwards, 1990). Elements such 
as lead, copper and nickel inhibit both growth and antibiotic 
production but zinc, manganese, cobalt and chromium enhance 
growth and inhibit actinorhodin production. Calcium will 
inhibit actinorhodin production and enhance growth but only 
if added early in the fermentation, indicating that its 
effect on antibiotic production is mediated through 
repression rather than inhibition of the biosynthetic 
enzymes.
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TEMPERATURE AND pH EFFECTS.
As changes in both temperature and pH of a medium affect 
both the growth rates of organisms and the activity and half 
life of their enzymes, they might also be expected to have an 
effect on the production of secondary metabolites.
The pH of the medium was claimed to be the effector in the 
interference by glucose in the biosynthesis of bacitracin by 
Bacillus licheniformis. The organic acids which built up on 
the fast metabolism of glucose were believed to cause a 
lowering of the pH and a decrease in the synthesis of 
bacitracin (Haavik, 1974b). This effect could be mediated via 
the alteration of the conformation of an activator protein so 
that it cannot switch on the expression of the bacitracin 
biosynthetic genes under these conditions. The drop in pH may 
also alter the activity of any biosynthetic enzymes already 
synthesised. The pH optima for many of the streptomycin 
biosynthetic enzymes has been found to be the same as the pH 
optimum for streptomycin biosynthesis. Changes in the pH 
during the fermentation of S .thermoviolaceus were found to 
affect both the timing and amount of granaticin produced. A 
rise in pH was found to correlate with the onset of 
production (James and Edwards, 1988).
Temperatures giving optimal growth rates have also been found 
to limit the production of secondary metabolites, with the 
optimal temperature for the synthesis of the biosynthetic
enzymes being different to that for their optimum activity, 
generally, the best temperatures for secondary metabolite 
formation are lower than those for optimum growth (Weinberg, 
1982; Weinberg, 1989) . This indicates that the effect of 
different temperatures may be related to their effect on the 
growth rate of the organism and expression of the antibiotic 
biosynthetic genes rather than the activity of the enzymes. 
Streptomycin production by S.griseus is much deminished at 
34-37°C due to alterations in the transcription of the 
biosynthetic genes (Baumberg et al., 1991).
EFFECT OF OXYGEN TENSION ON SECONDARY METABOLITE 
PRODUCTION.
Reduced oxygen tension has been associated with effects such 
as a drop in the specific activity of the enzyme 
deacetoxycephalospor in C synthetase in S .clavuligerus 
(Rollins et al., 1988) and a lower yield of aristeromycin in 
S.citricolor (J. Hanrahan, pers. commun. ) . Production of 
tetracyclines by S . aureofaciens and S. rimosus has also been 
shown to increase at higher oxygen tension (Liefke et al., 
1990) and limited diffusion of oxygen has been blamed for the 
drop in production of nikkomycins by S.tendae immobilised on 
glass beads when the thickness of the layer of organisms on
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the beads is increased (Truck et al., 1990b). Generally a 
higher oxygen tension appears to be beneficial for secondary 
metabolite production, although oxygen limitation has been 
linked to induction of erythromycin biosynthesis by 
Saccharopolyspora erythraea (Clark et al., 1991).
Studies on the effect of oxygen tension on the production of 
antibiotics by S . clavuligerus in defined media have shown 
that the drop off of antibiotic titre after its peak level is 
increased in reduced oxygen conditions. This was hypothesised 
to be due to derepression of antibiotic hydrolases under the 
low oxygen conditions (Yegneswaran et al., 1988). A similar 
effect may be responsible for the link between lower oxygen 
tensions and lower antibiotic titres described above.
BFFBCTS OF SPECIFIC NUTRIENTS ON SECONDARY METABOLITE 
PRODUCTION - PRECURSOR EFFECTS.
Apart from the general effects of carbon, nitrogen and 
phosphate suppression of secondary metabolism, certain 
primary metabolites, usually amino acids, have been found to 
specifically increase or decrease the production of a 
secondary metabolite (eg. Majumder and Kutzner, 1962; 
Yamamoto et al., 1977; Mendelowitz and Aharonowitz, 1982; 
Williamson et al., 1985; Goo et al., 1991). One of the best 
examples is the stimulation of alkaloid production in
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Claviceps by the amino acid tryptophan (Krupinski et al., 
1976) . Tryptophan is a common precursor for (Kobel and 
Sanglier, 1986), and is also able to negate the suppressive 
effect of excess phosphate on alkaloid biosynthesis. Other 
examples include the stimulation of penicillin biosynthesis 
by glutamine a possible amino donor in its biosynthesis 
(Aharonowitz and Friedrich, 1980) and the induction of 
cephalosporin production in Acremonium chrysogenum by 
methionine (Drew and Demain, 1975).
The pathways of primary metabolism in the producing organism 
also play a role in the inhibitory of inductive effects of 
certain nutrients. Lysine, for example, acts as a stimulant 
for lactam production in Streptomyces but as an inhibitor 
of their production in fungi. The reason for this difference 
is the different routes for the biosynthesis of lysine in the 
two types of organism. In fungi, lysine is synthesised via 
a-aminoadipic acid (a- AAA) , which is used in the 
biosynthesis of (3-lactam antibiotics. When extra lysine is 
added, feedback inhibition of the pathway results in the 
cessation of the synthesis of a-AAA and also therefore (3- 
lactams. In Streptomyces, the biosynthetic pathway to lysine 
does not involve a-AAA which is formed instead by the action 
of L-lysine amino transferase, a secondary metabolism enzyme 
(Madduri et al., 1991) not involved in the usual pathway of 
lysine catabolism which proceeds via cadaverine (Madduri et 
al., 1989).
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End product inhibition of the shikimate pathway by aromatic 
amino acids is also responsible for the negative effect that 
these compounds have on the biosynthesis of candicidin (Gil 
et al., 1985), an antibiotic which requires intermediates 
from this primary metabolic pathway for its biosynthesis.
AUTORBGULATORS.
The correlation between the developmental stages of 
antibiotic producing Actinomycètes and their production of 
secondary metabolites has led to the hypothesis that at least 
some of the secondary metabolites might act as effectors to 
control the differentiation events in the life cycle. This 
function may or may not have any relevance to the bioactivity 
associated with some of these compounds. Evidence that some 
of these compounds can indeed act as autoregulators has been 
found (Khoklov, 1982; Graffe, 1989). Although these compounds 
are not essential for the cell, they can have a profound 
effect on differentiation and secondary metabolite formation. 
The best known of these is A-factor from S.griseus, which was 
originally isolated as a factor capable of restoring the 
ability to sporulate and produce streptomycin to S.griseus 
mutants deficient in both of these functions. A-Factor is a 
y-butyrolactone (Fig. 3.1) and has been detected in 15% of
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examined Actinomycètes (Vining, 1990) although it might not 
have the same effect in all of these strains (Graffe, 1989). 
Other butyrolactones have also been found to affect 
antibiotic production and sporulation in S.coelicolor and 
S.virginiae indicating that the regulatory function might be 
a general property of this group of secondary metabolites 
(Graffe, 1989). Regulatory function is not, however limited 
to the butyrolactones, with both protein Factor C (Biro et 
al., 1980), nucleoside Factor B (Kawaguchi et al.,1984), and 
the ionophoric pamamycin (McCann and Pogell, 1979) also being 
able to affect morphological changes in different 
actinomycètes.
Figure 3.1. A-Factor.
MECHANISMS OF REGULATION.
It is unlikely that glucose, phosphate or ammonium moieties 
interact directly with genes to affect their expression and
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so secondary messengers which might have such a role have 
been sought.
In some bacteria, a mechanism involving cyclic adenosine 
monophosphate (cAMP) is used to control the expression of 
primary pathways for the utilisation of different carbon 
sources. The binding of cAMP to a protein and then the 
binding of that complex to to a promoter of an operon for the 
utilisation of some carbon sources is inhibited by low cAMP 
concentrations. In the presence of glucose, the enzyme 
responsible for cAMP production, adenylate cyclase, is 
inhibited so that cAMP levels are kept low. Regulation by 
cAMP has been implicated in the production of certain 
secondary metabolites but the evidence is somewhat 
contradictory. For example, the cAMP level and tylosin 
production are both increased by the addition of an adenylate 
cyclase stimulator to the producer S . fradiae and a high 
producing strain was also found to have an elevated cAMP 
content (Colombo et a l ., 1982). The onset of actinomycin
production by S.antibioticus, however, is not accompanied by 
any rise in the cAMP level (Vining, 1986) and neither is the 
derepression of chloramphenicol production in S.venezualae 
(Chatterjee and Vining, 1982). Although the onset of 
streptomycin production in S.griseus is accompanied by a 
change, it is a fall and the cAMP concentration then remains 
low throughout idiophase (Ragan and Vining, 1978). Addition 
of cAMP to a fermentation was found to stimulate growth and 
abolish secondary metabolite production (Gersch, 1980) and
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the effect of cAMP or adenylate cyclase activators in 
reversing the repressive effect of phosphate may be due to a 
stimulation of growth and consequent utilisation of excess 
phosphate.
Other nucleotide phosphates such as ppGpp, pppGpp and ATP 
have been looked at as possible secondary messengers. The 
levels of ppGpp and antibiotic production have been shown to 
be tightly coupled in mutants of S.griseus which are 
defective in their production of both aerial mycelium and 
antibiotics. They were found to have a lower concentration of 
ppGpp, which could be raised upon glucose starvation, which 
also stimulated aerial mycelium formation and antibiotic 
biosynthesis (Ochi, 1986). Similarly, in corresponding 
mutants of S.coelicolor A3(2), the level of ppGpp was 10-fold 
lower then in the wild-type (Ochi, 1990). As for ATP, the 
decrease in its intracellular concentration has been observed 
before the onset of antibiotic biosynthesis in S.griseus and 
the addition of phosphate to the fermentation will cause both 
the cessation of antibiotic synthesis and a concurrent 
increase in the concentration of ATP. A similar correlation 
between low ATP concentration and antibiotic biosynthesis has 
also been seen in other phosphate repressed systems. The 
observation of lowered ATP levels in overproducing mutants 
also points to an important role for this compound in control 
of antibiotic biosynthesis (Martin and Demain, 1980) .
Apart from individual phosphorylated nucleosides, the control 
of secondary metabolism has also been linked to the total
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adenylate pool, which takes into account the concentrations 
of ATP, ADP and AMP. It was found that chlortetracyline 
production by S .aureofaciens and tylosin production by 
S. fradiae both occurred after a fall in the total adenylate 
pool. Low levels of chlortetracycline production were 
associated with a high adenylate pool. Phosphate and glucose 
added to the medium both increased the adenylate pool (Vu- 
Trong et al., 1980; Curdova et al., 1976).
The enzyme glucokinase and its product glucose-6 -phosphate 
are also likely candidates for regulatory effectors. 
Glucokinase mutants are less sensitive to glucose repression, 
a situation which can be reversed by the cloning of an intact 
glucokinase gene into the mutant (Seno and Chater, 1983; 
Ikeda et al., 1984).
The proposed mechanisms of nitrogen catabolite repression 
have involved the enzymes of nitrogen assimilation as 
effectors (Aharonowitz, 1980). Under conditions of high 
ammonia, the nitrogen is assimilated using the enzyme 
glutamate dehydrogenase to make L-glutamic acid, but when, 
the ammonium level falls, it is assimilated using the 
glutamine synthetase/glutamate synthase (GS/GOGAT) pathway. 
In some organisms, alanine dehydrogenase has been 
demonstrated to have a nitrogen assimilatory role when 
ammonium levels are high (Aharonowitz and Friedrich, 1980). 
As the levels of all of these enzymes is controlled by the 
ammonium concentration, it may be that one or more of them 
plays a part in ammonium regulation of secondary metabolism.
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However, mutants deficient in glutamine synthetase, glutamate 
synthase or alanine dehydrogenase are still subject to 
ammonium repression so these enzymes are unlikely to be shown 
to have a role in this phenomenom (Demain and Brana, 1986) .
SUMMARY.
Th e  n u t r ie n t  s t a t u s  o f  a medium s i g n i f i c a n t l y  a f f e c t s  th e  
p r o d u c t i o n  o f  s e c o n d a r y  m e t a b o l it e s . I n  g e n e r a l ,  m edia 
s u p p o r t in g  o n l y  s u b o p t im a l  g ro w th  r a t e s  w i l l  a l l o w  th e  
p r o d u c t io n  o f  s e c o n d a r y  m e t a b o lit e s  a lt h o u g h  th e  p r e c is e  
r e q u ire m e n ts  v a r y  c o n s id e r a b l y  a c c o rd in g  to  th e  m e ta b o lite  
a nd  t h e  s p e c ie s  c o n c e r n e d . When s t u d y in g  a s e c o n d a ry  
m e t a b o l i t e ,  i d e n t i f i c a t i o n  o f  s u p p re s s iv e  o r  s t i m u la t o r y  
e le m e n ts  i s  im p o rt a n t  so t h a t  the  d e s ig n  o f  a medium g i v i n g  
s u f f i c i e n t l y  h ig h  l e v e l s  o f  th e  m e ta b o lite  can be a c h ie v e d . 
T h e  d i f f e r e n t  s e n s i t i v i t i e s  o f  th e  m e ta b o lite s  t o  th e  same 
l i m i t i n g  f a c t o r  may a ls o  le a d  t o  a l t e r a t io n s  in  th e  ty p e  and 
r e l a t i v e  c o n c e n t r a t io n s  o f  m e ta b o lite s  made u nd e r d i f f e r e n t  
c o n c e n t r a t io n s  o f  t h a t  f a c t o r  by a s in g le  s t r a i n .  Th e  p r e c is e  
m echanism  in v o lv e d  i n  s u p p re s s iv e  e f f e c t s  o f n u t r ie n t s  such 
as ammonium, g lu c o s e  and p h o sphate  i s  unknown b u t i t  seems 
l i k e l y  t h a t  A TP  a n d / o r  o t h e r  a d e n y la te s  and ppGpp p la y  an 
im p o rta n t  r o l e  i n  t h i s .
T h e  a im  o f  t h i s  s tu d y  was t o  i d e n t i f y  n u t r ie n t  f a c t o r s  
a f f e c t i n g  th e  p r o d u c t io n  o f  D N J. In  a d d i t io n  t o  t h i s  a medium 
was needed f o r  s t u d ie s  o n  th e  b io s y n t h e t ic  p ath w ay u s in g  
i s o t o p i c a l l y  l a b e l l e d  g lu c o s e . F o r th e s e  s t u d ie s , a medium
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was nee d ed  u s in g  g lu c o s e  as t h e  s o l e  c a rb o n  s o u rc e  and 
p r o d u c in g  s u f f i c i e n t  DNJ f o r  i s o l a t i o n  and a n a ly s is  in  th e  
s m a lle s t  volum e o f  medium and w i t h  t h e  b ig g e s t  y i e l d  from  the  
added g lu c o s e .
3.2. MATERIALS AND METHODS.
3.2.1. ASSAY PROCEDURES.
DETERMINATION OF DNJ BY TRBHALASB ASSAY.
Standard assay conditions were used to assay samples both 
before and after heat\acid treatment (See section 2.2.3). The 
values for percentage inhibition of trehalase were then 
converted into concentration of DNJ using the standard curve 
of inhibition of trehalase by DNJ solutions of different 
concentrations (Fig. 2.9). Samples containing over lmg\ml 
glucose were diluted with distilled water prior to assay to a 
concentration where the glucose would have no effect on the 
assay. Samples giving an inhibition of trehalase of over 60% 
were diluted so as to give a range of values from the graph. 
This was done as at inhibitions over 60% a smaller inaccuracy 
in the % inhibition would give a much larger inaccuracy in 
the concentration of DNJ read from the graph than at other 
points. All assays were carried out in at least triplicate.
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DNJ DETERMINATION BY OAS CHROMATOGRAPHY.
Determination of DNJ by GC was carried out as in section 
2.2.4 except that the concentration of the methyl-6 -D- 
glucoside solution was varied so that the amount of standard 
added was roughly equal to the anticipated concentration of 
DNJ. The concentration usually used for the defined medium 
samples was 1 0 jigXml.
GLUCOSE DETERMINATION.
Glucose was determined using the Peridochrom GOD-PAP glucose 
assay kit from Boehringer. The kit solution (1000^1) was 
added to the sample solution (20^1) and incubated at 37°C for 
30 minutes. The absorbance of the red solution produced was 
read at 510nm in a Pye-Unicam 1800 UV Spectrophotometer. Each 
sample was assayed in triplicate and the absorbances 
converted to glucose concentration by means of a standard 
curve, constructed using known concentrations of glucose 
under the above conditions.
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DETERMINATION OF NJ.
As NJ is an antibiotic, it was possible to assay it using an 
agar diffusion type bioassay. First, however, it was 
necessary to check that NJ was the only substance produced by 
the strains which can inhibit the growth of the sensitive 
strain, Micrococus luteus PCI1001. This was carried out with 
the use of bioautography.
Fermentations (30ml) of strains Streptomyces lavendulae 31434 
and S.nojiriensis, which are known to produce NJ, 
S. subrutilus 445 which might, and S .lividans TK24 which does 
not, were grown in soyabean medium (Section 2.2.2) at 28°C 
for 6 days. They were then centrifuged (3000 rpm for 10 
minutes in a Beckman JA20 rotor) and the supernatant used for 
the bioautography. The samples (10 x 10^1) along with 
standard solutions of nojirimycin (Gift of D.J. Hardick) were 
applied to a silica T.L.C. plate which was then developed 
with an ethanol:water (4:1) solvent system. After 
development, the plate was dried and laid face down on a 23cm 
square petri dish containing nutrient agar (150ml). After 1 
hour, the silica plate was removed and the agar overlayed 
with 70% nutrient agar (50ml) seeded with Micrococcus luteus 
PC11001 at a concentration of 106 cfu\ml. The plate was 
incubated at 30°C overnight and then inspected.
Having established that NJ was the only M. luteus growth 
inhibiting compound produced by S .lavendulae 31434, 
S.nojiriensis and S .subrutilus 445, the bioassay of NJ was
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performed as follows. A 150ml layer of nutrient agar in a 
23cm square dish was overlayed with 50ml 70% nutrient agar 
containing M.luteus at 106 cfu\ml. Sterile 1cm lengths of 
silicone tubing were then inserted into the top layer of the 
agar and the samples (50^ 11) added, both neat and 1/5 
dilutions, along with standard NJ solutions in a quasi latin 
square arrangement. The plate was incubated at 30°C overnight 
and then the diameters of the clear zones around the tubes 
were measured. NJ concentrations in the samples were 
calculated with reference to the diameters of the clear zones 
around the standard NJ solutions.
DETERMINATION OF STARCH IN FERMENTATION SAMPLES.
The sample (2ml) was applied to Dowex-50W x 2 (H+ form) (2ml) 
and then washed through with water (6ml). The pH of the 
eluate was adjusted to 5.5 and its volume to 10ml. 
Aspergillus niger glucoamylase was added (45 units) and 
incubated at 40°C for 1 hour. A sample dOjil) was then taken 
and GOD-PAP glucose assay kit solution (1000*11) added before 
a further incubation of 30 minutes at 37°C. The absorbance of 
the solution was then read at 510nm in a Pye-Unicam SP1800 UV 
spectrophotometer against a blank of sample treated similarly 
but without the addition of the glucoamylase. The absorbances
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were converted into starch concentrations with the use of a 
standard curve.
DETERMINATION OF DRY WEIGHT OF CELLS.
Samples (5 or 10ml) of fermentations were taken and acidified 
with an equal volume of 0.2M HCl. This was shaken, 
centrifuged (10 minutes at 3000 rpm in a Beckman JA20 rotor) 
and the supernatant poured off. The pellet was resuspended in 
0.05M Tris-HCl pH 7.0 (5ml) and filtered through pre-dried 
and weighed Whatman glass fibre filters. The filter was then 
dried in a drying oven for 48h before being re-weighed.
3.2.2. FERMENTATIONS - COMPLEX MEDIA.
PREPARATION OF SPORE SUSPENSIONS.
Spore suspensions were prepared according to the procedure of 
Hopwood et al (1985a). The final concentration of spores was 
adjusted to 108 cfu\ml and the suspensions stored at -20°C.
117
These were carried out by batch fermentation using a 2L glass 
vessel. The conditions were controlled by a Lifescience 
Bioreactor controller attached to the fermentation vessel. 
The fermentations were carried out in 1-1.51 of medium which 
was autoclaved in situ and inoculated with 5x30ml shake flask 
cultures (48h) in the same medium. Aeration was at ll\min 
with stirring at 750rpm and the temperature was kept at 28°C. 
The antifoam agent polypropylene glycol was added at 1% when 
the compex soyabean medium was used.
SMALL FLASK FERMENTATIONS.
Aliquots (30ml) of medium were autoclaved and inoculated with 
spore suspensions (1 0 0 nl - 1 0 7 spores) of the strain
concerned and incubated at 28°C, 190rpm in an orbital shaker. 
All assays were performed separately on triplicate flasks, 
mean results are shown, thus indicating only trends.
TIME COURSE EXPERIMENTS.
For time-course experiments, flasks were removed at intervals 
during the fermentation and analysed as described in 3.2.1. 
Samples for dry weight analysis were removed before 
centrifugation (3000rpm for 10 minutes in a Beckman JA20 
rotor) to obtain the supernatant for the other assays. The
LARGE SCALE FERMENTATIONS.
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trehalase assay was used for DNJ determinations. Supernatants 
were stored at -20°C in order for them all to be assayed at 
the same time. The dry weight analysis was carried out 
immediately.
THE EFFECT OF SLOW ADDITION OF GLUCOSE ON THE 
CONCENTRATION OF DNJ PRODUCED BY S . L A V B N D U L A B  31434 
AND S .SUBRUTILUS 445.
Fermentations of 445 and 31434 (6x30ml each) in soyabean 
medium with 4g\l D-glucose replacing the starch were carried 
out at 28°C, 190rpm in an orbital shaker. In half 
fermentations for each strain the glucose was all added at 
the start of the incubation but in the other half, the same 
total amount of glucose was added in 8 equal aliquots at 1 2 h 
intervals from the start of the fermentation. The 
fermentations were stopped after 7 days, centrifuged as 
previously described and the supernatant used for 
determination of DNJ by GC.
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Soyabean medium was made up containing 0, 2, 4, 6 , 8 , or
10g\l glucose (3 x 30ml fermentations for each glucose 
level). After inoculation with S.subruti1 us 445 spore 
suspension (lOOjil), the fermentations were incubated at 28°C, 
190rpm in an orbital shaker for 7 days. After centrifugation 
at 3000rpm for 10 minutes (Beckman JA20 rotor), DNJ 
concentration in the supernatants was determined by the 
trehalase assay.
3.2.3. FERMENTATIONS IN DEFINED MEDIA. THE EFFECT OF 
NUTRIENT CONDITIONS ON THE PRODUCTION OF DNJ BY 
8 . L A VENDULAE IN DEFINED MEDIA.
PRODUCTION OF DNJ IN DEFINED MEDIA WHICH ARE ALREADY 
DESCRIBED.
Aliquots (30ml) of the different defined media were 
inoculated with spore suspension of S.lavendulae 31434, 
S.subrutilus 445 or S.lividans TK24. They were incubated at 
28°C, 190 rpm before being harvested. Upon being harvested, 
the entire culture was centrifuged at 3000 rpm for 10 minutes 
in a pre-dried and weighed Universal bottle. The supernatant 
was decanted and the concentration in it assayed by the GC
EFFECT OF THE AMOUNT OF GLUCOSE IN SOYABEAN MEDIUM ON
THE PRODUCTION OF DNJ BY 3. SUBRUTILUS 445.
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method (Section 3.2.1.). The pellet was washed with 0.05M 
Tris-HCl pH 7.0 (2 x 10ml) and then dried for 48h in a drying 
oven before being re-weighed. The media used were MG A, ISP4, 
ISP5, ISP7, which are already described, and ST01, a medium 
composed of various elements of defined and complex media 
used in this study. The contents of all the media are 
detailed in the Appendix.
TIMB COURSE OF FERMENTATION OF S . LAVENDULAE 314 34 IN 
MINIMAL GLUCOSE MEDIUM (MOA).
A large scale fermentation of 31434 in MGA was carried out as 
described in section 3.2.2.. 1L of MGA, autoclaved in situ, 
was inoculated using 4 x 30ml cultures of 31434 which had 
been inoculated from a spore suspension of 31434 and 
incubated at 28°C, 190rpm in an orbital shaker for 48h. 
Samples were taken at intervals and their dry weight analysed 
as in section 3.2.1.. The DNJ content was assayed by the 
trehalase method.
THE EFFECT OF CARBON SOURCE ON THE PRODUCTION OF DNJ 
BY 9. LAVBNDULAB 31434 IN DEFINED MEDIA.
Fermentations on a 30ml scale were carried out as follows.
A basal medium containing 5.7mM K2 HPO4 , 2mM MgS0 4 .7 H 2 0 , 
85.5mM NaCl and 1ml per litre of a Trace Element Solution
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comprising 2.2% FeCl2 , 0.5% ZnCl2 . 0.25% MnCl2 .4H2 0 , 0.105% 
CUCI2 .2 H2O, 0.1% Nal, and 0.05% CaCl2 .6H2 0 was supplemented 
with lOmM L-arginine and one of several carbon sources at 
20mM. The pH of the medium was adjusted to 7.4 and autoclaved 
before being inoculated with spore suspension of 31434 
(100^ 11, 107 cfu) . The cultures were incubated at 28°C, 190rpm 
for 7 days. Upon harvesting they were treated as in the 
opening part of this section to find the dry weight and DNJ 
content of the fermentations.
EFFECT OF DIFFERENT NITROGEN SOURCES ON PRODUCTION OF 
DNJ BY 8. LAVENDULAE 31434 IN DEFINED MEDIA.
The basal medium described above was supplemented with 20mM 
D-glucose and one of the nitrogen sources at a concentration 
of lOmM. The fermentations (30ml scale) were inoculated and 
incubated as above and upon harvesting were treated in the 
same way in order to assess the dry weight and DNJ content of 
the fermentation. The fermentation with L-asparagine as 
nitrogen source was also carried out in a second basal medium 
as used by Vilches (Vilches et al., 1990) in order to see how 
this affected DNJ production.
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EFF E C T  OF V A R I O U S  A R O I N I N B :0 LUC08S AND 
PROLINB: GLUCOSE RATIOS ON THE PRODUCTION OF DNJ.
The same basal medium was used supplemented with nitrogen 
source (proline or arginine) at 10 or 20mM and D-glucose at 
concentrations between 0 and lOOmM. The same procedure was 
used for conducting the fermentations and assaying the dry 
weight and DNJ content.
EFFECT OF VARYING THE PROLINB CONTENT OF THE DEFINED 
MEDIUM ON THE PRODUCTION OF DNJ.
The above procedure was repeated but with the D-glucose 
content of the medium constant at 20mM and the L-proline 
concentration varied between 0 and lOOmM.
EFFECT OF INORGANIC PHOSPHATE CONCENTRATION ON THE 
PRODUCTION OF DNJ.
With the D-glucose and L-proline concentrations of the media 
constant at 20mM each, the phosphate concentration , in the 
form of K2HPO4 , was varied between 0 and 40mM in the above 
procedure.
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EFFECT OF AMMONIUM IONS ON THE PRODUCTION OF DNJ.
The above procedure was repeated with the phosphate 
concentration constant at 5.7 mM and with the addition of 
ammonium ions as (NH4>2S04 at concentrations of between 0 and 
40mM.
EFFECT OF INITIAL PH OF THE MEDIUM ON THE PRODUCTION 
OF D N J .
The same basal medium as above was used supplemented with 
20mM D-glucose and 40mM L-proline. The pH of the aliquots of 
medium was adjusted to values between 5.5 and 9.0 prior to 
autoclaving. The fermentations and analyses were carried out 
as described above.
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RESULTS AND DISCUSSION
PRODUCTION OF DNJ IN COMPLEX MEDIA.
FERMENTATIONS.
The use of the trehalase assay on the samples taken from the 
2L fermenter when the soyabean based media were used was a 
problem due to the solution going milky upon addition of the 
glucose assay kit solution. There was no such problem when 
the fermentations were carried out in the same medium on a 
smaller scale in shake flasks or in the fermentor with MGA 
and so the cause was probably the polypropylene glycol (PPG) 
anti foaming agent used with the complex medium in the 
fermentor. For this reason, the time-course studies were 
carried out in 250ml conical flasks containing 30ml aliquots 
of medium instead so that the addition of PPG was not needed.
TIME-COURSE STUDIES.
The study on the fermentation of S.lavendulae MB-733 in 
soyabean medium reported by Ezure et al. (1985) showed that 
NJ and DNJ were produced at different times during the 
fermentation. NJ was at a peak at 48h whereas DNJ was at its 
lowest at this stage and only reached a peak at 96h, by which 
time the NJ concentration was falling. The NJ peak value was 
about 700jig\ml and that for DNJ was around 150ng\ml. MB-733
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was a high producing strain and although the S.lavendulae 
31434 fermentation reflects the pattern of NJ and DNJ 
production seen in MB-733, the amount of DNJ produced is only 
about 35% of the level in MB-733.
In the 31434 fermentation, shown in Figure 3.2, the NJ was 
first detected at 53h peaked at lOOh and had fallen to 
undetectable levels again by 166h. DNJ was not detected until 
75h, and rose to 44.5jig\ml by 212h. It is interesting to note 
that soluble starch concentration was still over 70% of its 
initial value when DNJ synthesis began in contrast to the MGA 
and the improved defined medium where glucose was the carbon 
source and declined to much lower levels prior to DNJ 
biosynthesis.
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Figure 3.2. Fermentation of S .lavendulae 31434 in soyabean 
medium with starch as the major carbon source.
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In contrast to the fermentation of 31434, that of 
S.subrutilus 445 showed no temporal separation of the 
production of DNJ and NJ. When starch was used as the carbon 
source (Figure 3.3), both were detected at around lOOh when 
the amount of starch had been depleted to 50% of its original 
value. If the 20g\l soluble starch was replaced by 4g\l 
glucose (Figure 3.4), DNJ and NJ were detected at 92h and at 
this time, glucose had fallen to 14% of its original value. 
The fact that temporally the production occurs at the same 
time and that the production of DNJ is faster in the glucose 
containing medium indicate that glucose is probably not the 
only factor suppressing the production of DNJ earlier on in 
the fermentation. Levels of phosphate or nitrogen in the 
medium are probably also important. Although no additional 
phosphate was added, there may have been some in the soyabean 
medium which could contribute to suppression of DNJ 
production. The sodium nitrate added as a nitrogen source in 
addition to the soyabean is a more likely candidate as it 
will be utilised more quickly as a carbon source than the 
generally non-suppressive soyabean meal.
There are large differences seen in the NJ values from 
repeated fermentations of 445 in the soyabean medium with 
4g\l glucose as the carbon source. The most likely reason for 
this is inaccuracy in the assay procedure. Due to the 
instability of the NJ, new aliquots of NJ bisulphite adduct 
were converted to NJ and standard solutions made up
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Figure 3.3. Fermentation of S . subrutilus 445 in soyabean 
medium with starch as the major carbon source.
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from these each time an assay was performed. However, the 
lack of a single standard for use in each assay combined with 
the inaccuracy of converting and handing very small 
quantities of NJ would all have contributed to this problem. 
The values given therefore should be treated as indication of 
the trend of NJ concentration rather than its absolute value. 
The temporal differences in NJ production in 445 and 31434 
could reflect differences in the regulation of the compound 
in the two strains. This could also explain the differences 
in the response of DNJ production in the two species to a 
slow glucose feeding regime, as shown in Table 3.1, if NJ is 
a precursor to DNJ. With slow glucose feeding compared to the 
addition of all the glucose at the start of the fermentation, 
the titre of DNJ in the 31434 fermentation after 7 days rose 
from 48.47 to 63.2 ng\ml and that in 445 fell from 46.26 to 
27.8 ng\ml. The reason for this is again unclear but the fact 
that the amount of DNJ falls in 445 suggest that the level of 
glucose is kept at suppressive levels by the slow addition. 
In 31434 this might not be as important as NJ can still 
accumulate when at glucose concentrations repressing DNJ 
production and so when the production of DNJ is started, there 
is a large supply of NJ for quick conversion to the product.
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Strain Glucose addition Concentration of DNJ (^g/ml)
31434 Ail at start 48.47 ±  6.4
Stages 63.2 ± 12.1
445 All at start 46.26 ± 12
Stages 27.8 ±  10.2
Table 3.1. Alterations in DNJ production due to slow-feeding 
of glucose to strains 445 and 31434.
BFFBCT OF GLUCOSB CONTENT OF SOYABBAN MEDIUM O N  THB 
PRODUCTION OF DNJ BY S . SUBRUTILUS  445.
Th e  e f f e c t  o f  a d d in g  d i f f e r e n t  a m o un ts o f  g lu c o s e  t o  th e  
s o y a b e a n  m edium  w i t h o u t  th e  a d d i t i o n  o f  s t a r c h  was 
in v e s t ig a t e d  t o  a s s e s s  t h e  b e s t medium f o r  th e  i s o t o p i c a l l y  
la b e l le d  g lu c o s e  s t u d ie s .  A medium c o n t a in in g  o n ly  g lu c o s e  as 
a c a rb o n  s o u rc e  was n e e d ed  as i f  t h e r e  w ere tw o o r  more 
ca rb o n  s o u rc e s , th e  g lu c o s e , in c lu d in g  th e  la b e l le d  g lu c o s e  
m ig h t be used f o r  g ro w th  b e f o re  th e  o n s e t o f  DNJ p r o d u c t io n  
and so none w o uld  be a v a i l a b l e  f o r  in c o r p o r a t io n  i n t o  DNJ i f  
g lu c o s e  was t o  a c t  as a p r e c u r s o r .  T h e  amount o f  l a b e l l e d  
g lu c o s e  a v a i la b l e  was a l s o  l im it e d  so t h a t  th e  medium g i v i n g  
th e  b e s t y i e l d  o f  DNJ p e r  u n i t  o f g lu c o s e  added needed t o  be
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found as well as the one giving a high enough titre of DNJ 
for enough to be produced for isolation and characterisation 
from a reasonable volume of medium. A target of 30mg DNJ in 
total unpurified medium was set so that around lOmg could be 
isolated as its acetyl derivative for NMR analysis.
(yiQIUOOM
Figure 3.5. Effect of glucose concentration in Soyabean 
medium on the DNJ titre and "yield* from glucose.
The results, shown in Figure 3.5, demonstrate that the DNJ 
titre increased with glucose concentration up to 6 and 8g\l, 
where the DNJ titre reached 65.25 and 64.0 jigXml 
respectively. With 10mg\ml glucose, the DNJ concentration 
only reached 44.0jig\ml after 7 days. This finding again
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indicated that whereas high glucose concentrations may well 
repress the production of DNJ, sufficient is needed at the 
start of the fermentation to allow the establishment of a 
reasonable quantity of biomass to produce the DNJ.
The highest "yield" of DNJ (15.8 jigNmg glucose) was seen with 
only 2g\l glucose but to produce enough DNJ from this medium 
would need a litre fermentation. With 4g\l glucose, a small 
drop in the yield to 13.5 ng\mg glucose was seen but the 
titre of DNJ increased so that only a 600ml fermentation 
would be needed to get the required 30jig DNJ for isolation. 
As this volume would be easier to handle and the alteration 
in glucose concentration only resulted in a small fall in 
yield, the 4g\l glucose soyabean medium was used for the 
biosynthesis studies.
PRODUCTION O F  DNJ IN DBFINBD NBDIA.
DNJ PRODUCTION BY DIFFERENT STRAINS IN DBSCRIBBD 
DBFINBD MBDIA.
The DNJ titre in the media tried was a lot lower than in the 
complex media used, as shown in Table 3.2. The highest DNJ 
titre was produced in medium ST01 (18ng\ml) which was derived 
from features of the other defined and complex media used. 
This figure is around 1/3 of the typical figures seen in the 
complex media.
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M E D IU M S T R A I N D N J  O iG \ M L )
M G A 3 1 4 3 4 1 0
4 4 5 0
T K 2 4 0
IS P 4 3 1 4 3 4 13
4 4 5 1.5
T K 2 4 0
IS P S 3 1 4 3 4 0
4 4 5 0
T K 2 4 0
IS P 7 3 1 4 3 4 0
4 4 5 0
T K 2 4 0
S T0 1 3 1 4 3 4 1 4 .5
4 4 5 0
T K 2 4 0
Table 3.2. DNJ titres in different defined media.
S.lavendulae 31434 was able to produce DNJ in 3 of the 5 
media tested whereas S . subrutilus only produced it in 1 and 
even then at lower levels than 31434. S.lividans TK24 is a 
DNJ non-producer and so was used as a negative control in 
these experiments. The reason for the difference in the 
ability of these two normally producing strains to produce 
DNJ in these media is most likely to stem from them 
possessing slightly different mechanisms for the regulation 
of DNJ production. The difference has already been indicated 
by the temporal difference in the production of the 
hypothesised DNJ biosynthetic intermediate NJ in the two 
strains.
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It was also observed that the only media where DNJ production 
by S.lavendulae 31434 was observed were the ones which used 
either glucose or the glucose polymer starch as the main 
carbon source. However due to the small number of media 
tested and the fact that other components were also varied 
makes it impossible to say how important this pattern may be. 
As medium ST01 gave the highest production of DNJ, this was 
used as a starting point for the studies on the effects of 
different medium components on the production of DNJ. 
S.lavendulae 31434 was also used as it was the organism 
giving the highest production in the largest selection of 
media.
PRODUCTION OF DNJ BY S . L A V E N D U L A E  31434 IN MINIMAL 
OLUCOSB MEDIUM (MOA).
The fermentation of 31434 in MGA (Figure 3.6) shows a typical 
two phase separation of cell growth (as measured by dry cell 
weight) and DNJ production. This kind of pattern is seen for 
the production of most secondary metabolites, especially in 
media supporting a fast initial growth rate. The production 
of secondary metabolites is usually restricted to times in 
the fermentation when the growth rate is less than maximal 
due to the depletion of 1 or more growth limiting substrates 
(eg. carbon or nitrogen sources or phosphate). The production 
of secondary metabolites during the growth phase can be 
encouraged by cultivating the organism in a medium which only
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allows less than optimal growth, perhaps by the inclusion of 
a slowly utilised nitrogen source. In MGA, the production of 
DNJ by 31434 can be seen after 48h of incubation and has 
reached a maximum of 10.5 ng\ml by 95h. Comparison of the 
trehalase inhibition before and after heat\acid treatment 
indicates the presence of an acid\heat labile trehalase 
inhibitor on the fermentation from the time of inoculation to 
48h. Although no bioassay was carried out on these samples, 
it seems likely, knowing that NJ is produced by this strain 
and is an acid\heat labile trehalase inhibitor, that this 
inhibition is due to NJ in the fermentation. The detection of 
NJ at t=0h in the
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Figure 3.6. Fermentation of S.lavendulae 31434 in 
Glucose Medium (MGA).
Minimal
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fermentation can be explained by the presence of NJ in the 
small 48h fermentations used to inoculate the large 
fermentor. Another possibility is that the acid\heat labile 
inhibition of trehalase is due to proteases which degrade the 
trehalase being produced by the organism. However, since in 
control fermentations using the non-producing S.lividans TK24 
no such inhibition was seen, this option seemed unlikely.
No DNJ was produced in the medium until the growth of the 
cells had virtually stopped and the level of D-glucose had 
become significantly depleted. It may be that earlier on in 
the fermentation, the high levels of glucose or growth rate 
of the organism prevent the production of DNJ. The production 
of NJ does not appear to be under the same kind of control, 
being produced earlier in the fermentation when both the 
growth rate and the glucose concentration are high. If NJ is 
a biosynthetic precursor to DNJ, one might expect it to be 
subject to the same type of regulation at a molecular genetic 
level. However, if the delay in the appearance if DNJ is due 
to the inhibition of a synthase involved in the conversion of 
NJ to DNJ, and not due to repression of synthesis of the 
expression of the biosynthetic genes, then the temporal 
difference in the production of the two inhibitors could be 
reconciled with this. The biggest rises in the DNJ titre (ie. 
the highest rate of production) were seen immediately after 
the onset of its biosynthesis, and before the glucose became 
undetectable in the medium. It should also be noted that the 
dissolved oxygen level in the fermentation was seen to fall
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d u r i n g  th e  g ro w th  o f  th e  o rg a n is m  and was a t  i t s  lo w e s t 
d u r i n g  th e  p r o d u c t io n  o f  D N J. As th e  l e v e l  o f  DNJ i n  th e  
f e r m e n t a t io n  le v e l le d  o f f ,  i e .  p r o d u c t io n  came t o  a h a l t ,  th e  
c o n c e n t r a t io n  o f  d is s o lv e d  oxygen ro s e  a g a in . Th e  changes in  
d i s s o l v e d  o x y g e n  c o n c e n t r a t io n  d u r in g  t h i s  p e r i o d  a r e ,  
h o w e v e r , n o t  s i g n i f i c a n t l y  la r g e  t o  i n f e r  a n y  r e l a t i o n s h i p  
b etw ee n  them and th e  o n s e t o f  DNJ p r o d u c t io n .
EFFECT OF CARBON SOURCE ON THE PRODUCTION OF DNJ IN 
DEFINED MEDIA.
The production of DNJ by S.lavendulae 31434 in the basic ST01 
medium with various carbon sources was tested. A study on the 
effect of different carbon sources on the production of DNJ 
by Bacillus subtilis DSM 704 in a minimal salts medium with 
ammonium sulphate as nitrogen source has been described 
(Stein et al.. 1984) as has the effect of changing the carbon 
and nitrogen sources in a complex medium in its production by 
Streptomyces lavendulae MB-733 (Ezure et al., 1985).
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Carbon Source Dry weight cede
(mg/ml)
DNJO*0/ml) Specific DNJ
production (pg/mg)
O h ic o n 0.86 6.84 9.8
Starch 0 63 3.13
Mannose 0.81 0
Glycerol 0.69 0
Sucrose 040
Lactoae 0 2 9 0
Citric acid 0.22 0
No Carbon source 0.33 0
Table 3.3. DNJ production on different carbon sources in a 
defined medium.
The results of this study (Table 3.3) show that although 
glucose, soluble starch, mannose, glycerol and sucrose were 
all able to support the growth of S. lavendulae 31434, 
measurable amounts of DNJ were only produced when glucose, 
starch or sucrose were used. Although biomass was measured in 
the media with citric acid and lactose as carbon sources, the 
amount was no more than was seen in the control medium 
without any added carbon source in addition to the asparagine 
nitrogen source. The biomass produced in these media 
therefore probably reflects the utilisation of the asparagine 
as a carbon and nitrogen source. Although glycerol and 
mannose were found to yield the largest amount of biomass 
when used in the basal medium, neither was able to support
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the production of DNJ. The significance of the limitation of 
the production of DNJ to media containing glucose, starch or 
sucrose may reflect a need for glucose units, or enzymes 
involved in, or a product of the metabolism of glucose in the 
biosynthesis of the DNJ molecule. Contrary to these findings, 
Ezure reported the production of significant amounts of DNJ 
in a complex medium containing either glucose starch or 
glycerol as the main carbon source (Ezure et al., 1985). 
However as the medium used contained a complex nitrogen 
source, soyabean meal, the existence of other sugars such as 
glucose conjugated to components of the soyabean meal which 
could act as precursors in the biosynthesis of DNJ after the 
main carbon source is depleted cannot be discounted. 
Fructose, sorbitol and sucrose were found to support the 
production of DNJ by Bacillus subcilis DSM 704 at similar 
levels to glucose in a defined medium. When glycerol was used 
as carbon source, the amount of DNJ produced was only 2% of 
that produced on glucose (Stein et al., 1984). Although 
fructose acted as a carbon source for the production of DNJ 
by B.subtilis, it did not yield significant quantities with 
S . lavendulae MB-733 (Ezure et al., 1985), and was not 
included in the present study as S.lavendulae strains are 
unable to utilise fructose as a carbon source.
The observation that significant quantities of DNJ are 
generally produced on carbon sources which can provide either 
a glucose or a fructose unit may have implications for the 
biosynthetic pathway for DNJ.
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It is interesting to note that in this study, slightly higher 
titres of DNJ were produced when glucose was the main carbon 
source instead of the glucose polymer starch. This might 
indicate that glucose is not exerting a significant amount of 
suppression on the production of DNJ. Starch, from which the 
glucose units would be released more slowly might be expected 
to avoid any glucose effects on the production of DNJ.
EFFECT OF NITROGEN SOURCE ON THE PRODUCTION OF DNJ IN 
DEFINED MEDIA.
Both inorganic and amino acid nitrogen sources were tried as 
sole nitrogen source in the defined medium. Of these, only L- 
asparagine, L-arginine, L-proline, urea and sodium nitrate 
were able to support the production of DNJ, as shown in Table 
3.4. All of the nitrogen sources except L-valine were able to 
support significant growth of the organism. The highest 
specific production of DNJ (30.27^ig\mg mycelium) was measured 
with L-proline as the nitrogen source and next highest 
(11.63jig\mg mycelium) was seen with L-arginine. The slower 
growth rate promoted by the proline carbon source provided a 
better environment for the production of DNJ than the 
arginine and asparagine, both of which supported a higher 
amount of cell growth.
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NArogan Source D ry W *lg M  (m g/m l) D N J (pg/mO i 1 l\
L-Aaparaglna o .8 i 5.44 8.71
L-Tyroatna a s ? 0 0
L-A/glnlna 0.47 5.54 11.83
Sod ium  Nitrate 0.73 0.58 0.70
G lycine 0.43 0 0
L-G lutam lne 0.32 0 0
Urea a $ 7 3.58 0.74
L -tye lne 0.35 0 0
L-ProBne 0.1S 5.8 30.27
L-VaBne 0.04 0 0
Am m onium  Su lph ate 0.14 0 0
DL-Aapartate 0.23 0 0
L-Leuclne 0.44 0 0
L-T ryptop hM 0.301 0
N o N itrogen a o s s 0 •
Table 3.4. DNJ titres in a defined medium supplied with 
different nitrogen sources.
The production of DNJ in the basal medium from ST01 was 
compared with that in one used by Vilches et al. (1990) to 
study the effects of different nutrients on the biosynthesis 
of oleandomycin by S.antibioticus. Added nitrogen and carbon 
sources were the same. Although the highest dry weight was 
seen in the Vilches medium, the most DNJ was produced in the 
ST01 base (2.95 and 6.71ng\mg mycelium respectively). The 
reason for this is unclear but it may be due to the higher
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growth rate being incompatible with production of DNJ, or due 
to differences in the trace element solutions used in the two 
media.
EFFECT OF GLUCOSE:NITROGEN SOURCE RATIO ON THE 
PRODUCTION OF DNJ.
The glucose concentration was varied between 0 and lOOmM in 
media containing 10 or 20mM L-arginine or L-proline. For both 
nitrogen sources at each concentration, the concentration of 
glucose giving the highest titre of DNJ after 7 days was 
found to be 20mM (see Figure 3.7). Furthermore this was also 
the concentration giving the highest amount of biomass. 
Proline again proved to be a better nitrogen source than 
arginine for DNJ production and the 20mM nitrogen source gave 
in both cases the most DNJ and the highest dry weight. The 
20mM proline nitrogen source also allowed the production of 
DNJ in a medium containing a higher amount of glucose. 
7.13ng\ml was produced on 60mM glucose in the medium 
containing 20mM proline whereas none was made with this 
glucose
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Figure 3.7. The optmimum glucose:nitrogen source ratio for 
production of DNJ in a defined medium.
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concentration on lOmM proline. A possible reason for this 
could be that in the medium containing the higher amount of 
proline, more growth and glucose consumption can take place 
before the growth is halted due to the nitrogen source 
running out. When this happens, there is less glucose left at 
the end of growth to suppress the production of DNJ.
Again, cell growth was seen when no glucose was added as a 
carbon source showing that proline was able to act as both 
carbon and nitrogen source under these conditions.
EFFECT OF PROLINE CONCENTRATION ON PRODUCTION OF DNJ.
As 20mM glucose was found to give the highest production of 
DNJ at both 10 and 20mM proline, this concentration was used 
for further studies. When the proline concentration was 
varied between 0 and lOOmM, a different pattern was seen than 
that seen when the glucose concentration was varied. This is 
shown in Figure 3.8. The DNJ titre produced after 7 days 
incubation increased with proline concentration up to 40mM 
proline, with a maximum of 20.7 5^ig\ml DNJ being produced at 
this concentration. The highest yield of biomass was with 
20mM proline and no DNJ production at all was seen at proline 
concentrations of over 50mM.
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Figure 3.8. Effect of varying proline concentration 
production of DNJ in a defined medium.
EFFECT OF PHOSPHATE CONCENTRATION ON THE PRODUCTION
OF DNJ.
As can be seen from the results in Figure 3.9, the 
concentration of inorganic phosphate in the medium has a 
marked effect on the production of DNJ by S. lavendulae 31434. 
No growth or production was seen if no phosphate was added to 
the medium which is not surprising since phosphate is needed 
for the synthesis of cell components such as nucleic acids 
and in intermediates in primary metabolic pathways such as 
glycolysis. The most DNJ was produced with the lowest of the 
other phosphate concentrations used, 5mM. At concentrations 
above this, less and less DNJ was produced and at 20mM 
phosphate, no DNJ was seen at all.
These results indicate that the phosphate suppresses the 
production of DNJ but it cannot be said whether this is 
likely to be due to inhibition of biosynthetic enzymes or due 
to their repression by the phosphate.
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Figure 3.9. Suppression of DNJ production in a defined medium 
by phosphate.
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EFFECT OF ADDED AMMONIUM IONS ON THE PRODUCTION OF 
DNJ.
To see if DNJ production was suppressed by ammonium, 
different concentrations of ammonium ions, as ammonium 
sulphate, were added. The results are shown in Table 3.5. No 
DNJ was produced in media containing ammonium ions at lOmM or 
over and so it can be said that the production of DNJ 
suppressed by the addition of ammonium sulphate to the 
medium. It cannot be said whether it is due to inhibition or 
repression effects or whether it is due to a lowering of pH 
of the medium due to the import of ammonium -into the cell. 
Ammonium sulphate was found not to be a good nitrogen source 
for the growth of this organism (see earlier) which could be 
for the same reason. Without any method of pH control, it is 
not possible to determine whether the effect seen here is due 
to the effect of the ammonium or a change in pH.
Aiv>monlum concentration (m M ) D ry w alghl (mg/nri) Concentration at DN J (ÿsg/mQ
1.30 1 U
0.44 0
0.42 0
0.51 •
40 0.50 •
Table 3.5. Inhibition of DNJ production by ammonium sulphate.
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EFFECT OF INITIAL MEDIUM pH ON THE PRODUCTION OF DNJ.
Neutral and alkaline initial pH values were found to give the 
best production of DNJ and also the highest biomass, as shown 
in Figure 3.10. The optimum pH for DNJ production in this 
medium was 7.5 whereas the highest amount of biomass was seen 
with the initial pH at 9.0. The pH value of 7.5 may be most 
suitable because it provides a slower than optimum growth 
rate which is so often conducive to expression of the genes 
for secondary metabolite formation. A similar pattern is seen 
with the production of chlortetracyline. The optimum pH for 
the process is, at 5.8 to 6.0, slightly below the optimum pH 
for the growth of the producing organism (Weinberg, 1989). 
Although the data presented here give an indication of the 
best initial pH of the medium for a batch fermentation in 
which no pH control was being employed, a study involving 
fermentations under controlled pH conditions would be able to 
give details of the most beneficial pH for the medium during 
the actual phase of DNJ production.
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FERMENTATION OF S .LAVBNDULAB 31434 IN THE IMPROVED
DEFINED MEDIUM.
The time-course study in the improved defined medium (a 
combination of the best conditions from the defined medium 
studies) shows again that no DNJ is produced by the organism 
until a significant quantity of biomass has accumulated and 
most of the glucose has been depleted from the medium.
There was a longer lag phase before cell mass started rising 
compared to the fermentation in MG A, but this is probably due 
to the different inocula used. The MGA fermentation was 
carried out in a 2L Jar fermentor and inoculated with 48h 
grown cells, whereas this fermentation was carried out on 
small scale and was inoculated with spore suspension. There 
was a rapid increase in biomass, consumption of glucose and 
increase in DNJ titre between 90 and 135h and the curve of 
DNJ accumulation followed that of biomass accumulation fairly 
closely. The fact that DNJ synthesis was more closely coupled 
to cell growth in this medium may have been due to the change 
in the nitrogen source from asparagine, which would be 
assimilated fairly rapidly, to the more slowly assimilated 
proline.
The titre of DNJ at the end of the study (203h) was 14.8ng/ml 
and at 7 days incubation, it was 12^g/ml. Although this titre 
is less than was measured at 7 days incubation in the ST01 
medium used in the initial defined medium study, it must be 
considered that the spore suspension for inoculating the
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flasks, and the precise conditions of culture could have been 
slightly different in the two cases. The results of the 
different components of this study (eg. the effect of 
different nitrogen sources, or the effect of varying the 
proline concentration) are a better indication of the 
improvement made to the DNJ titre by these individual 
changes.
Figure 3.11. Fermentation of S.lavendulae 31434 in the 
improved defined medium.
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GENERAL CONCLUSIONS.
Although the experimental data presented here represents only 
a very limited survey of the factors affecting the production 
of DNJ different media, it has resulted in the design of a 
defined medium which supports fairly diffuse growth of 
S.lavendulae and a level of DNJ production of about 25% of 
that in the soyabean medium. It was hoped to be able to use a 
defined medium for the isotope incorporation studies 
described in the next chapter, but as the production in such 
media was not sufficiently high to allow easy isolation of 
the product (s), a variation on the soyabean medium of Ezure 
et al. (1985), using glucose as the main carbon source was 
devised instead. The data in defined media also gives helpful 
pointers with respect to the biosynthetic pathway and how the 
synthesis of this metabolite may be regulated. It is clear 
that a complicated series of interacting factors control the 
growth rate of the organism and its production of DNJ. 
Inorganic phosphate is clearly a suppressive factor and 
ammonium ions might also be. Glucose was always very low in 
samples which were found to contain DNJ. In fermentations 
using glucose as the carbon source, the glucose was almost 
depleted before the onset of production, strongly implicating 
that this is suppressing DNJ production in the fermentations. 
On the other hand glucose is the carbon source which supports 
the highest DNJ titres out of the sources tested. This might 
be explained by the need for a supply of glucose units which
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are readily accessible and not bound up in di- or 
oligosaccharides for the biosynthesis, or for enzymes or 
intermediates involved in the metabolism of glucose, in the 
biosynthesis of DNJ. Although glucose may be suppressive, it 
is also essential that glucose units are supplied to the 
growing cells as glucose, starch, or a disaccharide 
containing the glucose unit in order to create the right 
environment of enzymes or intermediates for the biosynthesis 
of DNJ.
It is interesting to note that the biosynthesis of 
streptomycin, an antibiotic which is derived from glucose, is 
also under glucose repression but is produced in a medium 
containing glucose as the main carbon source and soyabean 
meal as the nitrogen source (Shapiro, 1989) .
Growth rate alone seems not to be an important factor in the 
control of DNJ biosynthesis since in some experiments, but 
not all, the conditions giving the highest DNJ titres were 
also the ones giving the highest amount of biomass.
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CHAPTER 4. STUDIES ON THE BIOSYNTHETIC PATHWAY OP
DNJ .
4.1. INTRODUCTION.
Although secondary metabolites are produced with a large and 
diverse range of structures from simple amino sugars such as 
DNJ to large macrolide antibiotics including the 
antihelminthic avermectins, they are synthesised from a 
relatively small number of precursors. Figure 4.1 shows how 
some of these precursors, derived from primary metabolism, 
are used to make different types of secondary metabolite.
In Chapter 1, DNJ and DMJ were introduced as plant-derived 
alkaloids, but they may also be considered as belonging to 
the aminosugars which are produced by microorganisms. The 
biosynthetic origins of these two families of compounds are, 
however quite different. Alkaloids are generally derived from 
amino acids such as tryptophan or lysine whereas the 
aminosugars and aminocyclitols of antibiotics are all 
synthesised from D-glucose. Either of these two origins could 
be applicable to the biosynthesis of DNJ and so is worth 
considering in more detail.
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Figure 4.1. Major routes to secondary metabolites from
primary metabolism.
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Swainsonine is another glycosidase-inhibiting alkaloid which 
has been found in both plants and microorganisms. The 
biosynthesis of swainsonine in Rhizoctonia leguminicola has 
been shown start with lysine and is proposed to proceed as 
shown in Figure 4.2 (Harris et al., 1988a).
Swainsonina
Harris at ml., 1988a.
Figure 4.2. Biosynthesis of swainsonine from lysine.
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Direct proof of the involvement of the bracketed intermediate 
is, at this stage, not available. The same pathway is also 
used for the biosynthesis of swainsonine in the locoweed 
Astragalus oxyphysus, although a branching of the pathway 
leading to the formation of another alkaloid, slaframine, is 
missing in the plant (Harris et al., 1988b). Studies on the 
early stages of the biosynthetic pathway have shown that 
pipecolic acid is synthesised from lysine via saccharopine 
and A l ,6 -piperidine carboxylic acid (Wickwire et al., 
1990) . An amino nitrogen from the precursor amino acid is 
incorporated into the ring system during the cyclisation. The 
pathway involves two stereospecific hydroxylations, at C-2 
and C-8 , and an inversion of stereochemistry at C-8a via the 
formation of the iminium ion.
Glucose is the biosynthetic precursor to the sugar components 
of the aminoglycoside antibiotics (Umezawa et al., 1986). 
These antibiotics are made only of sugar units but other 
antibiotics, such as the macrolides also can have glycosidic 
components. The sugars used in antibiotics can be ones like 
mannose and glucose, taken directly from primary metabolism, 
or unusual sugars synthesised especially for, and used only 
in, antibiotics. Examples of the second type include the 
aminocyclitols streptidine and bluensidine, used in the 
construction of the antibiotics streptomycin and bluensomycin 
(see Figure 4.3) respectively.
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Streptomycin Bluensomycin
Figure 4.3.
During the biosynthesis of the aminocyclitols from D-glucose, 
the sugar backbone is incorporated intact into the product 
molecule, but its substituents can undergo a number of 
different transformations. These transformations include 
épimérisations, reductions, aminations, isomerisations, 
oxidations and dehydroxylations. They can be exemplified by 
the biosynthesis of streptidine shown in Figure 4.4.
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Figure 4 . 4 .  Biosynthesis of streptidine.
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The initial conversion of the D-glucose to myo-inositol 
provides the cyclitol base which is used for the biosynthesis 
of other cyclitol moieties of aminoglycoside antibiotics. The 
m y o -inositol is then oxidised by the enzyme m y o ­
inositol :NAD+-2-oxidoreductase to provide a carbonyl group 
for the introduction of an amino group into the molecule. 
Amination of the precursor by glutamine is accompanied by an 
inversion of stereochemistry and yields scyllo-inosamine. 
Scyllo-inosamine is then phosphorylated at the 4-position, 
and amidino group transferred from arginine to the existing 
amino group and then the product is dephosphorylated again to 
give guanidinodeoxy-scyllo-inositol. The hydroxyl group at C- 
2 is then oxidised and alanine acts as a donor for the amino 
group then transferred to this position. Phosphorylation at 
the C - 6  position and the addition of a second amidino group 
from arginine results in the production of streptidine-6- 
phosphate which is incorporated into the streptomycin 
molecule (Grisebach, 1978). The phosphate group is not 
removed from the streptidine unit until the final step in the 
streptomycin biosynthesis. This dephosphorylation activates 
the antibiotic and the introduction of the phosphate group is 
believed to act to protect the producing organism from an 
active form until it is ready for export out of the cell 
(Cundliffe, 1989).
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When considering possible routes for the biosynthesis of DNJ, 
pathways from lysine (Fig. 4.5) as in the case of 
swainsonine, and D-glucose (Fig. 4.6) as in the case of the 
aminosugars, were hypothesised.
Figure 4.5. Hypothesised biosynthesis of DNJ from lysine.
In the route from lysine, the nitrogen is provided by the 
lysine and is incorporated into the ring during cyclisation, 
as in the biosynthesis of swainsonine, to pipecolic acid. The 
carboxyl group could then be reduced to a hydroxymethyl group 
and then three stereospecific hydroxylations at positions 2,3 
and 4 would lead to the production of DNJ. A  further 
hydroxylation at C-l would produce NJ, but it is not 
hypothesised as a precursor in this route. Indeed, DNJ would
Lysine
OH
DNJ
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be more likely to act as a precursor to NJ if this pathway 
were in operation.
CHO CHO
CH 2OH
Nojirimycin DNJ
Figure 4.6. Hypothesised biosynthesis of DNJ from D-glucose.
The pathway from D-glucose does not require any 
stereospecific hydroxylations but just the introduction of an 
amino group at C-5 to yield NJ upon cyclisation, which can 
then be converted easily to DNJ. At the time of commencement
of these studies, nothing had been published on the 
biosynthetic pathway of DNJ apart from a mention that NJ was 
derived from glucose via an inversion of the sugar backbone 
(Yamaguch and Yonehara, 1967). However, it appears that full 
details of this finding were never published.
The finding that NJ was made in fermentations where DNJ was 
also produced (Ezure et al., 1985) including that of 
S.subrudlus 445 (see Chapter 3), either before or at the 
same time as DNJ, and the similarity in these two compounds 
made the hypothesis that NJ was a precursor to DNJ 
reasonable. This, coupled with the mention of NJ biosynthesis 
from D-glucose and the aminosugar biosynthesis only from D- 
glucose, suggested that this sugar was the more likely 
precursor. Hence the isotope incorporation studies were 
started using isotopically labelled D-glucoses.
The biosynthetic significance of the presence of DMJ in DNJ- 
producing fermentations (Ezure et al., 1988; Chapter 2, this 
thesis) was not established at this stage although the 
incidence of the DNJ, DMJ and NJ in the fermentations of both 
S.lavendulae 31434 and S.subrutilus 445 was taken as an 
indication that the same pathway was probably being used in 
the two strains, which are taxonomically very closely 
related.
Evidence from the nutritional studies in Chapter 3 also 
pointed towards D-glucose as the biosynthetic precursor for 
DNJ. Firstly, carbon uources supporting production of DNJ 
were ones which could provide a glucose unit to the organism.
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with the more accessible forms of glucose allowing more DNJ 
production. Secondly, if lysine was a precursor for DNJ 
production, one might expect it to have some stimulatory 
effect on DNJ production when fed to the medium. No such 
effect was seen, in fact no DNJ production at all was seen 
when lysine was used as a nitrogen source.
All of the work described in this section was carried out in 
collaboration with David Hardick of the Department of 
Chemistry, University of Warwick, except the personal 
communications, which are his work alone.
4.2. MATERIALS AND METHODS.
4.2.1. ISOTOPE INCORPORATION STUDIES.
INCUBATION OF LABELLED PRECURSORS WITH S . S U B R U T  I L U  S 
445 .
The medium used was soyabean medium with the soluble starch 
carbon source replaced by D-glucose at a concentration of 
4g\l. DNJ concentrations at the end of the fermentations were 
assayed by the standard trehalase inhibition assay and by the 
gas chromatographic method, both of which are described in 
Chapter 2.
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I1-2H]-D-glucose (lg, 98 atm. %2H, Aldrich) was used to 
make up 750ml of the medium. The remaining 2g D-glucose 
needed being made up with unlabeled material. The medium was 
divided up into 30ml aliquots and autoclaved. Each 30ml 
aliquots were inoculated with S . subrut i1 us 445 spore 
suspension (lOOjil, 107 spores), incubated at 28°C, 190
r.p.m., for 7 days and pooled before isolation of the DNJ and 
DMJ. Analysis of the isotope incorporation pattern was then 
carried out.
INCUBATION WITH [l-aH]-D-GLUCOSB.
INCUBATION WITH [1-13C ]-D-OLUCOSB .
[1-1 3C]-D-Glucose (250mg, 98.7 atm. %1 3C, obtained from
Aldrich) was used to make up 125ml of medium. The remaining 
250mg D-glucose was made up from unlabeled material. The 
fermentation was then carried out as above.
INCUBATION WITH [2-aH]-D-OLUCOSB.
[2-2H]-D-Glucose (0.5g, obtained from D. Hardick) was added 
to 1.5g of unlabeled D-glucose and used to make up 500ml of 
medium. The fermentation was continued as above.
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FERMENTATION IN DEUTERIUM OXIDE.
The medium (100ml) was made up in deuterium oxide (100%) and 
divided into 30ml aliquots. The aliquots were autoclaved and 
then inoculated and incubated as for the [ 1-2H]-D-glucose
incubation. Unlabelled DNJ (2 0 mg) was added to the
fermentât ion prior to the isolation to facilitate the
isolation of a sufficient quantity of DNJ for 2H NMR
analysis.
INCUBATION WITH [6 ,6 -aHa] -NOJIRIMYCIN.
The medium was made up using 100% unlabeled D-glucose and 
divided into 30ml aliquots. After autoclaving, each aliquot 
was inoculated with S. subrutilus 445 spore suspension (100|il, 
107 spores) and incubated at 28°C, 190 r.p.m.. During the 
fermentation, I6 ,6-2H2 l-NJ (obtained from D. Hardick) was 
added in two aliquots of 0.775 mg each 70h and 119h after 
inoculation. After 7 days, the fermentations were pooled and 
the DNJ\ DM J isolated and the isotope incorporation pattern 
analysed.
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ISOLATION OF DNJ AND DNJ.
The isolation procedure used was as described in Chapter 2 up 
to and including the alumina column step. Sometimes the 
separation of the two compound achieved on the alumina was 
sufficient for analysis without further purification, or the 
DNJ\DMJ mixture was also sometimes subjected to analysis 
straight from this step. Alternatively, the two compounds 
were further separated on a silica column using 30% ethyl 
acetate in dichloromethane as solvent after having been 
acetylated.
ANALYSIS OF ISOTOPE INCORPORATION PATTERNS.
Positioning and incorporation of the isotopes was analysed 
using 1 3C, *H and 2H NMR which was carried out on a Bruker 
WH400, Bruker ACF 250MHz or a Perkin Elmer 220MHz 
spectrometer. Samples of acetylated DNJ or DMJ were run at 
90°C in d-pyridine. Samples of free DNJ or DMJ were run in 
deuterium oxide at 25°C. Incorporations were also analysed 
using mass spectrometry. Mass spectra were run on a Kratos 
MS80 spectrometer using ammonia chemical ionisation.
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4.3. RESULTS AND DISCUSSION.
Table 4.1 shows the results of the isotope incorporation 
studies.
Labeled substrats %  Substrate labeled Labeled product«) «  Product labeled *  Dilution odabel
[1-*H]-0-Qlucoee 33 (O-HJ-ONJ , Pro-S proton 
[©-■ Hl-DMJ/ot C-6 labeled
21.7
21.9 3
8
[2-*H]-D-Glucoee 25 [»-■HJ-DNJ. Pro-R proton 
[6-*H]-DMJ/ 0(04 labeled
5.8 23
6.5 26
[1-'*C]-D-Qlucoee 50 [S-’*CJ-DNJ
[8--CJ-DMJ 33 M
(•.M il-N J m [6,6-*H)-DNJ
[6,S-*H]-DMJ N/A N/A
•HJO 100 NONE 0 0
Table 4.1. Results of isotope incorporation studies.
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The incorporation of 2H and 13C labels from D-glucose into 
specific positions in DNJ and DMJ during the fermentation of 
S.subrutilus 445 confirm that these compounds are both 
derived biosynthetically from D-glucose. The glucose in the 
medium at the start of the fermentation would have been used 
for the growth of the organism prior to being used in DNJ 
biosynthesis and so a reduced proportion of the original 
label in the medium would be recovered in the DNJ and DMJ. 
The results from the C-l and the C-2 labeled glucose 
incubations also show that the biosynthetic pathway for DNJ 
and DMJ involves a head to tail (C-l to C-6 ) inversion of the 
carbon backbone of the molecule, as reported for the 
biosynthesis of NJ (Yamaguchi and Yonehara, 1967). This 
evidence supports the hypothesis that NJ is a precursor to 
DNJ. The finding that both C-l and C-2 labeled glucose 
incubations led to the incorporation of the label into the C- 
6 of DNJ and DMJ is consistent with an isomerisation of the 
glucose to fructose via an enediol during the biosynthesis of 
the two compounds. Such an isomerisation is shown in Figure 
4.7. The transfer of the deuterium from the C-2 position to 
the C-l position during the isomerisation results in its 
incorporation into the C - 6 position of both DNJ and DMJ after 
the inversion of the sugar backbone. The biosynthesis of the 
aminosugar mycosamine, found in polyene macrolide antibiotics
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has also been hypothesised to involve the formation of an 
enediol intermediate (Martin, 1977).
D-Glucose Enediol intermediate
Figure 4.7. Glucose to fructose isomerisation showing 
movement of deuterium label from C-2 to C-l.
The involvement of glucose isomerase or glucose-6-phosphate 
isomerase, whose mechanisms both use a cis-enediol 
intermediate (Rose, 1975), is implicated by the pattern of 
deuterium incorporation seen with incubations with 1- and 2- 
deuteroglucoses. The deuterium from the C-l of glucose was 
incorporated into the pro-S position at C-6 of DNJ and the 
one from the [2-2H]-D-glucose was incorporated into the pro-R 
position of DNJ. This pattern is consistent with the one 
given by the catalysis of the isomerisation by either glucose 
isomerase or glucose-6-phosphate isomerase (Bock et al., 
1983) .
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The dilution of the label from [1-2H]-D-glucose and 11-13C ] - 
D-glucose to 66% of their original value in the glucose added 
to the medium at the start of the fermentation probably 
arises from the use of glucose units from other sources eg. 
soyabean meal in the biosynthesis of DNJ. The finding that 
DNJ can be synthesised in the soyabean medium even when no D- 
glucose is specifically added to it (see Chapter 3, the 
effects of glucose concentration on DNJ production by 
S .subrutilus 445 in soyabean medium) supports this point. The 
glucose units required are probably present in the soyabean 
meal as glucosides which will only be liberated for use as a 
carbon source by the organism once the more accessible added 
source is well depleted. This source would only make up a 
very small proportion of the total available glucose at the 
start of the fermentation, but by the time that the 
biosynthesis of DNJ begins, the added glucose pool is 
depleted to such an extent that these other (unlabeled) 
sources of glucose are able to make up a much larger 
proportion of the glucose available for DNJ biosynthesis. It 
may be that in S.lavendulae 31434, where NJ is made early on 
in the fermentation, the dilution of the label could be much 
smaller due to its incorporation into the biosynthetic 
intermediates at a stage when the glucose pool contains a 
much larger percentage of label. Time did not permit 
investigation of this point.
When 12-2H1-D-glucose is used, a much greater dilution of the 
deuterium label is observed, to approximately 23-26% of its
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original value, compared to dilution to 66% with the C-l 
labeled compounds. This could be due to exchange of the 
deuterium during transfer from C-2 to C-l of glucose by the 
isomerase with an unlabeled proton from the solvent whilst 
bound to the enzyme. In an attempt to verify this, a 
fermentation was carried out with the medium made up in 
deuterium oxide (100%). If an exchange of the deuterium label 
with protons in the water was ocurring, as described, one 
would expect a fermentation in deuterium oxide to result in 
the incorporation of deuterium label into the DNJ produced. 
The lack of label in the DNJ isolated at the end of the 
fermentation was surprising and the reason for it unclear. 
The lack of incorporation may be due to a kinetic isotope 
effect, causing the incorporation of protons present in the 
medium due to exchange with groups on the media components in 
preference to deuterium from the deuterium oxide. It is worth 
noting that only a 2% incorporation of deuterium into 
fructose was seen when glucose was incubated with glucose 
isomerase in deuterium oxide at neutral pH, a percentage 
which increased slightly with increasing pH (Bock et al., 
1983), despite an earlier report that almost all aldose- 
ketose isomerases show some exchange with the solvent (Rose 
et al.,1975).
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Figure 4.8. First pathway proposed for the biosynthesis of DNJ 
and DMJ from D-glucose.
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On the basis of the above results, the pathway in Fig. 4.8 
was proposed for the biosynthesis of DNJ and DMJ from D- 
glucose (Hardick et al., 1991). Following the isomerisation 
of D-glucose to fructose, it was proposed that an oxidation 
at C-5 and an amination at C-2 would lead to the formation of 
(3). To avoid the incidence of a symmetrical intermediate 
which would presumably have resulted in the equal labelling 
at C-l and C-6 of the DNJ, the amination would have to occur 
before the oxidation step. Alternatively, phosphorylation of 
the glucose at C-6 would lead to the required asymmetry, as 
would the the conjugation to a nucleoside diphosphate via C-l 
as is seen for the biosynthesis of deoxysugars (Grisebach, 
1978). If the transformation were to take place whilst the 
intermediate was still enzyme-bound, the problem would also 
be avoided.
Isomerisation of (3) to (4), in a reverse of the (1) to (2) 
conversion, could result in the formation of either (4a) or 
(4b), depending on which face of the carbonyl group in (3) 
was attacked. This would require the action of one enzyme 
which could act on either face of the carbonyl group, or two 
enantiospecific enzymes, each acting on only one of the 
faces. The linear forms would cyclise to give (5a) and (5b), 
with the inversion of the glucose carbon backbone ocurring 
due to the cyclisation occurring between the aldehydic group 
at what was C-6 of glucose and the amino group at the 
original C-2. This leads to the C-l of glucose becoming the
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exocyclic C-6 of NJ (5a) and NJ B (5b) . These compounds are 
then dehydroxylated at C-l to form DNJ (6a) and DMJ (6b) . The 
occurrence of NJ and DMJ in the fermentations of S.subrutilus 
445 can be explained by this pathway which also hypothesises 
the existence of manno-NJ (NJ B) in the fermentation, 
although this compound has not specifically sought during 
this study. It should be noted that NJ B has been co-isolated 
with NJ from S.lavendulae SF425 fermentations (Niwa et al., 
1984).
The role of NJ as a precursor to DNJ was confirmed by the 
results of the incubation with (6 ,6-2H2 l -NJ. The label was 
incorporated into both DNJ and DMJ from the deuterated NJ 
indicating that either an epimerisation between the gluco- 
and manno- forms of NJ or DNJ was taking place, or that the 
transformation from (3) to NJ was operating in reverse so 
that (3) could then be converted to the DNJ branch of the 
pathway. The latter of the two could not be the case, since 
both of the C-6 protons of DNJ and DMJ were labeled from 
[6 ,6 -2H2 ]-NJ, and this would not be the case if conversion 
back to the aldehyde group at the new C-6 had occurred. 
Incubation with [5-2H]-D-glucose led to the incorporation of 
the deuterium label into the C-2 position of DMJ without the 
labeling of DWT (D. Hardick, personal communication) 
confirming that an isomerisation takes place from NJ B to NJ 
via a carbonyl group, resulting in the lack of label in the 
DNJ. Negligible incorporation of label into DMJ is seen when 
deuterium labeled DNJ is fed to the fermentation (D.Hardick,
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personal communication) and so one can conclude that the 
epimerisation takes place at the NJ level. Furthermore, the 
observation that the label from the C-5 of glucose is 
incorporated into either of the products shows that there is 
no carbonyl group at the new C-2 in any intermediate prior to 
NJ B, thereby showing that (3) in figure 4.8 is not an 
intermediate.
in the light of the results from the incubations with [6,6- 
2H 2 l-NJ and [5-2H]-D-glucose, the revised biosynthetic 
pathway shown in Figure 4.9 is proposed.
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Figure 4.9. Revised biosynthetic pathway to DNJ and DMJ from 
D-glucose.
The order of the amination at C-2 and the oxidation at C-6 of 
fructose is unclear, as is the precise stage at which the
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epimerisation takes place. It may be that the reaction takes 
place at the NJ B level only or at both the NJ B and the DMJ 
levels. The epimerisation cannot only be taking place at the 
DMJ level, or the NJ found in the fermentations of 
S.subrutilus would not be formed. The reaction could be 
catalysed by a single enzyme acting on both NJ B and DMJ, or 
on two different enzymes acting on one each. The proportion 
of the DNJ and DMJ produced therefore depends on the affinity 
of the epimerase for the manno- form relative to the gluco- 
form. Epimerases have been found to be involved in the 
biosynthesis of 3,5-deoxysugars of gram negative bacteria 
(Melo and Glaser, 1968; Gaugler and Gabriel, 1973), and 3,5- 
epimerases are also involved in the biosynthesis of some 
aminosugar and aminocyclitol components of antibiotics, such 
as the streptose moiety of streptomycin in S . griseus (Wahl ee 
al., 1975). The reaction catalysed by the 3,5-epimerase in 
dihydrostreptose biosynthesis is shown in Figure 4.10.
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Wahl » t a l . .  1975.
Figure 4.10. Reaction catalysed by 3,5-epimerase during the 
biosynthesis of the dihydrostreptose unit of streptomycin.
The question of the source of the amino group introduced into 
the molecule has not been addressed in this study. The most 
likely candidate for the amino donor is glutamine, which acts 
as an amino donor in the biosynthesis of streptidine. Alanine 
also donates an amino group for the biosynthesis of 
streptidine, but it is a weaker donor than glutamine, as is 
glutamate (Umezawa et al., 1986).
In biosynthetic pathways from D-glucose, the transformations 
are very often carried out on the the sugar after it is 
conjugated to a nucleoside diphosphate, such as uridine 
diphosphate (UDP), or another group. Sugar nucleoside 
diphosphates are the precursors in the biosynthesis of 
deoxyhexoses in bacteria (Grisebach, 1978). Mycarose, for 
example, is synthesised as its TDP-derivative from TDP- 
glucose in S.griseus (Pape and Brillinger, 1973). The
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biosynthesis of the streptidine component of streptomycin 
involves the phosphorylation of the intermediates rather than 
their derivatisation with a nucleotide diphosphate (see Fig. 
4.4). Whereas the nucleosides are attached to the C-l 
position of the sugar, the phosphate groups are added to the 
C-6 position.
The intermediates in the biosynthetic pathway of DNJ may also 
be derivatised. In the majority of the fermentations, the 
labeled compound was the precursor and only the final product 
was analysed and so intermediates could have been derivatised 
but no evidence of that is seen. The fact that deuterium was 
incorporated into DNJ and DMJ from underivatised deutero-NJ 
shows that if another group has been introduced into the 
molecule, such as a nucleoside diphosphate or a phosphate 
group, then it has been removed by the NJ stage. This is 
understandable since the free NJ is found in the fermentation 
of S.subrutilus 445. If the intermediates in DNJ biosynthesis 
are derivatised it is unlikely that they have a nucleoside 
diphosphate group attached at the C-l position as this would 
be expected to interfere with the action of the isomerase 
during the glucose to fructose isomerisation. Phosphorylation 
at C-6 is more likely but the intermediate would have to be 
dephosphorylated prior to the oxidation of that group to the 
aldehyde and the formation of the NJ B. The inclusion of a 
dephosphorylation step may lead to the same kind of 
inhibition of product formation by the inhibition of a 
phosphatase as seen in the biosynthesis of streptomycin. In
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Che nutritional studies, inorganic phosphate was found to 
inhibit the production of DNJ in S.lavendulae 31434, which 
probably follows the same pathway. Alternatively, the 
complete biosynthesis of DNJ could take place without and 
such derivatisation of the intermediates at all.
In summary, it is clear that the biosynthesis of DNJ and DMJ 
from D-glucose in S .subrutilus 445 follows a pathway which 
shows many similarities with the biosynthesis of aminosugars 
and aminocyclitols in other Streptomyces and related 
organisms. This is in contrast to the biosynthesis of other 
alkaloids, such as swainsonine, in plant and fungi, which are 
made from amino acids including lysine and tryptophan. It 
would be very interesting to see whether the same path is 
used in the mulberry to make DNJ and in Lonchocarpus sp. to 
make DMJ.
Swainsonine biosynthesis follows the same pathway in both the 
fungus Rhizoctonia and the plant Astragalus (Harris et al., 
1988b). It has been hypothesised that this could be due to a 
transfer of the genetic information needed to make the 
swainsonine from the microorganism to the plant. A similar 
situation may be the case for DNJ and DMJ biosynthesis in 
plants and microorganisms. The soil provides an environment 
for the intimate contact between soil microorganisms, such as 
streptomycetes, and the rhizosphere of plants, facilitating 
infection and the transfer of genetic material between the 
two. Leguminous plants, of which Lonchocarpus is an example, 
are well known for their participation in such interactions.
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If the same biosynthetic pathway were found to be used for 
the synthesis of DNJ in plants, then this would be good 
evidence for the transfer of the biosynthetic genes from the 
microoganism to the plant. The occurrence of DNJ in the 
mulberry and DMJ in Lonchocarpus might be accounted for by 
two different transfer events where genes for different parts 
of the pathway failed to be transferred or that the 
capability of making one of the compounds in each plant was 
lost during the evolution of the plant.
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CHAPTER 5. ATTEMPTED CLONING OF THE BIOSYNTHETIC
GENES FOR DNJ.
5.1. INTRODUCTION.
The development of recombinant DNA methodology suitable for 
application to Streptomyces and their production of secondary 
metabolites has led to the accumulation of important data 
concerning the organisation and regulation of genes involved 
in these processes, about their products, and their 
evolution. As with other areas of research on secondary 
metabolism, most of the information available is concerned 
with antibiotics, and a relatively small number of these have 
been studied in any great detail. The advantage of dealing 
with compounds with antibiotic activity is their ease of 
detection with a suitable indicator organism. This is 
particularly useful when screening for possibly only a single 
producing colony amongst thousands.
ORGANISATION OF ANTIBIOTIC BIOSTNTHETIC GENES.
Genetic analysis has shown that the biosynthetic genes for 
antibiotics are generally clustered (Jones, 1989; Seno and 
Baltz, 1989). The biosynthetic cluster for methylenomycin in 
S.coelicolor is situated on the SCPl plasmid (Kirby and
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Hopwood, 1977) but is the only example of a plasmid borne 
biosynthetic cluster found so far, the chromosome being the 
more usual location. Seno and Baltz (1989) do, however, 
hypothesise that some of the clusters which are believed to 
be located on the chromosome of the producing streptomycete 
will in fact turn out to be located on large linear plasmids 
also carried by some strains.
The biosynthetic clusters contain all of the genes encoding 
the biosynthetic enzymes in addition to any resistance 
determinants. In some cases there is a sub-clustering of the 
biosynthetic genes, with the genes for enzymes acting early 
on in the biosynthetic pathway being positioned together and 
apart from the genes acting later on in the pathway. The 
“late“ genes may also be clustered together. Such internal 
organisation is seen in the biosynthetic gene clusters of 
antibiotics including tylosin (Seno and Baltz, 1989), 
actinorhodin, (Malpartida and Hopwood, 1984), and 
tetracenomycin C (Motamedi and Hutchinson, 1987). Sub­
clustering is not a general pattern though and does not apply 
to the organisation of other biosynthetic genes such as those 
for chloramphenicol (Vats et al., 1987) or undecylprodigiosin 
(Seno and Baltz, 1989) .
One or more resistance genes is usually also clustered with 
those for the biosynthetic enzymes, along with positive or 
negative regulatory elements. The clustering of the 
biosynthetic and resistance genes may be important for 
insuring that they are all expressed at the same time and
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that sufficient resistance is conferred to cover the amount 
of antibiotic being made. This organisation would also 
minimise the chance losing of the resistance gene without 
also losing the biosynthetic capability. An organism may 
possess two resistance mechanisms to a given antibiotic, one 
to protect against the antibiotic when it is made by the 
organism itself and another to protect against the antibiotic 
when it is encountered by chance after being produced by 
another organism. As these two situations would involve 
different levels of the antibiotic and possibly occur at 
different stages of growth, then the two resistance genes 
need to be under different types of regulation. This type of 
situation is seen with kanamycin resistance in the producer 
S.kamtmyceticus (Seno and Baltz, 1989) .
The clustering of the biosynthetic and resistance genes for 
an antibiotic has made their cloning and study considerably 
less difficult than if they had been spread randomly around 
the genome
STRATEGIES EMPLOYED POR THE CLONING OP GENES INVOLVED 
IN THE BIOSYNTHESIS OP ANTIBIOTICS.
The cloning of a gene, or genes, initially involves the 
construction of a gene library in a suitable vector. The 
methods used in the construction of the library are basically 
the same for all cases, but the strategy used for the
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screening of the library for the genes involved in antibiotic 
production depends largely on how much information, of a 
biochemical and genetic nature, is available on the 
antibiotic and its production. The construction of a gene 
library can use a bacteriophage, such as $C31, or a plasmid 
as a vector. Plasmid vectors are most often used and many are 
available in various sizes and copy numbers. The choice of 
vector for a cloning program is important since some can 
accommodate larger pieces of DNA than others and the 
existence of a gene in more than one copy might be lethal in 
some cases making the use of a single copy plasmid essential 
for the successful cloning of such a gene. Plasmids have been 
engineered from naturally ocurring plasmids including SCP2 
from Streptomyces coelicolor (Lydiate et al., 1985; Bibb et 
al., 1980) to include markers for easy selection of 
transformants containing plasmids with inserts. For example, 
the often used pIJ702 has been engineered to contain the 
thiostrepton resistance gene from S. azureus and the melanin 
gene from S. antibioticus (Jones, 1989).
Construction of a gene library involves the partial digestion 
of the genome of the producing organism using a restriction 
endonuclease to produces fractions of the genome of different 
sizes. The pieces are then taken and ligated into the cloning 
site of a plasmid which has been cut with the same, or a 
compatible, restriction endonuclease. The cloning site of 
pIJ702 is located in the melanin gene so that insertional 
inactivation of this gene occurs when a DNA fragment is
190
ligated into it. Upon transformation of a suitable host, 
those containing plasmid can be selected for using the 
resistance to thiostrepton that they will have acquired from 
the plasmid and those with a plasmid with an insert by 
visually locating those thiostrepton resistant colonies which 
cannot make melanin.
Screening for transformants containing antibiotic production 
genes is carried out using a number of different methods, 
alone or in conjunction with one another. If little or 
nothing is known about the biochemistry or genetics of the 
production of the antibiotic in question, then the 
transformation of a non-producing host and screening the 
transformants for production of the antibiotic is one of the 
options available. This method requires the cloning of large 
pieces of DNA (at least 10Kb) to give the best possibility of 
including all of the biosynthetic genes, and any resistance 
determinants and regulatory elements, needed for the 
biosynthesis of the antibiotic without self-destruction of 
the producer. Although this procedure may be used alone to 
clone biosynthetic pathways, it is more likely to be used 
with other methods to verify that all of the cluster is 
included on a fragment of DNA which has been detected using 
one of the methods described below.
Blocked mutants are very useful tools for the study of both 
the genetics and biochemistry of the biosynthesis of an 
antibiotic and also in the cloning of the genes involved. A 
blocked mutant is a mutant form of an antibiotic producing
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organism which has an aberration in one of the genes needed 
for the biosynthesis of the antibiotic. Because of the change 
in the gene, its product is no longer functional and so the 
antibiotic is not made. The mutation may be in a gene 
encoding an enzyme involved in the biosynthetic pathway, or 
in one of the regulatory elements. Feeding studies, where an 
intermediate produced by one blocked mutant is able to be 
converted into the antibiotic product by another mutant which 
is mutated in a different gene in the pathway can be used to 
put the mutants in order of the biosynthetic steps which they 
are blocked in. The analysis of the intermediates which build 
up in the blocked mutants will also allow identification of 
intermediates in the biosynthetic pathway. If a blocked 
mutant is transformed with vector carrying an intact copy of 
the gene which has the mutation and the gene is expressed, 
the production of the antibiotic will be restored. This 
complementation of the mutation can easily be screened for 
amongst transformants. In addition to the gene to complement 
this particular block, the cloned fragment may also contain 
other adjacent biosynthetic genes, which can be tested for by 
the complementation of mutants blocked in other genes, and 
may indeed contain the whole biosynthetic cluster and be able 
to confer production of the antibiotic on a non-producing 
species.
Complementation of blocked mutants is widely used in cloning 
strategies and has successfully been applied to the cloning 
of the biosynthetic clusters for actinorhodin form
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S.coelicolor (Malpartida and Hopwood, 1984), bialaphos from 
S . hygroscopicus (Murakami et al.,1986), undecylprodigiosin 
from S.coelicolor (Feitelson and Hopwcod, 1983), 
tetracenomycin C (Motamedi and Hutchinson, 1987) and 
cephalosporin form S . clavuligerus (Piret et al., 1990), 
amongst others. Apart from being used to clone clusters of 
genes, the complementation of blocked mutants is used to 
analyse the gene content of fragments of DNA cloned by the 
other methods. The advantage of using the blocked mutant 
complementation method is that only one of the genes needs to 
be cloned to achieve a positive result, this gene can then be 
used as a probe to detect that gene in clones containing 
larger fragments of the producers DNA which will hopefully 
also contain additional parts of the cluster. No previous 
genetic or biochemical knowledge of the biosynthesis is 
required for the application of this method but the 
generation of the blocked mutants required can be tedious and 
difficult in Strepiomyces (Jones, 1989).
If a resistance gene has been or can be cloned then the 
observation that resistance genes are often clustered with 
the biosynthetic genes can be used to find these biosynthetic 
genes in the same way that one gene found by blocked mutant 
complementation can be used to find others clustered with it. 
The initial cloning of the resistance gene requires the 
generation of a gene library from the producer in a host 
which is sensitive to the antibiotic and the screening of the 
transformants for resistant colonies. This method requires
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that the resistance and antibiotic biosynthetic genes are 
clustered together and will not be applicable to the 
biosynthetic clusters of non-antibiotic secondary 
metabolites. Neither biochemical or genetic information is 
needed for this approach, which has been applied, for 
example, to the cloning of a 35Kb fragment of DNA from 
Saccharopolyspora erythraea encoding resistance to and 
production of erythromycin, cloned into Streptomyces lividans 
(Stanzak et al.. 1986), and in the cloning of the bialaphos 
biosynthetic cluster from S.viridochromogenes (Hara et al., 
1991).
If more of the biochemistry of the biosynthetic pathway is 
known, then it may be possible to screen for clones 
containing the gene for a specific biosynthetic enzyme. This 
can be done in a number of ways. Detection of the enzyme 
product can be carried out if a suitable biochemical enzyme 
assay type detection system is available, as in the cloning 
of the p-aminobenzoic acid synthetase of candicidin 
biosynthesis in S.griseus (Gil and Hopwood, 1983), or if an 
antibody to the enzyme has been generated to which a label 
can be attached. Both of these systems require that the 
cloned genes are expressed in the host, as do the 
complementation and total cloning approaches already 
described. A third method for looking for a clone containing 
a gene for a particular product does not require the 
expression of that gene but does need an amino acid sequence 
for at least some of the enzyme to be available. An
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oligonucleotide probe is constructed with a sequence which 
corresponds to the amino acid sequence of part of the enzyme 
and then is used to probe a library for the gene. A 44b 
probe, corresponding to the amino terminus of the macrocin-O- 
methyl transferase, an enzyme involved in the biosynthesis of 
tylosin and its use to probe a genomic library in a 
bacteriophage vector led to the identification of a 40Kb 
fragment of DNA coding for 9 biosynthetic genes and a 
resistance determinant from the producer S.fradiae (Cox et 
al., 1986). This approach has also been used in the cloning 
of the deacetoxycephalosporin C synthetase gene from 
S.clavuligerus (Kovacevic et al., 1989).
The cloned genes for two enzymes in the biosynthesis of 
actinorhodin have been used to probe gene libraries from 
other polyketide antibiotic producers, who use very similar 
enzymes in their biosynthsis, and have successfully located 
biosynthetic genes for milbemycin in S . hygroscopicus and 
granaticin in S.violaceoruber (Malpartida et al., 1987). This 
technique may also be applicable to the cloning of 
biosynthetic clusters for other families of antibiotics using 
similar enzymes.
When a plasmid is used as a cloning vector, integration of 
the cloned genes and vector into the host cell genome does 
not usually occur. When the cloned DNA has homology to part 
of the host cells chromosome, for example when the donor is a 
mutant form of the host strain, however, homologous 
recombination resulting in the incorporation of the vector
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and insert into the host cell DNA can occur. The method of 
mutational cloning relies on this event and was used in the 
cloning of the methylenomycin (Chater and Bruton, 1983) genes 
which are situated on the SCPl plasmid of S.coelicolor (Kirby 
and Hopwood, 1977). A gene library was constructed in phage 
$C31 KC400 which was then used to transfect the 
methylenomycin producer. If the $C31 KC400 contained a piece 
of a methylenomycin gene, then homologous recombination with 
the corresponding gene in the host would lead to the 
insertion of the vector as into the gene, thereby 
inactivating it. Screening for a disruption of methylenomycin 
production would therefore show which transformants had the 
virus integrated into one of the methylenomycin genes.
The strategy chosen for the cloning of genes involved in 
antibiotic biosynthesis depends on how much is known of the 
system. The approaches described above which involve the 
hybridisation of cloned DNA to an oligonucleotide probe do 
not require the expression of the gene in the host whereas 
those based on the detection of a product do. The expression 
of cloned genes in a heterologous host appears not to be 
subject to many restraints (Jones, 1989), but the choice of 
host is still very important since restriction systems in a 
heterologous system might degrade DNA which is foreign. In 
all cases, one must be aware of the possibility of switching 
on previously silent genes in the host by the introduction of 
foreign DNA. A silent phenoxazinone synthetase gene was 
activated in S.lividans by the transformation with cloned DNA
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from S.antibioticus (Jones and Hopwood, 1984). The cloned DNA 
did not encode the phenoxazinone synthetase gene. 
Hybridisation studies using a cloned phenoxazinone gene have 
shown its presence in a silent form in other Streptomyces 
species indicating that silent genes might be common in this 
genus (Jones, 1989).
WHY CLONB GENES FOR THE BIOSYNTHESIS OF ANTIBIOTICS?
The analysis of cloned antibiotic biosynthetic genes can lead 
to the accumulation of a great deal of information about the 
biosynthesis of the product and its regulation. 
Identification of the location of, and the effect of 
elimination of, the regulatory regions will indicate whether 
the pathway is under positive or negative regulatory control, 
or both. The sequencing of the biosynthetic genes will give 
information on the number of genes involved and comparison of 
the sequences with those of genes with a known function in a 
gene bank might also indicate the nature of the reactions 
that the gene products are catalysing.
On a more applied side, the identification of the regulatory 
elements and how they act might lead to the engineering of an 
overproducing strain for example by removing negative 
regulatory elements or increasing the number of elements 
having a positive effect on antibiotic production in the gene 
cluster. Finally, the cloning of antibiotic genes and the
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application of the technology associated with it has led to 
the production of novel hybrid antibiotics (Hopwood et al., 
1985b).
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5.2. MATERIALS AND METHODS.
5.2.1. ATTEMPTED CLONING OF THE BIOSYNTHETIC GENES 
FOR DNJ.
ISOLATION OF 8 . LAVENDVLAE 31434 CHROMOSOMAL DNA.
S. lavendulae 31434 was inoculated as a spore suspension 
(lOOlil) into Tryptone Soya Broth (TSB, Oxoid) supplemented 
with 10% sucrose (30ml) . After incubation at 28°C, 190 rpm 
for 2 days, the culture was centrifuged at 3000 rpm in a 
Beckman JA20 rotor for 15 minutes and the pelleted mycelium 
washed with 10.3% sucrose (2x20ml). The "total" DNA was 
isolated according to the following method, adapted from 
procedure 4 of Hopwood et al (1985a). Wet mycelium (50-100mg) 
was suspended in lysozyme solution (see Appendix, 500^1) and 
incubated at 37°C for 30 minutes. 2% SDS solution was then 
added (250^1) and the solution vortexed. The solution was 
then repeatedly extracted with neutral phenol-chloroform (see 
Appendix) until no white precipitate was seen at the 
interface. 3M Sodium acetate pH 4.5 (0.1 volume) and ethanol 
(2 volumes) were then added and the mixture left at -20°C 
overnight to precipitate the DNA. The precipitated DNA was 
pelleted by centrifugation in a microfuge at high speed for 
10 minutes and then washed with 70% ethanol. After drying in 
a vacuum desiccator for 5 minutes, the pellet was dissolved
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in T.E. Buffer (see Appendix, 500(11) . All DNA preparations 
were inspected on a mini (25ml) agarose electrophoresis gel. 
Ones showing digestion of the chromosomal DNA were discarded. 
Chromosomal DNA samples were stored in T.E. buffer at 4°C.
QUANTIFICATION OF DNA.
The spectrophotometric assay of Hopwood et al (1985a) was 
used to quantify the DNA in the samples. Typically the 
solutions were found to contain 0.1 to 0.3)ig\)il.
PARTIAL DIGESTION OF 3 . LAVENDULAE 31434 DNA.
Sau 3a restriction endonuclease (8)il, 8U) was added to a
mixture of chromosomal DNA solution (100)il) and lOx E4 buffer 
(12)il) to start the digest. At 30 second intervals, aliquots 
(2 0 )1 1 ) were removed from the incubation and added to a 
mixture of 0.5M EDTA pH 8.0 (1)11) and agarose gel loading dye 
(2)il) . The samples were then run on a (0.8%) agarose gel 
(100ml) at 100V.
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A slice of agarose containing DNA fragments from the partial 
digest of 10Kb size and above was cut from the gel and the 
fragments eluted from this by the electrophoresis in dialysis 
tubing method of Hopwood et al (1985a). The fragments were 
stored at -20°C in T.E. buffer.
ISOLATION OF DNA FRAGMENTS FROM THE AGAROSE GEL.
ISOLATION OF PLASMID pIJ943.
Figure 5.1. Plasmid plJ943 (Hopwood et al., 1985a)
A strain of SCreptomyces lividans TK24 containing the plasmid 
pIJ943 (see Figure 5.1) was grown in YEME (see Appendix) 
supplemented with 5% PEG 6000 and 5^g\ml thiostrepton for 72h 
at 28°C, 190 rpm. The cells were then centrifuged for
201
30 minutes at 10 000 rpm in a Beckman JA10 rotor at 20°C and 
the mycelium washed with 10.3% sucrose. The pellet was 
resuspended in 25mM EDTA, 25mM Tris, 0.3M sucrose (45ml) and 
lysozyme (50mg) added. After incubation at 37°C for 60 
minutes, the appearance of the solution had become very 
mucosal and a freshly made up solution of 2% SDS in 0.3M 
sodium hydroxide (30ml) was added. Thorough but gentle mixing 
was followed by an incubation at 70°C for 15 minutes, until 
the solution had cleared. The solution was cooled and then 
the protein removed by repeated extractions with neutral 
phenol-chloroform. 3M Sodium acetate (7ml) and isopropanol 
(70ml) were then added, the mixture left at room temperature 
for 30 minutes and then centrifuged at 10 000 rpm for 20 
minutes. The supernatant was decanted and the pellet 
resuspended in TE buffer with lOmM sodium chloride. 10mg\ml 
heat-treated ribonuclease in 0.3M sodium acetate pH 4.8 
(50^1) was added and incubated at 37°C for a further 20 
minutes. 3M Sodium acetate (1ml) was added prior extraction 
once with neutral phenol-chloroform (5ml) and twice with 
chloroform:isoamyl alcohol (24:1, 2 x 5ml). Isopropanol 
(10ml) was added to the aqueous solution and after 10 minutes 
at room temperature it was centrifuged at 10 000 rpm for 10 
minutes. The pellet was dissolved in TE buffer (4.2ml) and 
10mg\ml ethidium bromide (0.5ml) and caesium chloride (4.7g) 
added. The resulting solution was then centrifuged in a Vti 
65 rotor at 20#C,
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55 000 rpm for 18h and the band containing the plasmid DNA 
removed from the gradient after this time. This fraction was 
then extracted with isoamyl alcohol (4 x 0.5ml) to remove the 
ethidium bromide and then the aqueous layer made up to 0.5ml 
with distilled water. Ethanol (two volumes) was then added 
and after an incubation at -20°C overnight, the precipitated 
DNA was pelleted by centrifugation in a microfuge at high 
speed for 10 minutes. The pelleted DNA was washed with 70% 
ethanol (0.5ml), dried in a vacuum desiccator for 5 minutes 
and redissolved in TE buffer (20*il). Plasmid was stored in TE 
buffer at -20°C.
LINEARISATION OF pIJ943 AND REMOVAL OF 3' PHOSPHATE 
GROUPS.
Plasmid pIJ943 in TE (5*ll, 15*ig) , 10 mg\ml ribonuclease
(lOjll) and Bgl II restriction endonuclease (50U) were 
incubated in 100*11 final volume of a suitable buffer at 37°C 
for lh. TE buffer (400*il) and Calf intestinal alkaline 
phosphatase (0.5U) added. After a further incubation of lh at 
37°C, the solution was extracted with neutral phenol- 
chloroform (500*il) and chloroform: isoamyl alcohol (24:1, 
500*11). 3M Sodium acetate pH 4.8 (50*il) and ethanol (1ml) 
were then added and the solution left at -20°C overnight to 
precipitate the DNA. The precipitated DNA was pelleted by 
centrifugation at high speed in a microfuge for 10 minutes
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and then washed with 70% ethanol before being redissolved in 
TE buffer (10|ll). The linearised plasmid was stored at -20°C 
in the TE buffer.
LIGATION OF 8. L A V ENDULAE 31434 DNA FRAGMENTS WITH THE 
LINEARISED pIJ943.
Ligation reactions typically contained linearised and 
phosphatase treated plasmid pIJ943 (0.25^g), and chromosomal 
fragments from S .lavendulae 31434 (l^g) in a final volume of 
50^1 including T4 DNA ligase (5U). The ligation was carried 
out at 17°C overnight and the ligation mixture then stored at 
-20°C until used for transformation.
PREPARATION OF S T R B P T O M Y C B S  L Z V I D A N S  TK24 
PROTOPLASTS.
S . lividans TK24 protoplasts were prepared according to the 
method of Hopwood et al (1985a) .
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Freshly prepared protoplasts were used for each 
transformation since a large proportion were found not to 
survive the freezing and thawing process.
The protoplasts were transformed with the ligation mixture 
according to the method of Hopwood et al (1985a) and were 
plated onto dried R5 (see Appendix) . After incubation for 24h 
at 30°C, the plates were overlayed with soft nutrient agar 
(SNA, see Appendix) supplemented with tyrosine and 100ng\ml 
thiostrepton.
Control transformations were also carried out using intact 
PIJ943 and also linearised pIJ943, both without any added 
chromosomal fragments.
TRANSFORMATION OF S . L I V I D A N S  TK24 PROTOPLASTS.
SCREENING FOR PRODUCTION OF NOJIRIMYCIN BY 
TRANSFORMANTS.
Colonies growing through the thiostrepton containing overlay 
and not producing the pigment melanin were picked off the 
regeneration plates and transferred to RASS (see Appendix) 
plates containing 50jig\ml thiostrepton. After incubation at 
30°C for 5 days, the spores were used to inoculate a 21cm x 
21cm square plate containing nutrient agar (200ml) . The plate 
was incubated at 30°C for 3 days and then overlayed with 70% 
nutrient agar seeded with Micrococcus luteus PCI 1001 (106
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CFU/ml) . After a further incubation at 30°C for 24h, the 
plate was inspected and colonies around which there was a 
zone of no M.luteus growth were investigated further.
BIOAUTOORAPHY, TRBHALASB INHIBITION AND GAS 
CHROMATOGRAPHIC INVESTIGATION.
Transformants giving a positive result in the above screen 
were grown in soyabean medium (30ml, see Appendix) for 4 days 
at 28°C, 109 rpm and then the cultures centrifuged to pellet 
the mycelium. The supernatants were subjected to the standard 
trehalase assay and gas chromatographic analysis, as 
described in Chapter 2, and to bioautographic analysis after 
TLC, as described in Chapter 3.
5.2.2. GENERATION OF BLOCKED MUTANTS.
MUTAGENESIS.
S.lavendulae 31434 spore suspension (7 x 100^1) was pelleted 
in a microfuge and then the supernatant removed and each 
pellet resuspended in sterile 0.2M phosphate buffer pH 7.0 
(lml). Ethyl methane sulphonic acid (EMS) was then added to
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give concentrations of between 0 and 3% EMS. The tubes were 
sealed and whirlimixed before being incubated at 37°C for lh. 
0.16m sodium thiosulphate (9ml) was then added to neutralise 
the EMS. Serial 1 in 10 dilutions were prepared for each of 
the seven samples and then each dilution plated onto nutrient 
agar in triplicate (3 x lOOjil). The plates were incubated at 
30°C for 3 days and then the colonies which had grown 
counted. The EMS concentration giving only 1% survivors, 
compared to the control without any EMS, was used for the 
screening.
SCREENING FOR BLOCKED MUTANTS.
The spore suspension treated with 3% EMS was diluted to give 
single colonies upon regeneration at 30°C on nutrient agar 
plates. Colonies growing on these plates were picked off and 
put onto RASS plates and incubated for 4 days or until 
sporing well. Spores from these were transferred onto 21cm x 
21cm square plates containing nutrient agar (200ml). After 
incubation overnight at 30°C, the plates were overlayed with 
70% nutrient agar (150ml) seeded with Micrococcus luteus 
PCI1001 (106 cfu\ml). After incubation at 30°C for 24h, those 
mutants without a ring of M.luteus growth inhibition around 
them were screened again by the same method but with a 3 day 
incubation replacing the overnight one described above. Those 
still giving no inhibition of M.luteus were grown in soyabean
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medium (30ml) for 4 days at 28°C, and then the culture 
supernatant subjected to bioassay and bioautography after TLC 
as described in Chapter 3.
FEEDING STUDIES WITH THE BLOCKED MUTANTS.
The blocked mutants detected in the above screens were 
streaked onto nutrient agar plates, three per plate in 
triangular arrangement, but not so that the growth would 
touch that of any of the others. These were incubated at 30°C 
for 3 days and then ovelayed with 70% nutrient agar seeded 
with Micrococcus luteus PCI1001 (106 cfu\ml). After a further 
incubation at 30°C for 24h, the plates were examined.
The feeding experiments were also carried out in liquid 
media. Pairs of the mutants were inoculated, in each 
combination, into soyabean medium (30ml) and incubated at 
28°C, 190 rpm for 4 days. The mycelium were then removed by 
centrifugation and the supernatant used for bioassay and 
bioautography with M. luteus after TLC separation as described 
in Chapter 3.
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5.3. RESULTS AND DISCUSSION.
ATTEMPTED CLONING OF THE BIOSYNTHETIC GENES FOR DNJ.
The lack of availability of information on the genetics or 
the biochemistry of, or mutants blocked in DNJ production 
meant that options for approaches to cloning the biosynthetic 
genes were limited. Although DNJ has no antibiotic activity, 
NJ, which has been shown to be a direct precursor of DNJ, 
has. It was initially planned to clone a resistance 
determinant to NJ and use that to probe a genomic library for 
the DNJ genes, assuming that they were clustered. However, 
the very limited availability of NJ which would be needed in 
significant amounts for screening for a resistant clone, 
coupled with the lack of sensitivity of non-producing 
Streptomyces strains tested with NJ made this approach 
unattractive. Even if enough NJ was available and a sensitive 
E.coli strain could be used as a host, the lack of 
sensitivity exhibited by Streptomyces could mean that they 
are not naturally sensitive and require no resistance 
determinant. Despite this, the bioactivity of NJ would 
provide a quicker method for screening for transformants 
harbouring genes for the DNJ pathway than would the trehalase 
assay for DNJ.
The only approach left was to try to clone the whole pathway 
into a heterologous non-producing host ad to screen 
transformants for NJ or DNJ production. Streptomyces lividans
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TK24 was chosen as the host. It did not produce either DNJ or 
NJ and does not possess a restriction system which would be 
able to degrade any foreign DNA introduced into it. The 
plasmid pIJ943, a single copy number plasmid of 20.6Kb was 
also chosen for the protocol. The advantage of using a low 
copy number plasmid is that these are generally more stable 
when carrying large fragments of inserted DNA than are higher 
copy number ones.
Transformation frequencies seen for the ligation mixture into 
S.lividans TK24 protoplasts were typically in the order of 10 
to 100 per ng of plasmid DNA, or around 10‘ 4 of the 
regenerated protoplasts. This is a low frequency in terms of 
the plasmid DNA, 107 per jig is quoted as a reasonable 
frequency for the transformation of S.lividans protoplasts 
(Jones, 1989). The proportion of regenerated protoplasts is 
not very low, indicating that the efficiency of the ligation 
and transformation procedures were generally not the main 
problem. If plasmid was probably being transformed into 
protoplasts which were then failing to regenerate, improving 
the regeneration frequency from around 1 0 - 5  would increase 
the number of transformants recovered. The cloning attempt 
was abandoned, for reasons which will be discussed later, 
before any attempt at improving the protoplast regeneration 
could take place.
Of the first 242 transformants isolated, inhibition of 
M.luCeus PCI1001 was seen by three, transformants 2J, 13L and 
13P. 2J was found to have an appearance very like that of
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TK24, growing as a white colony which developed a red, non- 
diffusable pigment, but the other two were much more like the 
TK24 with the pIJ943 plasmid which grew as a white colony and 
then made a dark blue pigment which diffused into the medium. 
When S.lividans TK24 was initially tested in the screening 
assay, it gave no positive effect, but when the TK24 strain 
harbouring the plasmid was tried, an inhibitory ring was seen 
around the colony (see figure 5.2).
Figure 5.2. inhibition of M.luteus by 2J and TK24 with 
PIJ943.
This result was highly unexpected since the plasmid contained 
no antibiotic determinants itself. There was the possibility 
that the presence of the plasmid in the cell was somehow 
causing the expression of a previously silent antibiotic
gene, an effect which is not unknown (Jones and Hopwood, 
1984), or that the plasmid is causing a change in the 
environment in the cell so that a previously ncn-antibiotic 
metabolite was being converted into an active form. As the 
presence of the blue pigment, which was not melanin since it 
was produced on RASS which contains no tyrosine, correlated 
well with the inhibition of the M.luteus, this was the main 
suspect. The isolation of resistant strains of M.luteus from 
within the zone of growth inhibition around the S. lividans 
containing the pIJ943 was then attempted so that they could 
be used for screening without the interference of the 
inhibition effect due to the pIJ943. However, no M.luteus 
colonies grew within the zones, which is unusual if an 
antibiotic is involved, and so it was assumed that the 
inhibition by pIJ943 is not due to an antibiotic but probably 
to some other effect such as a change in pH preventing the 
growth of the indicator organism. A change in pH could also 
explain the change in pigmentaion between the red of 
S . lividans TK24 without the plasmid and the blue with it. 
Alternatively, it may have been that the effect was due to 
the tyrosinase (melanin) gene in the pIJ943. If the M.luteus 
was a tyrosine auxotroph, then the breakdown of all of the 
tyrosine around the colony would also have resulted in no 
M.luteus growth. The result in the previously mel* 
transformants could have been to a loss of the insert in the 
melanin gene resulting in the restoration of an active 
tyrosinase. It was assumed that the two transformants
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producing the blue pigment were giving a positive result with 
M.luteus for the same reason as TK24 with the pIJ943 and so 
investigations on these strains were stopped but those on 2J 
were continued. The results are shown in Table 5.1.
2J TK24 ♦  pU943 TK24
Trahalasa
a ssa y
5 % 0 % 0 %
M.lutsus
b ioassay V -
G as
Chromatography
Table 5.1. Results of investigations on transformant 2J .
The results of the investigations on 2J show a pattern of 
results very similar to those seen for TK24 with pIJ943 and 
it is clear that the inhibition seen due to both of these 
strains is not due to nojirimycin. 2J shows no inhibition of 
M.luteus on the bioassay and although TK24*piJ943 does, this 
is at an rf on TLC (as shown by bioautography - see Figure 
5.3) which is very different to that seen for the NJ
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5.3> which is very different to that seen for the NJ 
standard. No significant activity was seen against trehalase 
by 2J was seen either. The inhibition seen due to 2J could 
possibly have been a weak version of the inhibition exhibited 
by TK24+plJ943 and indeed on prolonged culture, a slight blue 
coloration was seen around the substrate mycelium.
Figure 5.3. Bioautography of 2J fermentation supernatant.
It was also clear that this method was not suitable for 
screening for transformants in this system. It might be more 
applicable to a system involving a different plasmid, or for 
cloning back into blocked mutants, but its use here had to be 
abandoned. Time did not permit the setting up of another 
cloning strategy.
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BLOCKED MUTANTS
The same method as for the screening of the transformants was 
used to screen for mutants blocked in the biosynthesis of NJ. 
Spores of S .lavendulae 31434 were treated with the mutagen 
EMS at different concentrations and the one showing only 1% 
survival was screened for non-production of NJ. Spores were 
mutagenised instead of the mycelium,as this avoided the 
problem of having to fragment the mycelium into single cells 
before mutagenesis. As spores each contain only one copy of 
the genome, then any mutations cannot be masked by intact 
copies of the gene in other copies of the genome which might 
be present if incompletely fragmented mycelia were used.
After the primary screening of 2000 regenerated colonies with 
an overlay of M.luteus, after 24 h incubation, as shown in 
Figure 5.4, 39 putative blocked mutants were identified. When 
the incubation time was increased to 72h, prior to overlay, 
the 39 were reduced to only 8 , the ones
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which were eliminated at this stage probably just being 
slower growing mutants which did not produce the NJ until 
later than 24h incubation. The 8 remaining mutants were then 
grown in soyabean medium and the supernatant from the 
cultures tested for bioactivity. Out of these, 4 were still 
not producing an antibiotic compound and so were used for 
cross-feeding experiments.
Mutant feeding experiments were first carried out on agar and 
the results showed little evidence of cross-feeding. A small 
halo of M.luteus growth inhibition was seen around the end of 
the growth of mutant 191 which was closest to mutant IOC on 
one of the plates, but this was not repeated on the other 
plate where these two mutants met. The inhibition was 
accompanied by a brown coloration of the area around the 191 
growth where the inhibition was seen. None of the mutants 
isolates in this screen produced a pigment unless, as in this 
case, inhibition of M.luteus was also seen. Upon cross­
feeding in the liquid media, all of the cultures containing 
191 were coloured and all showed inhibition of M.luteus 
growth. Upon bioautography, it was clear that the inhibition 
in these cultures was due to NJ. In a culture containing only 
191, the same was seen showing that the inhibition in the 
others was due to a reversion of 191 to NJ production. No 
production of NJ was seen with any of the other crosses. 
These results are shown in figure 5.5.
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This lack of cross feeding may have been due Co all of Che 
mucancs having Cheir mucacions in Che same scruccural gene, 
or some regulacory elemenc. A mucacion in a regulacory 
elemenc could resulc in no NJ producción wichouc accually 
producing an incermediace which could feed an earlier blocked 
mucanc and resulc in NJ producción. Alcernacively, mucancs 
noc exporcing incermediaces would also noc cross feed, 
whichever genes are mucaced in chese mucancs, Che likelihood 
is ChaC Chey will be posicioned wich Che biosynchecic genes 
and so complemenCaCion of Che mucancs would possibly provide 
a handle on Che biosynchecic genes for cloning purposes. For 
any more Chan chis however, a more comprehensive sec of NJ 
blocked mucancs would be needed and alchough Che presenc work 
has noc provided Chis, ic does appear ChaC Che screen using 
dececcion of NJ by M.luteus is an easy and quick way Co 
screen for such mucancs.
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CONCLUSIONS
In this project, an enzymatic assay system for DNJ has been 
developed which avoids interference by NJ by chemically 
removing it from the sample to be assayed. NJ and DNJ inhibit 
a very similar range of enzymes and previous assay systems 
have only accounted for the presence of the other inhibitor 
in cultures by using an enzyme which is inhibited more 
strongly by one than the other (eg. Stein et al., 1984; Ezure 
et al., 1985). Pig kidney trehalase was used in this study. 
It was found to be inhibited by DNJ and NJ with Ki values of 
3.43 x 10" 6 and 2.6 x 10'5M respectively. The Km value for 
the hydrolysis of trehalase by this enzyme was found to be 
1.7mM, which compared well to the literature value of 2.ImM 
(Yonehara, 1987). The NJ was removed from samples by a heat 
and acid treatment and this allowed only the DNJ to be 
assayed. Results from this assay were comparable to those 
obtained from a gas chromatographic assay.
A known DNJ producer, S.lavendulae ATCC 31434 was obtained 
from the American Type Cultre Collection and the trehalase 
inhibition assay used to screen for other DNJ producers. 
S.subrutilus 445 was highlighted in the screen and found to 
produce both DNJ and DMJ. S.lavendulae also produces DMJ 
(Ezure et al., 1988).Comparison of the fermentation of 31434 
and 445 revealed temporal differences in the production of NJ 
by the two strains. Whereas 31434 produced NJ early on in the 
fermentation, and DNJ later when growth had stopped and any
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glucose in the medium had been much depleted, the production 
of both of these compounds by 445 was found to occur late in 
the fermentation.
Studies on the effects of culture conditions and nutrients on 
the production of DNJ in defined media showed that glucose, 
and starch were by far the best carbon sources for the 
biosynthesis and that proline was the best nitrogen source, 
of the ones tried. High levels of phosphate, ammonium 
sulphate and glucose were all found to supress the production 
of DNJ and the best initial pH for production in a batch 
culture was 7.5.
The biosynthetic pathway of DNJ and DMJ is closer to those of 
aminosugars in Streptomyces than the alkaloids produced by 
fungi. Glucose was shown to be the biosynthetic precursor to 
both DNJ and DMJ and a pathway hypothesised which proceeds 
via a glucose to fructose isomerisation. After amination and 
oxidation, épimérisation of NJ B produces NJ. The NJ and NJ B 
are dehydroxylated at C-l to yield DNJ and DMJ respectively. 
The importance of glucose and starch as carbon sources can be 
better understood in the light of these findings on the 
biosynthetic pathway as they provide the correct precursors 
and enzymatic environment for the biosynthesis of DNJ. 
Although glucose supresses DNJ production when it is present 
in high concentrations, it is still detectable when 
biosynthesis starts. DNJ titres stop rising when glucose 
becomes undetectable (see Figure 3.6, Fermentation of 31434 
in MGA). The glucose consumed during the production phase
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then probably goes partly to providing the metabolic energy 
for the cells but also to provide the precursors for the 
biosynthesis. The presence of glucose or starch early in the 
fermentation would ensure that all of the enzymes needed for 
the metabolism of glucose, including glucose isomerase which 
is hypothesised to be involved in the biosynthesis of DNJ 
(see Chapter 4), would be induced and present in the cell 
when DNJ biosynthesis starts. The finding that starch is not 
as good as glucose could reflect the fact that it provides a 
slightly less accessible supply of glucose units.
Attempts were also made at cloning the biosynthetic genes for 
DNJ, but interference with the screening assay caused by the 
presence of the cloning plasmid led to its abandonment. 
Mutants blocked in the biosynthesis of NJ were isolated 
though and will hopefully be used in genetic and biochemical 
investigations into the biosynthesis of DNJ which are being 
continued in the group.
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APPENDIX
OATMEAL AGAR (per litre)
20g Fine Oatmeal 
lg Yeast Extract 
15g Agar
SOYABEAN MEDIUM
2% Soluble Starch 
1% Soyabean Meal 
0.05% KCl 
0.05% MgS04 .7H20 
0.5% NaCl
\
0.2% NaN03 
0.35% CaC03 
pH 7.4
In some of the fermentations, the soluble starch in the above 
recipe was exchanged for D-glucose of various concentrations.
MINIMAL GLUCOSE MEDIUM (MGA) (per litre)
2g D-Glucose 
lg L-Asparagine 
0 .5g K2HPO4 
0.5g MgS04 .7H20
lml Trace Element Solution (T.E.S.) 
pH 7.4
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T.B.S .
1% FeS04 .7H20 
0.1% CuS04 .5H20 
0.1% ZnS04 .7H2O
ISP4 (par litre)
lOg Soluble Starch
lg K2HP04
lg MgS04 .7H20
lg NaCl
2g (NH4)2S04
2g CaC03
lml T.E.S.
Unadjusted pH 7.0-7.4
T.I.8.
0.1% FeS04 .7H2O 
0.1% MnCl2 .4H20 
0.1% ZnS04 .7H20
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lOg Glycerol 
lg L-Asparagine 
lg K2HP04 
lml T.E.S.
pH 7.4
T.l.8.
0.1% FeS04 .7H20 
0.1% MnCl2 .4H20 
0.1% ZnS04 .7H20
ZSP7 (per litre)
15g Glycerol 
0.5g Tyrosine 
lg L-Asparagine 
0.5g K2HP04 
0.5g MgS0 4-7H20  
0.5g NaCl 
lml T.E.S. 
pH 7.3
T.B.S.
0.1% FeS0 4.7H20  
0.1% MnCl2 .4H20 
0 .1 % ZnS0 4.7H20
ISP5 (per litre)
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4g D-Glucose 
lg L-Asparagine 
lg K2HP04 
0.5g MgS0 4.7H20  
5g NaCl 
2g NaN03 
lml T.E.S.
pH 7.4
ST01 (par litra)
2.2% FeCl2 
0.5% ZnCl2 
0.25% MnCl2 .4H20 
0.105% CuCl2 .2H20 
0.15 Nal 
0.05% CaCl2 .6H20
LYSOZYME SOLUTION
2mg/ml Lysozyme
50)ig/ml Ribonucléase (heat-treated) 
0.3M Sucrose 
25mM Tris (pH 8.0)
25mM EDTA
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NEUTRAL PHENOL-CHLOROFORM
8-Hydroxyquinoline (0.05g) was added to phenol crystals (50g) 
and enough 0.1M tris buffer (pH 8.0) added to dissolve the 
solids. The upper, aqueous, layer was decanted and to the 
lower layer an aqual volume of chloroform:isoamyl alcohol 
(24:1) was added. This reagent was stored at 4°C in the dark.
SOFT NUTRIENT AGAR.
8g Difco nutrient broth
5g Bacto agar
1000ml Distilled water
100ml Tyrosine suspension (1.5g/L)
YENS .
3g Difco yeast extract 
5g Difco bacto-peptone 
3g Oxoid malt extract 
lOg D-Glucose 
340g Sucrose 
1000ml Distilled water.
After autocalving, add;
2ml MgCl2. 6H20 (2.5M)
25ml Glycine (20%)
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All slashes included in concentration units in the text are 
orientated in the wrong direction.
e.g. mg\ml should read mg/ml.
